Life sciences, Urology

前立腺癌

Active Surveillance for Localized Prostate Cancer: A Retrospective Single-Center Study., Akihiko Sugino; Yoshiyuki Miyazawa; Shun Nakazawa; Yusuke Tsuji; Yuji Fujizuka; Seiji Arai; Yoshitaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, Mar. 2026, International journal of urology : official journal of the Japanese Urological Association, 33, 3, e70433, Scientific journal

Computed Tomography-Guided Biopsy of a Ureteral Urothelial Carcinoma Mimicking a Submucosal Bladder Tumor at the Ureterovesical Junction., Akira Ohtsu; Yuji Fujizuka; Seiji Arai; Masakazu Yamaguchi; Hiroyuki Tokue; Tatsuro Maehara; Takanori Shimizu; Yoshitaka Sekine; Hayato Ikota; Kazuhiro Suzuki, Jan. 2026, IJU case reports, 9, 1, e70132, Scientific journal

Intermittent Recurrence of Ureterosciatic Hernia After Spontaneous Resolution, Complicated by Emphysematous Pyelonephritis., Akira Ohtsu; Keisuke Hori; Seiji Arai; Yuki Morimura; Ayaka Igarashi; Yuji Fujizuka; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, Nov. 2025, IJU case reports, 8, 6, 591, 595, Scientific journal

A Qualitative Review of Clinical Decision-Making Using [99mTc]Tc-Mercaptoacetyltriglycine Renal Scintigraphy in Patients With Malignant Ureteral Obstruction., Akira Ohtsu; Seiji Arai; Tirso Peña; Yusuke Otani; Mai Onose-Kato; Yusuke Tsuji; Tatsuhiro Sawada; Yuji Fujizuka; Yoshitaka Sekine; Hidekazu Koike; Tetsuya Higuchi; Kazuhiro Suzuki, 12 Oct. 2025, Journal of medical radiation sciences, Scientific journal

phiはPSAよりも早期に前立腺癌を検出できるか?5年間の縦断的検診コホートからの知見, 関根 芳岳; 藤塚 雄司; 中澤 峻; 辻 裕亮; 大津 晃; 宮澤 慶行; 新井 誠二; 野村 昌史; 小池 秀和; 松井 博; 伊藤 一人; 鈴木 和浩, Oct. 2025, 日本癌治療学会学術集会抄録集, 63回, O50, 2

Small cell bladder carcinoma with a high tumor mutational burden responding to sequential cisplatin-etoposide and pembrolizumab: a case report., Akira Ohtsu; Yuji Fujizuka; Seiji Arai; Takanori Shimizu; Yuki Ozawa; Shun Imanari; Masakazu Yamaguchi; Tomohiro Agata; Mai Onose; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Nobuaki Ohtake; Kazuhiro Suzuki, Oct. 2025, International cancer conference journal, 14, 4, 440, 445, Scientific journal

;;;;;;;;;;, Aug. 2025, 40, 2, 174, 174

Aug. 2025, 40, 2, 174, 174

Jul. 2025, 38, 臨増, 780, 780

Jul. 2025, 38, 臨増, 796, 796

Jul. 2025, 38, 臨増, 804, 804

Jul. 2025, 38, 臨増, 804, 804

Jul. 2025, 38, 臨増, 806, 806

Jul. 2025, 38, 臨増, 811, 811

Jul. 2025, 38, 臨増, 812, 812

Jul. 2025, 38, 臨増, 814, 814

Jul. 2025, 38, 臨増, 823, 823

Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia., Masanori Aoki; Hiroshi Matsui; Sota Kurihara; Nobuaki Ohtake; Shun Nakazawa; Yusuke Tsuji; Yuji Fujizuka; Seiji Arai; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Kazuhiro Suzuki; Yoshiyuki Miyazawa, May 2025, Anticancer research, 45, 5, 2195, 2204, Scientific journal

The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivo., Yoshitaka Sekine; Daisuke Oka; Akira Ohtsu; Hiroshi Nakayama; Takeshi Miyao; Yoshiyuki Miyazawa; Seiji Arai; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 21 Mar. 2025, BMC cancer, 25, 1, 521, 521, Scientific journal

Utility of Combining Prostate Health Index and Magnetic Resonance Imaging for the Diagnosis of Prostate Cancer., Yoshitaka Sekine; Yuji Fujizuka; Shun Nakazawa; Yusuke Tsuji; Akira Ohtsu; Yoshiyuki Miyazawa; Seiji Arai; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Kei Shibuya; Kazuto Ito; Hayato Ikota; Kazuhiro Suzuki, 17 Mar. 2025, International journal of urology : official journal of the Japanese Urological Association, 32, 6, Scientific journal

Feb. 2025, 75, 1, 83, 83

Afebrile tuberculous prostatic abscess with rectal fistula after intravesical Bacillus Calmette-Guérin immunotherapy., Tatsuhiro Sawada; Ayaka Igarashi; Seiji Arai; Akira Ohtsu; Yuji Fujizuka; Shun Nakazawa; Yoshitaka Sekine; Hidekazu Koike; Yosuke Furuya; Kazuhiro Suzuki, Jan. 2025, IJU case reports, 8, 1, 69, 72, Scientific journal

Analysis of urinary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospective study, Yoshiyuki Miyazawa; Hiroshi Nakayama; Hidemasa Kawamura; Yuhei Miyasaka; Masahiro Onishi; Takuya Kaminuma; Yoshitaka Sekine; Hiroshi Matsui; Tatsuya Ohno; Kazuhiro Suzuki, 19 Nov. 2024, Radiation Oncology, 19, 1, Scientific journal

;;;;;;;;;, Nov. 2024, 38回, P14, 1

Nov. 2024, 74, 4, 318, 318

Nov. 2024, 74, 4, 318, 319

前立腺癌診断における"phiファーストアプローチ"による不要な前立腺生検の回避, 関根 芳岳; 藤塚 雄司; 中澤 峻; 辻 裕亮; 大津 晃; 宮澤 慶行; 新井 誠二; 野村 昌史; 小池 秀和; 松井 博; 渋谷 圭; 伊藤 一人; 鈴木 和浩, Oct. 2024, 日本癌治療学会学術集会抄録集, 62回, O21, 2

化学療法が奏効した腫瘍遺伝子変異最高スコア膀胱小細胞癌に免疫療法を施行した一例, 大津 晃; 新井 誠二; 藤塚 雄司; 小澤 優樹; 今成 駿; 松本 昴樹; 山口 将和; 縣 知弘; 小野瀬 舞; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 大竹 伸明; 鈴木 和浩, Oct. 2024, 日本癌治療学会学術集会抄録集, 62回, P7, 8

前立腺癌に対する重粒子線治療16回照射の長期治療成績, 大西 真弘; 河村 英将; 宮澤 慶行; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩; 大野 達也, Oct. 2024, 日本癌治療学会学術集会抄録集, 62回, O24, 2

傾向スコアマッチング法を用いたRARPと重粒子線治療後の性機能QOLスコア比較研究, 宮澤 慶行; 小池 秀和; 河村 英将; 岡 大祐; 久保 亘輝; 大西 真弘; 宮坂 勇平; 周東 孝浩; 関根 芳岳; 松井 博; 大野 達也; 鈴木 和浩, Oct. 2024, 日本癌治療学会学術集会抄録集, 62回, O24, 5

TMB-high膀胱小細胞癌にペムブロリズマブ療法を行った一例(A case of TMB-high small cell carcinoma of the bladder treated with pembrolizumab), 大津 晃; 新井 誠二; 関根 芳岳; 鈴木 和浩, Sep. 2024, 日本癌学会総会記事, 83回, P, 3247

Aug. 2024, 39, 2, 211, 211

;;;;;;;;;;, Aug. 2024, 74, 3, 227, 227

Jul. 2024, 33回, 40, 40

Jun. 2024, 37, 6, 554, 554

Jun. 2024, 37, 6, 554, 555

Jun. 2024, 37, 臨増, 728, 728

Jun. 2024, 37, 臨増, 737, 737

Jun. 2024, 37, 臨増, 757, 757

Jun. 2024, 37, 臨増, 766, 766

Jun. 2024, 37, 臨増, 768, 768

Jun. 2024, 37, 臨増, 773, 773

May 2024, 57, Suppl.1, 742, 742

May 2024, 57, Suppl.1, 742, 742

May 2024, 57, Suppl.1, 859, 859

;;;;;;;;;;;;;;;;;;;;;;;, May 2024, 74, 2, 183, 183

;;;;;;;;;;;;;;;;;;;;;, May 2024, 74, 2, 184, 184

Carbon Ion Radiation Therapy for Nonmetastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis, Yuhei Miyasaka; Hidemasa Kawamura; Hiro Sato; Nobuteru Kubo; Hiroyuki Katoh; Hitoshi Ishikawa; Hiroshi Matsui; Yoshiyuki Miyazawa; Kazuto Ito; Kazuhiro Suzuki; Tatsuya Ohno, Apr. 2024, Advances in Radiation Oncology, 9, 4, 101432, 101432, Scientific journal

Comparison of sexual function after robot-assisted radical prostatectomy and carbon-ion radiotherapy for Japanese prostate cancer patients using propensity score matching., Yoshiyuki Miyazawa; Hidekazu Koike; Daisuke Oka; Hidemasa Kawamura; Nobuteru Kubo; Yuhei Miyasaka; Masahiro Onishi; Takahiro Syuto; Yoshitaka Sekine; Hiroshi Matsui; Tatsuya Ohno; Kazuhiro Suzuki, 05 Mar. 2024, BMC cancer, 24, 1, 300, 300, Scientific journal

Feb. 2024, 57回, 237, 237

Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression., Daisuke Oka; Yoshitaka Sekine; Yusuke Tsuji; Hiroshi Nakayama; Yoshiyuki Miyazawa; Seiji Arai; Hidekazu Koike; Kazuhiro Suzuki, Jan. 2024, Anticancer research, 44, 1, 93, 98, Scientific journal

Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells., Yoshiyuki Miyazawa; Yoshitaka Sekine; Daisuke Oka; Shun Nakazawa; Yusuke Tsuji; Hiroshi Nakayama; Kazuhiro Suzuki, Dec. 2023, Anticancer research, 43, 12, 5377, 5386, Scientific journal

;;;;;;;;;, Nov. 2023, 37回, P, 11

;;;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 318, 318

Predictive models of long‐term survival outcomes following radical cystectomy, Akira Ohtsu; Seiji Arai; Yuji Fujizuka; Yoshiyuki Miyazawa; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 30 Oct. 2023, Cancer Medicine, Scientific journal

前立腺癌診断における、[-2]proPSA関連インデックスとPI-RADSとの比較, 関根 芳岳; 藤塚 雄司; 辻 裕亮; 青木 雅典; 大津 晃; 宮澤 慶行; 新井 誠二; 野村 昌史; 小池 秀和; 松井 博; 渋谷 圭; 伊藤 一人; 鈴木 和浩, Oct. 2023, 日本癌治療学会学術集会抄録集, 61回, O9, 1

進行性腎細胞癌に対してアベルマブ・アキシチニブ併用療法施行した2症例, 野村 昌史; 加藤 舞; 辻 裕亮; 前野 佑太; 中野 裕美; 金山 あずさ; 澤田 達宏; 青木 雅典; 大津 晃; 宮澤 慶行; 藤塚 雄司; 新井 誠二; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Oct. 2023, 日本癌治療学会学術集会抄録集, 61回, P4, 2

エンフォルツマブ・ベドチンの群馬大学の初期使用経験からみた有害事象について, 藤塚 雄司; 新井 誠二; 大津 晃; 前野 佑太; 辻 裕亮; 加藤 舞; 澤田 達宏; 金山 あずさ; 青木 雅典; 宮澤 慶行; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Oct. 2023, 日本癌治療学会学術集会抄録集, 61回, P24, 3

膀胱憩室術後、後腹膜に発生した尿路上皮がんの一例, 大津 晃; 新井 誠二; 藤塚 雄司; 宮澤 慶行; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Oct. 2023, 日本癌治療学会学術集会抄録集, 61回, P26, 3

回腸導管に生じた静脈瘤出血に対して画像下治療をおこなった肝硬変患者の一例, 櫻井 彩夏; 大津 晃; 新井 誠二; 青木 雅典; 池谷 美穂; 徳江 浩之; 堀 慶典; 藤塚 雄司; 関根 芳岳; 小池 秀和; 鈴木 和浩, Oct. 2023, 日本癌治療学会学術集会抄録集, 61回, P26, 1

群馬大学重粒子線医学センターにおける高リスク前立腺癌に対する重粒子線治療, 松井 博; 河村 英将; 大西 真弘; 安達 彰子; 岡野 奈緒子; 宮澤 慶行; 藤塚 雄司; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 鈴木 和浩; 大野 達也, Oct. 2023, 日本癌治療学会学術集会抄録集, 61回, P27, 2

Successful embolization of subcutaneous mesenteric varices within an ileal conduit in a patient with liver cirrhosis, Ayaka Sakurai; Akira Ohtsu; Seiji Arai; Masanori Aoki; Miho Ikeya; Hiroyuki Tokue; Keisuke Hori; Yuji Fujizuka; Yoshitaka Sekine; Hidekazu Koike; Kazuhiro Suzuki, 20 Sep. 2023, IJU Case Reports, Scientific journal

尿路上皮癌に対するFGFR阻害薬の耐性獲得後の新規治療薬の検討(Investigation of new therapeutic agents for FGFR inhibitor resistant urothelial cancer), 澤田 達宏; 新井 誠二; 大津 晃; 辻 裕亮; 前野 佑太; 加藤 舞; 関根 芳岳; 鈴木 和浩, Sep. 2023, 日本癌学会総会記事, 82回, 1065, 1065

Aug. 2023, 36, 臨増, 859, 859

Aug. 2023, 36, 臨増, 863, 863

Aug. 2023, 36, 臨増, 876, 876

Aug. 2023, 73, 3, 199, 205

Aug. 2023, 36, 臨増, 863, 863

Aug. 2023, 73, 3, 199, 205

Aug. 2023, 36, 臨増, 859, 859

Aug. 2023, 36, 臨増, 863, 863

Aug. 2023, 36, 臨増, 863, 863

Aug. 2023, 36, 臨増, 876, 876

Jul. 2023, 32回, 35, 35

Jul. 2023, 32回, 42, 42

Relationship Between Adherent Perinephric Fat and Sex Hormone Levels in Serum and Fat in Patients Undergoing Robotic-Assisted Partial Nephrectomy: A Prospective Study, Yoshiyuki Miyazawa; Masashi Nomura; Nozomi Matsumura; Yuji Fujizuka; Yoshitaka Sekine; Yusuke Tsuji; Takahiro Syuto; Hideaki Yokoo; Kazuhiro Suzuki, Jul. 2023, JU Open Plus, 1, 7, Scientific journal

;, Jun. 2023, 81, 増刊6 臨床前立腺癌学, 348, 352

A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS., Yoshiyuki Miyazawa; Toshiyuki Nakamura; Yutaka Takezawa; Nobuaki Shimizu; Yasushige Matsuo; Haruyuki Ogura; Tomoyuki Takei; Yoshitaka Sekine; Seiji Arai; Kazuhiro Suzuki, Jun. 2023, The Prostate, 83, 8, 759, 764, Scientific journal

The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide., Yoshiyuki Miyazawa; Keisuke Hori; Yusuke Tsuji; Yoshitaka Sekine; Seiji Arai; Yuji Fujizuka; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, 31 May 2023, International journal of urology : official journal of the Japanese Urological Association, 30, 10, Scientific journal

Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report., Akira Ohtsu; Seiji Arai; Yuji Fujizuka; Reon Fukuda; Keisuke Hori; Yuki Morimura; Rintaro Kawahara; Takuya Shiraishi; Hiroomi Ogawa; Yoshiyuki Miyazawa; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, 10 May 2023, BMC urology, 23, 1, 88, 88, Scientific journal

May 2023, 56, Suppl.1, 763, 763

May 2023, 73, 2, 179, 179

May 2023, 73, 2, 179, 180

May 2023, 73, 2, 181, 181

May 2023, 73, 2, 181, 181

May 2023, 73, 2, 179, 179

May 2023, 73, 2, 179, 180

May 2023, 73, 2, 181, 181

Carbon‐ion radiotherapy for inoperable upper tract ureteral cancer, Tatsuji Mizukami; Hidemasa Kawamura; Nobuteru Kubo; Hiro Sato; Masahiro Kawahara; Akiko Adachi; Hiroshi Matsui; Kazuhiro Suzuki; Jun‐ichi Saitoh; Takashi Nakano; Tatsuya Ohno, 23 Apr. 2023, Asia-Pacific Journal of Clinical Oncology, 20, 3, 365, 371, Scientific journal

前立腺癌診断マーカーとしての[-2]proPSA関連インデックスの有用性の検討(Availability of [-2]proPSA related indices in a diagnosis of prostate cancer), 関根 芳岳; 須藤 佑太; 藤塚 雄司; 辻 裕亮; 青木 雅典; 大津 晃; 齋藤 智美; 宮澤 慶行; 新井 誠二; 野村 昌史; 小池 秀和; 松井 博; 鈴木 和浩, Apr. 2023, 日本泌尿器科学会総会, 110回, AOP04, 03

群馬大学におけるエンフォルツマブベドチンの初期使用経験(Initial experience of Enfortumab Vedtin at Gunma University Hospital), 藤塚 雄司; 新井 誠二; 大津 晃; 須藤 佑太; 澤田 達宏; 青木 雅典; 齋藤 智美; 宮澤 慶行; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Apr. 2023, 日本泌尿器科学会総会, 110回, PP21, 01

COVID-19感染により初期診断および治療が遅れた2症例(Two cases of delayed initial diagnosis and treatment due to COVID-19 infection), 齋藤 智美; 石尾 典子; 堀 慶典; 福田 怜雄; 青木 雅典; 大津 晃; 藤塚 雄司; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Apr. 2023, 日本泌尿器科学会総会, 110回, PP70, 02

非転移性去勢抵抗性前立腺癌の重粒子線治療の後向き解析(Retrospective analysis of carbon ion radiotherapy for nonmetastatic castration-resistant prostate cancer), 河村 英将; 宮坂 勇平; 大西 真弘; 安達 彰子; 久保 亘輝; 岡野 奈緒子; 宮澤 慶行; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩; 大野 達也, Apr. 2023, 日本泌尿器科学会総会, 110回, OP49, 01

前立腺癌術後再発に対するIMRTを用いた救済放射線治療の治療成績(Clinical results of salvage intensity-modulated radiation therapy after radical prostatectomy), 大西 真弘; 河村 英将; 小池 秀和; 松井 博; 関原 哲夫; 羽鳥 基明; 大竹 伸明; 福間 裕二; 長谷川 正俊; 鈴木 和浩; 大野 達也, Apr. 2023, 日本泌尿器科学会総会, 110回, OP51, 04

前立腺癌診断マーカーとしての[-2]proPSA関連インデックスの有用性の検討(Availability of [-2]proPSA related indices in a diagnosis of prostate cancer), 関根 芳岳; 須藤 佑太; 藤塚 雄司; 辻 裕亮; 青木 雅典; 大津 晃; 齋藤 智美; 宮澤 慶行; 新井 誠二; 野村 昌史; 小池 秀和; 松井 博; 鈴木 和浩, Apr. 2023, 日本泌尿器科学会総会, 110回, AOP04, 03

ロボット鏡視下腎部分切除術における腎周囲固着脂肪と血中内、組織内性ホルモン濃度の関係(前向き観察研究)(The relationship between adherent perinephric fat and sex hormone levels in serum and fat tissue of patients treated by RAPN; prospective study), 宮澤 慶行; 野村 昌史; 周東 孝浩; 藤塚 雄司; 関根 芳岳; 辻 裕亮; 加藤 舞; 前野 佑太; 澤田 達宏; 新井 誠二; 小池 秀和; 松井 博; 鈴木 和浩, Apr. 2023, 日本泌尿器科学会総会, 110回, OP15, 05

非転移性去勢抵抗性前立腺癌の重粒子線治療の後向き解析(Retrospective analysis of carbon ion radiotherapy for nonmetastatic castration-resistant prostate cancer), 河村 英将; 宮坂 勇平; 大西 真弘; 安達 彰子; 久保 亘輝; 岡野 奈緒子; 宮澤 慶行; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩; 大野 達也, Apr. 2023, 日本泌尿器科学会総会, 110回, OP49, 01

去勢抵抗性前立腺癌患者における新規マーカー[-2]proPSAのバイオロジーと有用性の検討(Biology and usefulness of [-2]proPSA as a prognostic marker in CRPC patients), 宮澤 慶行; 堀 慶典; 辻 裕亮; 加藤 舞; 野村 恵; 斎藤 智美; 藤塚 雄司; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Apr. 2023, 日本泌尿器科学会総会, 110回, OP70, 03

群馬大学におけるエンフォルツマブベドチンの初期使用経験(Initial experience of Enfortumab Vedtin at Gunma University Hospital), 藤塚 雄司; 新井 誠二; 大津 晃; 須藤 佑太; 澤田 達宏; 青木 雅典; 齋藤 智美; 宮澤 慶行; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Apr. 2023, 日本泌尿器科学会総会, 110回, PP21, 01

Feb. 2023, 73, 1, 97, 97

Feb. 2023, 73, 1, 97, 97

Feb. 2023, 73, 1, 98, 98

Feb. 2023, 73, 1, 99, 100

Feb. 2023, 73, 1, 97, 97

Feb. 2023, 73, 1, 97, 97

Feb. 2023, 73, 1, 98, 98

Feb. 2023, 73, 1, 99, 100

;;;;;;;;;;;;;;;;;;;, Jan. 2023, 56, 1, 19, 22

Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin., Yoshiyuki Miyazawa; Takanori Shimizu; Yoshitaka Sekine; Seiji Arai; Akira Ohtsu; Yuji Fujizuka; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, Jan. 2023, IJU case reports, 6, 1, 37, 40

Nov. 2022, 72, 4, 424, 424

;;;;;;;;;, Nov. 2022, 36回, AP, 4

Nov. 2022, 72, 4, 424, 424

;;;;;;;;, Oct. 2022, 9, 2, 191, 193

99mTc-MAG3腎シンチグラフィーは腫瘍性尿管閉塞ドレナージの腎機能改善を予測する, 大津 晃; 新井 誠二; 金山 あずさ; 野村 恵; 斎藤 智美; 澤田 達宏; 須藤 佑太; 青木 雅典; 宮澤 慶行; 藤塚 雄司; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Oct. 2022, 日本癌治療学会学術集会抄録集, 60回, O4, 2

群馬大学における前立腺癌に対する重粒子線治療, 松井 博; 河村 英将; 大西 真弘; 安達 彰子; 久保 亘輝; 岡野 奈緒子; 宮澤 慶行; 藤塚 雄司; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 鈴木 和浩; 大野 達也, Oct. 2022, 日本癌治療学会学術集会抄録集, 60回, O38, 1

ホルモン非依存性前立腺癌細胞株における、スタチン併用によるX線治療効果への影響, 関根 芳岳; 岡 大祐; 中山 紘史; 宮澤 慶行; 新井 誠二; 小池 秀和; 松井 博; 鈴木 和浩, Oct. 2022, 日本癌治療学会学術集会抄録集, 60回, O73, 2

当院における進行性腎癌に対するペムブロリズマブ・レンバチニブ併用療法の初期経験, 野村 昌史; 金山 あずさ; 澤田 達宏; 野村 恵; 齋藤 智美; 須藤 佑太; 青木 雅典; 大津 晃; 宮澤 慶行; 藤塚 雄司; 新井 誠二; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Oct. 2022, 日本癌治療学会学術集会抄録集, 60回, P28, 5

去勢抵抗性前立腺癌患者における新規マーカー[-2]proPSAのバイオロジーと有用性の検討, 宮澤 慶行; 関根 芳岳; 新井 誠二; 加藤 舞; 辻 裕亮; 澤田 達宏; 須藤 佑太; 大津 晃; 青木 雅典; 齋藤 智美; 藤塚 雄司; 野村 昌史; 小池 秀和; 松井 博; 鈴木 和浩, Oct. 2022, 日本癌治療学会学術集会抄録集, 60回, P49, 6

異なる転機を辿った自己導尿患者に発生した浸潤性膀胱癌, 加藤 舞; 新井 誠二; 岡 大祐; 大木 亮; 古谷 洋介; 須藤 佑太; 佐々木 隆文; 大津 晃; 藤塚 雄司; 宮澤 慶行; 関根 芳岳; 小池 秀和; 柴田 康博; 伊藤 一人; 鈴木 和浩, Oct. 2022, 日本癌治療学会学術集会抄録集, 60回, P51, 5

Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study., Hiroji Uemura; Kazuki Kobayashi; Akira Yokomizo; Shiro Hinotsu; Shigeo Horie; Yoshiyuki Kakehi; Norio Nonomura; Osamu Ogawa; Mototsugu Oya; Kazuhiro Suzuki; Atsushi Saito; Keiko Asakawa; Satoshi Uno; Seiji Naito, 10 Aug. 2022, International journal of clinical oncology, 27, 10, Scientific journal

Aug. 2022, 16, 2, 149, 156

Aug. 2022, 35, 8, 860, 861

;;;;, Aug. 2022, 35, 8, 909, 911

;;;;;;;;;;;;;;;;;;;;;, Aug. 2022, 72, 3, 295, 295

;;;;;;;;;;;;;;;;;;;;;;, Aug. 2022, 72, 3, 295, 295

;;;;;;;;;;;;;;;;;;;;;;, Aug. 2022, 72, 3, 296, 296

Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells, Akira Ohtsu; Seiji Arai; Tatsuhiro Sawada; Mai Kato; Yuta Maeno; Yoshiyuki Miyazawa; Yuji Fujizuka; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, Aug. 2022, Biochemical and Biophysical Research Communications, Scientific journal

May 2022, 55, Suppl.1, 469, 469

May 2022, 55, Suppl.1, 516, 516

May 2022, 55, Suppl.1, 674, 674

May 2022, 55, Suppl.1, 775, 775

Apr. 2022, 98, 1, 312, 312

Apr. 2022, 9, 1, 35, 40

Apr. 2022, 9, 1, 35, 40

Feb. 2022, 72, 1, 119, 119

Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer., Hiroshi Nakayama; Yoshitaka Sekine; Daisuke Oka; Yoshiyuki Miyazawa; Seiji Arai; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Feb. 2022, The Prostate, 82, 3, 314, 322, Scientific journal

;;;;, Jan. 2022, 35, 1, 27, 31

Variants in HOXB13, G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men., Sota Kurihara; Hiroshi Matsui; Nobuaki Ohtake; Masanori Aoki; Yoshitaka Sekine; Seiji Arai; Hidekazu Koike; Kazuhiro Suzuki; Yoshiyuki Miyazawa, 2022, Cancer diagnosis & prognosis, 2, 5, 542, 548, Scientific journal

Changes in Renal Function of Patients With Prostate Cancer: Focus on Androgen Deprivation Therapy., Yoshiyuki Miyazawa; Yoshitaka Sekine; Seiji Arai; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, 2022, Cancer diagnosis & prognosis, 2, 6, 686, 690, Scientific journal

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study., Hiroji Uemura; Kazuki Kobayashi; Akira Yokomizo; Shiro Hinotsu; Shigeo Horie; Yoshiyuki Kakehi; Seiji Naito; Norio Nonomura; Osamu Ogawa; Mototsugu Oya; Kazuhiro Suzuki; Atsushi Saito; Satoshi Uno; Hideyuki Akaza, Jan. 2022, BJUI compass, 3, 1, 26, 36, Scientific journal

;;;;;;;, Dec. 2021, 109回, PP13, 05

;;;;;;;;;;;, Dec. 2021, 109回, PP65, 01

転移性去勢抵抗性前立腺癌と原発腫瘍で認めたドライバー遺伝子との関連(Metastatic castration-resistant prostate cancer remains dependent on oncogenic drivers found in primary tumors), 新井 誠二; Einstein David; 鈴木 和浩; Balk Steven; Sowalsky Adam; Russo Joshua, Dec. 2021, 日本泌尿器科学会総会, 109回, ISA04, 04

;;;;;;;;;;;;, Dec. 2021, 109回, OP31, 07

;;;;;;;;;;, Dec. 2021, 109回, PP01, 04

;;;;;;;;;;;;, Dec. 2021, 109回, PP05, 01

;;;;;;;;;;;;, Dec. 2021, 109回, PP08, 07

;;;;;;, Dec. 2021, 109回, PP12, 02

;;;;;;;;;;;;, Dec. 2021, 109回, PP13, 04

;;;;;;;;;;;, Dec. 2021, 109回, PP68, 04

;;;;;;;;;;;;, Dec. 2021, 109回, PP34, 01

Carbon ion radiotherapy for prostate cancer with bladder invasion, Yuhei Miyasaka; Hidemasa Kawamura; Hiro Sato; Nobuteru Kubo; Tatsuji Mizukami; Hiroshi Matsui; Yoshiyuki Miyazawa; Kazuto Ito; Takashi Nakano; Kazuhiro Suzuki; Tatsuya Ohno, Dec. 2021, BMC Urology, 21, 1, Scientific journal

Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer, Yoshitaka Sekine; Hiroshi Nakayama; Yoshiyuki Miyazawa; Seiji Arai; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 13 Oct. 2021, Oncology Letters, 22, 6, Scientific journal

Presepsin as a predictor of septic shock in patients with urinary tract infection., Yoshitaka Sekine; Kazuhiko Kotani; Daisuke Oka; Hiroshi Nakayama; Yoshiyuki Miyazawa; Takahiro Syuto; Seiji Arai; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Masami Murakami; Kazuhiro Suzuki, 12 Oct. 2021, BMC urology, 21, 1, 144, 144, Scientific journal

根治的膀胱全摘除術後の長期予後予測モデル, 大津 晃; 伊藤 一人; 野村 恵; 青木 雅典; 岡 大祐; 斎藤 智美; 宮澤 慶行; 周東 孝浩; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 鈴木 和浩, Oct. 2021, 日本癌治療学会学術集会抄録集, 59回, O17, 2

Propensity score matching法による前立腺癌に対するRARPと重粒子線治療の性機能比較, 宮澤 慶行; 岡 大佑; 小池 秀和; 河村 英将; 宮坂 勇平; 大津 晃; 周東 孝浩; 新井 誠二; 関根 芳岳; 松井 博; 大野 達也; 鈴木 和浩, Oct. 2021, 日本癌治療学会学術集会抄録集, 59回, O65, 1

;;;;, Sep. 2021, 14, 3, 318, 321

タンパク翻訳阻害剤HomoharringtonineはAR陽性前立腺癌細胞に殺細胞効果を示す, 大津 晃; 新井 誠二; 澤田 達宏; 鈴木 和浩, Sep. 2021, 日本癌学会総会記事, 80回, [P14, 4]

Aug. 2021, 71, 3, 226, 226

Aug. 2021, 71, 3, 226, 226

Aug. 2021, 71, 3, 231, 231

Aug. 2021, 71, 3, 231, 231

Aug. 2021, 71, 3, 231, 231

Aug. 2021, 71, 3, 232, 232

Aug. 2021, 71, 3, 232, 232

Aug. 2021, 71, 3, 259, 259

;;;;;;;;;, Jul. 2021, 30回, 36, 36

A Prospective Study of the Relationship Between Clinical Outcomes After Enzalutamide and Serum Androgen Levels Measured via Liquid Chromatography-tandem Mass Spectrometry in Patients with Castration-resistant Prostate Cancer., Yoshiyuki Miyazawa; Yoshitaka Sekine; Seiji Arai; Toshiyuki Nakamura; Yutaka Takezawa; Nobuaki Shimizu; Yasushige Matsuo; Haruyuki Ogura; Tomoyuki Takei; Kazuhiro Suzuki, Jul. 2021, European urology open science, 29, 59, 67, Scientific journal

;;;;;;;;;;;;;, Jun. 2021, 67, 6, 268, 268

Jun. 2021, 34, 臨増, 793, 793

;;;;;;;;;;;;;, Jun. 2021, 34, 臨増, 791, 791

;;;;;;;;;, Jun. 2021, 30, 1, 97, 100

;;;;;;;;;;;;;;;;;;;;, May 2021, 71, 2, 161, 161

;;;;;;;;;;;;;;;;;;;;;;, May 2021, 71, 2, 163, 163

;;;;;;;;;;;;;;;;;;;;;, May 2021, 71, 2, 163, 164

;;;;;;, Apr. 2021, 97, 1, 255, 255

Mar. 2021, 54, 3, 155, 158

Microscopic Review on the Curability and Invasiveness of Heavy Ion Radiotherapy in a Patient with Locally Advanced High-grade Prostate Cancer without Biochemical Recurrence:, Kohei Kurokawa; Masamitsu Takatama; Toshio Fukuda; Keiji Suzuki; Masahide Kawamura; Tatsuya Ohno; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki, 01 Feb. 2021, The Kitakanto Medical Journal, 71, 1, 47, 52, Scientific journal

;, Jan. 2021, 48, 1, 35, 40

Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese Institute, YOSHIYUKI MIYAZAWA; YOSHITAKA SEKINE; SEIJI ARAI; DAISUKE OKA; HIROSHI NAKAYAMA; TAKAHIRO SYUTO; MASASHI NOMURA; HIDEKAZU KOIKE; HIROSHI MATSUI; YASUHIRO SHIBATA; KAZUHIRO SUZUKI, 2021, In Vivo, 35, 1, 373, 384, Scientific journal

;;;;;;;;;;;;, Dec. 2020, 108回, 1529, 1529

;;;;;;;;;;;;, Dec. 2020, 108回, 866, 866

;;;;;;;;;;;;, Dec. 2020, 108回, 856, 856

;;;;;;;;;;;, Dec. 2020, 108回, 1342, 1342

;;;;;;;;;;;, Dec. 2020, 108回, 1838, 1838

Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial., Hiroji Uemura; Hisashi Matsushima; Kazuki Kobayashi; Hiroya Mizusawa; Hiroaki Nishimatsu; Karim Fizazi; Matthew Smith; Neal Shore; Teuvo Tammela; Ken-Ichi Tabata; Nobuaki Matsubara; Masahiro Iinuma; Hirotsugu Uemura; Mototsugu Oya; Tetsuo Momma; Mutsushi Kawakita; Satoshi Fukasawa; Tadahiro Kobayashi; Iris Kuss; Marie-Aude Le Berre; Amir Snapir; Toni Sarapohja; Kazuhiro Suzuki, 23 Nov. 2020, International journal of clinical oncology, 26, 3, 578, 590, Scientific journal

Nov. 2020, 34回, P, 5

;;;;, Nov. 2020, 33, 11, 1451, 1459

;;;;;;;;;;, Oct. 2020, 53, Suppl.1, 789, 789

CRPCに対するEnzalutamide投与後血中アンドロゲン濃度上昇と効果についての探索的研究, 宮澤 慶行; 宮尾 武士; 中村 敏之; 竹澤 豊; 清水 信明; 松尾 康滋; 小倉 治之; 武井 智幸; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 鈴木 和浩, Oct. 2020, 日本癌治療学会学術集会抄録集, 58回, O63, 2

群馬大学重粒子線医学センターにおける高リスク前立腺癌に対する重粒子線治療, 松井 博; 河村 英将; 神沼 拓也; 久保 亘輝; 佐藤 浩央; 宮澤 慶行; 周東 孝浩; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 柴田 康博; 伊藤 一人; 鈴木 和浩; 大野 達也, Oct. 2020, 日本癌治療学会学術集会抄録集, 58回, P, 350

ミトコンドリアE3リガーゼMARCH5は細胞内ストレスおよびNOXAに依存してMCL1を分解する, 新井 誠二; 大津 晃; 澤田 達宏; 鈴木 和浩, Oct. 2020, 日本癌学会総会記事, 79回, OJ8, 1

MCL1阻害剤とミトコンドリア標的薬の併用療法は前立腺癌細胞のアポトーシスを誘導する, 大津 晃; 新井 誠二; 澤田 達宏; 鈴木 和浩, Oct. 2020, 日本癌学会総会記事, 79回, PJ8, 3

オートファジーに着目した去勢抵抗性前立腺癌細胞に対するスタチンの抗腫瘍効果の研究, 宮澤 慶行; 関根 芳岳; 新井 誠二; 鈴木 和浩, Oct. 2020, 日本癌学会総会記事, 79回, PJ14, 7

Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug., Yukie Endo; Aina Oka; Akihito Uehara; Sayaka Toki; Sei-Ichiro Motegi; Osamu Ishikawa; Yoshiyuki Miyazawa; Kazuhiro Suzuki, Oct. 2020, The Journal of dermatology, 47, 10, e359-e360

;;;;;;;;, Sep. 2020, 62, 6, 584, 584

Cabazitaxel in patients aged ≥80 years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan., Nobuaki Matsubara; Kazuhiro Suzuki; Hirotaka Kazama; Shoko Tsukube; Takeshi Seto; Hideyasu Matsuyama, Sep. 2020, Journal of geriatric oncology, 11, 7, 1067, 1073, Scientific journal

Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial., Kazuto Ito; Mikio Kobayashi; Motokiyo Komiyama; Seiji Naito; Kazuo Nishimura; Junji Yonese; Katsuyoshi Hashine; Shiro Saito; Gaku Arai; Mitsuru Shinohara; Naoya Masumori; Nobuaki Shimizu; Takefumi Satoh; Atsushi Yamauchi; Tatsuo Tochigi; Yutaka Takezawa; Hiroyuki Fujimoto; Akira Yokomizo; Ken-Ichi Kakimoto; Iwao Fukui; Katsuyuki Karasawa; Taiji Tsukamoto; Miwako Nozaki; Masaru Hasumi; Hiromichi Ishiyama; Mikinobu Ohtani; Masaaki Kuwahara; Masaoki Harada; Yasuo Ohashi; Toshihiko Kotake; Tadao Kakizoe; Kazuhiro Suzuki; Hidetoshi Yamanaka, 01 Sep. 2020, Cancer, 126, 17, 3961, 3971, Scientific journal

YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression., Takeshi Miyao; Hidekazu Koike; Yoshitaka Sekine; Akira Ohtsu; Daisuke Oka; Kazuhiro Suzuki, Sep. 2020, Anticancer research, 40, 9, 5091, 5095, Scientific journal

;;;;;, Aug. 2020, 96, 1, 288, 288

;;;;;;;;;;;;;;;;, Aug. 2020, 96, 1, 367, 367

Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m2) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study., Hideyasu Matsuyama; Nobuaki Matsubara; Hirotaka Kazama; Takeshi Seto; Shoko Tsukube; Kazuhiro Suzuki, 13 Jul. 2020, BMC cancer, 20, 1, 649, 649, Scientific journal

Jun. 2020, 33, 臨増, 899, 899

Jun. 2020, 33, 臨増, 910, 910

May 2020, 70, 2, 83, 94

May 2020, 70, 2, 163, 164

May 2020, 70, 2, 168, 168

;, Apr. 2020, 7, 1, 55, 59

;;;;;, Apr. 2020, 37, 2, 136, 141

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer., Narisa Dewi Maulany Darwis; Takahiro Oike; Hidemasa Kawamura; Masahiro Kawahara; Nobuteru Kubo; Hiro Sato; Yuhei Miyasaka; Hiroyuki Katoh; Hitoshi Ishikawa; Hiroshi Matsui; Yoshiyuki Miyazawa; Kazuto Ito; Kazuhiro Suzuki; Soehartati Gondhowiardjo; Takashi Nakano; Tatsuya Ohno, 04 Mar. 2020, Cancers, 12, 3, Scientific journal

;;;;;;;;, Mar. 2020, 28, 1, 57, 58

Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702"., Hidemasa Kawamura; Nobuteru Kubo; Hiro Sato; Tatsuji Mizukami; Hiroyuki Katoh; Hitoshi Ishikawa; Tatsuya Ohno; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki; Takashi Nakano, 30 Jan. 2020, BMC cancer, 20, 1, 75, 75, Scientific journal

Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml., Kazuto Ito; Akira Yokomizo; Shoji Tokunaga; Gaku Arai; Mikio Sugimoto; Koichiro Akakura; Hisashi Hasumi; Hideki Sakai; Akiko Ouraji; Ryo Oki; Eiji Kashiwagi; Yoshitomo Kobori; Hiromi Hirama; Hiroki Kitoh; Hiroji Uemura; Tomoaki Hakariya; Kazuhiro Suzuki, Jan. 2020, The Journal of urology, 203, 1, 83, 91, Scientific journal

Quality of life in prostate cancer patients receiving particle radiotherapy: A review of the literature., Hidemasa Kawamura; Nobuteru Kubo; Hiro Sato; Yuhei Miyasaka; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki; Tatsuya Ohno, Jan. 2020, International journal of urology : official journal of the Japanese Urological Association, 27, 1, 24, 29, Scientific journal

Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study., Kazuhiro Suzuki; Nobuaki Matsubara; Hirotaka Kazama; Takeshi Seto; Shoko Tsukube; Hideyasu Matsuyama, 27 Dec. 2019, Japanese journal of clinical oncology, 49, 12, 1157, 1163, Scientific journal

;;;;;;;;;, Dec. 2019, 21, 4, 409, 409

;;;;;;;;;;;;;;;;;, Nov. 2019, 69, 4, 349, 349

;;;;;;;;;;;;;;;;;, Nov. 2019, 69, 4, 350, 350

Nov. 2019, 33回, P, 4

Nov. 2019, 33回, P, 11

尿路上皮癌に対するペムブロリズマブの初期治療経験, 大津 晃; 柴田 康博; 岡 大祐; 青木 雅典; 中山 紘史; 宮澤 慶行; 周東 孝浩; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Oct. 2019, 日本癌治療学会学術集会抄録集, 57回, P98, 2

群馬大学における前立腺癌に対する重粒子線治療, 松井 博; 河村 英将; 久保 亘輝; 佐藤 浩央; 宮坂 勇平; 周東 孝浩; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 柴田 康博; 伊藤 一人; 鈴木 和浩; 大野 達也; 中野 隆史, Oct. 2019, 日本癌治療学会学術集会抄録集, 57回, P107, 5

Oligomets前立腺癌に対する局所放射線療法とアンドロゲン除去療法の併用治療経験, 宮澤 慶行; 青木 雅典; 大津 晃; 岡 大祐; 中山 紘史; 周東 孝浩; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 鈴木 和浩; 久保 亘輝; 河村 英将, Oct. 2019, 日本癌治療学会学術集会抄録集, 57回, P108, 7

CRPCに対するEnzalutamideの効果と血中アンドロゲン濃度の関連についての前向き研究, 宮澤 慶行; 宮尾 武士; 中村 敏之; 竹澤 豊; 清水 信明; 松尾 康滋; 小倉 治之; 武井 智幸; 新井 誠二; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 鈴木 和浩, Oct. 2019, 日本癌治療学会学術集会抄録集, 57回, O36, 1

Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening., Kazuto Ito; Ryo Oki; Yoshitaka Sekine; Seiji Arai; Yoshiyuki Miyazawa; Yasuhiro Shibata; Kazuhiro Suzuki; Isao Kurosawa, Oct. 2019, International journal of urology : official journal of the Japanese Urological Association, 26, 10, 956, 970, Scientific journal

Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer., Hiroyoshi Suzuki; Hiroji Uemura; Atsushi Mizokami; Narihiko Hayashi; Yasuhide Miyoshi; Satoshi Nagamori; Yutaka Enomoto; Hideyuki Akaza; Takayuki Asato; Tadayuki Kitagawa; Kazuhiro Suzuki, Oct. 2019, Cancer medicine, 8, 13, 5891, 5902, Scientific journal

;;;;;;;;;, Sep. 2019, 30, 1, 308, 308

抗アポトーシス蛋白阻害剤併用による前立腺癌新規治療法の開発(Combination therapies with BH3 mimetic drugs for prostate cancer), 新井 誠二; 大津 晃; 鈴木 和浩, Sep. 2019, 日本癌学会総会記事, 78回, P, 1049

An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression., Yoshiyuki Miyazawa; Yoshitaka Sekine; Nobuaki Shimizu; Yutaka Takezawa; Toshiyuki Nakamura; Takeshi Miyao; Hiroshi Nakayama; Sota Kurihara; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Sep. 2019, The Prostate, 79, 12, 1462, 1470, Scientific journal

;;;;;;;;;;, Jul. 2019, 28回, 53, 53

;;;;;;;;, Jul. 2019, 28回, 52, 52

Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study., Kubo N; Kawamura H; Oike T; Sato H; Iwanaga M; Mizukami T; Adachi A; Matsui H; Ito K; Suzuki K; Nakano T, Jul. 2019, In vivo (Athens, Greece), 33, 4, 1235, 1241, Scientific journal

;;;;;;;;;;;, Jun. 2019, 32, 臨増, 738, 738

;;;;;;;;;;;;, Jun. 2019, 32, 臨増, 758, 758

;;;;;;;;;;;;, Jun. 2019, 32, 臨増, 759, 759

;;;;;;;;;;;, Jun. 2019, 32, 臨増, 766, 766

Improved Arterial Preservation Achieved by Combined Use of Indocyanine Green Angiography and Doppler Detector During Microsurgical Subinguinal Varicocelectomy., Sota Kurihara; Yasuhiro Shibata; Seiji Arai; Yoshitaka Sekine; Yoshiyuki Miyazawa; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki; Tetsuya Nakamura, 09 May 2019, Journal of investigative surgery : the official journal of the Academy of Surgical Research, 33, 10, 1, 7, Scientific journal

;;;;;;;;;;;;;;, May 2019, 52, Suppl.1, 607, 607

;;;;;;, May 2019, 52, Suppl.1, 694, 694

;;;;;;;;;;;;;;;;;;, May 2019, 69, 2, 174, 174

Apr. 2019, 107回, PP1, 018

;;;;;;;;;;;;, Apr. 2019, 107回, PP1, 203

;;, Apr. 2019, 32, 特別号, 126, 135

;;;;;;;;;;, Apr. 2019, 6, 1, 148, 152

;;, Apr. 2019, 107回, SY11, 4

;;;;;;;;;, Apr. 2019, 107回, AOP, 113

;;;;;;;;;;;;, Apr. 2019, 107回, OP, 409

;;;;;;;;;;;;, Apr. 2019, 107回, PP1, 012

;;;;;;;;;;;;, Apr. 2019, 107回, PP1, 211

;;;;;;;;;;;;, Apr. 2019, 107回, PP2, 012

;;;;;;;;;;;;, Apr. 2019, 107回, PP3, 001

;;, Apr. 2019, 95, 1, 195, 195

;;, Apr. 2019, 95, 1, 290, 290

;;;;;, Apr. 2019, 95, 1, 372, 372

;;;;;, Apr. 2019, 95, 1, 470, 470

;;;;;;;;;;;;;;;;;;;;;;, Mar. 2019, 32, 3, 302, 302

;;;;;;;;;;;;;;;;;, Mar. 2019, 32, 3, 303, 303

Prevalence and clinical characteristics of overactive bladder in systemic sclerosis., Motegi SI; Sekiguchi A; Sekine Y; Nakayama H; Suzuki K; Ishikawa O, Mar. 2019, Modern rheumatology, 30, 2, 1, 5, Scientific journal

;;, Feb. 2019, 32, 2, 131, 134

;;, Jan. 2019, 23, 1, 31, 36

Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases., Shunji Takahashi; Seigo Kinuya; Norio Nonomura; Nobuo Shinohara; Kazuhiro Suzuki; Hiroyoshi Suzuki; Katsumasa Nakamura; Takefumi Satoh; Ukihide Tateishi; Toshiyuki Yoneda; Hiroyuki Horikoshi; Tsukasa Igawa; Takao Kamai; Mitsuru Koizumi; Takeo Kosaka; Nobuaki Matsubara; Hideaki Miyake; Atsushi Mizokami; Takashi Mizowaki; Naoki Nakamura; Masahiro Nozawa; Takeo Takahashi; Hiroji Uemura; Motohide Uemura; Akira Yokomizo; Mana Yoshimura; Yoshiyuki Kakehi, Dec. 2018, Oncology and therapy, 6, 2, 157, 171, Scientific journal

Nov. 2018, 32回, P, 3

Nov. 2018, 32回, P, 7

Nov. 2018, 32回, P, 8

Nov. 2018, 32回, P, 8

Nov. 2018, 109, Suppl., S58, S59

;, Oct. 2018, 28, 11, 1441, 1449

群馬大学における高リスク前立腺癌に対する重粒子線治療, 松井 博; 河村 英将; 久保 亘輝; 佐藤 浩央; 宮坂 勇平; 宮澤 慶行; 周東 孝浩; 野村 昌史; 関根 芳岳; 小池 秀和; 柴田 康博; 伊藤 一人; 鈴木 和浩; 大野 達也; 中野 隆史, Oct. 2018, 日本癌治療学会学術集会抄録集, 56回, O20, 5

CRPCに対するエンザルタミド治療早期、増悪時のPSA動態に着目した予後予測因子の検討, 宮澤 慶行; 清水 信明; 竹澤 豊; 中村 敏之; 宮尾 武士; 蓮見 勝; 悦永 徹; 奥木 宏延; 村松 和道; 牧野 武朗; 岡崎 浩; 関根 芳岳; 小池 秀和; 松井 博; 鈴木 和浩, Oct. 2018, 日本癌治療学会学術集会抄録集, 56回, P43, 4

Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening., Ryo Oki; Kazuto Ito; Rie Suzuki; Yuji Fujizuka; Seiji Arai; Yoshiyuki Miyazawa; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 01 Oct. 2018, International journal of cancer, 143, 7, 1611, 1619, Scientific journal

;;;;, Oct. 2018, 5, 2, 213, 218

Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching., Mizuki Onozawa; Hideyuki Akaza; Shiro Hinotsu; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Taiji Tsukamoto, Oct. 2018, Cancer medicine, 7, 10, 4893, 4902, Scientific journal

;;;;;;;;;, Sep. 2018, 26, 1, 86, 86

;;;;;;;;;, Aug. 2018, 33, 2, 228, 228

Assessment of antimicrobiral prophylaxis in transperineal prostate biopsy: A single-center retrospective study of 485 cases., Kyoko Baba; Yoshitaka Sekine; Yoshiyuki Miyazawa; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Aug. 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 24, 8, 637, 640, Scientific journal

;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 822, 822

;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 837, 837

;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 841, 841

;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 842, 842

;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 850, 850

;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 851, 851

;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 852, 852

Impact of GnRH antagonist and LHRH agonist on the gonadal axis, Yoshiyuki Miyazawa; Yoshitaka Sekine; Kazuhiro Suzuki, 11 May 2018, Hormone Therapy and Castration Resistance of Prostate Cancer, 31, 40, In book

;;;;;;;;;;;;;;;;;, May 2018, 51, Suppl.1, 558, 558

;;;;;;;;;;;;;;;;;;;, May 2018, 51, Suppl.1, 799, 799

;;;;;;;;;;;;;;;;;, May 2018, 51, Suppl.1, 865, 865

;;;;;;;;;;;;;;;;;;, May 2018, 68, 2, 134, 134

;;;;;;;;;;;;;;;;;;, May 2018, 68, 2, 134, 135

;;;;;;;;;, May 2018, 68, 2, 135, 135

May 2018, 1, 1, 07, 15

;;;;;;;;;;;;, Apr. 2018, 106回, OP, 466

;;;;;;;;;;;;, Apr. 2018, 106回, PP1, 214

;;;;;;;;;;;;, Apr. 2018, 106回, PP2, 069

;;;;;;;;;, Apr. 2018, 106回, PP2, 234

;;;;;;;;;;;;, Apr. 2018, 106回, PP3, 133

;;;;;;;;;;;;, Apr. 2018, 106回, PP3, 295

;;;;;;;;;;;, Apr. 2018, 106回, PP3, 356

;;;;;;;;;;;;, Apr. 2018, 106回, PP2, 202

腎細胞癌に対する経皮凍結アブレーション後の局所再発に影響する因子(Factors affecting local recurrence after percutaneous cryoablation for renal cell carcinomas), Kimura Shintaro; Miyazaki Masaya; Watanabe Yoshiya; Kumasaka Soma; Shibuya Kei; Tokue Hiroyuki; Nomura Masashi; Suzuki Kazuhiro; Tsushima Yoshito, Apr. 2018, IVR: Interventional Radiology, 33, Suppl., 303, 303

Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism., Yoshitaka Sekine; Hiroshi Nakayama; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Seiji Arai; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Mar. 2018, Oncology letters, 15, 3, 3167, 3172, Scientific journal

Feb. 2018, 36, 2, 85, 94

[Bone and calcium metabolism associated with malignancy. Bone metastasis of prostate cancer:overview of clinical features and treatments.]., Kazuhiro Suzuki; Yoshiyuki Miyazawa, 2018, Clinical calcium, 28, 11, 1441, 1449, Scientific journal

2018, 5, 1, 147, 150

Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2018, IN VIVO, 32, 2, 409, 412

;;;;;;;;, Dec. 2017, 93, 3, 755, 755

;;;;;;;;, Dec. 2017, 93, 3, 761, 761

;;;;;;;;;, Nov. 2017, 30, 3, 189, 189

;;;;;;;;, Nov. 2017, 30, 3, 254, 254

;;;;;;;;;, Nov. 2017, 30, 3, 261, 261

Nov. 2017, 30, 3, 275, 275

;;;;;;;;;;;;;;;;;;, Nov. 2017, 67, 4, 375, 375

;;;;;;;;;;;;;;;;;;, Nov. 2017, 67, 4, 375, 375

;;;;;;;;;;;;;;;;;;;, Nov. 2017, 67, 4, 376, 376

;;;;;;;;;;;;;;, Oct. 2017, 55回, P65, 2

;;;;;;;;;;;;;;, Oct. 2017, 55回, P65, 3

当院TESE/MESA症例における精子採取予測因子の検討, 北原慈和; 柴田康博; 阿部いおり; 根岸淳江; 茂木美里; 小林未央; 飯塚円香; 中里智子; 満下淳地; 鈴木和浩; 岸裕司, 01 Oct. 2017, 日本生殖医学会雑誌, 62, 4, 404

去勢抵抗性前立腺癌(CRPC)の逐次療法を再考する, 鈴木 和浩; 鈴木 啓悦; 小坂 威雄; 土谷 順彦; 三宅 秀明, Sep. 2017, Prostate Journal, 4, 2, 209, 217

Sep. 2017, 35, 9, 89, 95

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Yoshiyuki Miyazawa; Yoshitaka Sekine; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 29 Aug. 2017, BMC Urology, 17, 1, 70, Scientific journal

;;;;;;;;, Aug. 2017, 52, 総会臨時, 493, 493

Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL., Yuji Fujizuka; Kazuto Ito; Ryo Oki; Rie Suzuki; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Aug. 2017, International journal of urology : official journal of the Japanese Urological Association, 24, 8, 602, 609, Scientific journal

Impact of lymph node dissection on clinical outcomes during nephroureterectomy in patients with clinically node-negative upper urinary tract urothelial cancer: Subanalysis of a multi-institutional nationwide case series of the Japanese Urological Association, Junichi Inokuchi; Masatoshi Eto; Tomohiko Hara; Hiroyuki Fujimoto; Hiroyuki Nishiyama; Jun Miyazaki; Eiji Kikuchi; Shiro Hinotsu; Takuya Koie; Chikara Ohyama; Hiroomi Kanayama; Tsuneharu Miki; Kazuhiro Suzuki; Hiroyuki Nakanishi; Tomoharu Fukumori; Seiji Naito, 01 Jul. 2017, Japanese Journal of Clinical Oncology, 47, 7, 652, 659, Scientific journal

Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Yoshiyuki Miyazawa; Yoshitaka Sekine; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Jul. 2017, ANTICANCER RESEARCH, 37, 7, 3667, 3671, Scientific journal

;;;;;;;;;;;;, May 2017, 30, 臨増, 904, 904

;;;;;;;;;;;;, May 2017, 30, 臨増, 904, 904

;;;;;;;;;;;;, May 2017, 30, 臨増, 904, 904

;;;;;, May 2017, 30, 臨増, 911, 911

;;;;;;;;;;;, May 2017, 30, 臨増, 923, 923

;;;;;;;;;;;;;;;;;;;, May 2017, 50, Suppl.1, 705, 705

;;;;;;;;;;;;;;;;;;, May 2017, 50, Suppl.1, 708, 708

Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Yasuhiro Shibata; Seiji Arai; Yoshiyuki Miyazawa; Takahiro Shuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki, May 2017, PROSTATE, 77, 6, 672, 680, Scientific journal

Apr. 2017, 105回, OP25, 2

;;;;;;;;;;, Apr. 2017, 105回, OP23, 6

;;;;;;;;;;;;, Apr. 2017, 105回, OP40, 1

;;;;;;;, Apr. 2017, 105回, OP48, 4

;;;;;;;;;;;;, Apr. 2017, 105回, OP71, 6

Apr. 2017, 105回, OP81, 2

;;;;;;;;;;, Apr. 2017, 105回, PP10, 02

;;;;;;;;;;;;, Apr. 2017, 105回, PP57, 05

;;;;;;;;, Apr. 2017, 105回, OP41, 1

;;;;;, Apr. 2017, 32, Suppl., 181, 181

;;;;;;;;;;;;, Apr. 2017, 105回, OP41, 3

;;;, Apr. 2017, 4, 1, 69, 78

LH-RHアゴニスト投与後に下垂体卒中を発症した前立腺癌症例の内分泌学的検討, 澤田 達宏; 宮澤 慶行; 金山 あずさ; 周東 孝浩; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩; 堀口 和彦; 山田 正信, Apr. 2017, 日本泌尿器科学会総会, 105回, OP71, 2

High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL, Y. Miyoshi; H. Uemura; K. Suzuki; Y. Shibata; S. Honma; M. Harada; Y. Kubota, No, Mar. 2017, ANDROLOGY, 5, 2, 262, 267, Scientific journal

Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells., Yoshiyuki Miyazawa; Yoshitaka Sekine; Haruo Kato; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki, Mar. 2017, The Prostate, 77, 4, 337, 349, Scientific journal

;;;;;;;;;;;;;;;;, Feb. 2017, 67, 1, 71, 71

;;;;;;;;;;;;;;, Feb. 2017, 67, 1, 71, 71

;;;;;;;;;;;;;;;;;, Feb. 2017, 67, 1, 73, 74

腎腫瘤に対する経皮的冷凍切除 単一施設の初期経験(Percutaneous Cryoablation for Renal Masses:A Single Center Initial Experience), Kimura Shintaro; Miyazaki Masaya; Tokue Hiroyuki; Nomura Masashi; Suzuki Kazuhiro; Tsushima Yoshito, Feb. 2017, 日本医学放射線学会学術集会抄録集, 76回, S233, S233

;;;;;;;;;;, Jan. 2017, 92, 3, 796, 796

2017, 4, 2, 293, 297

2017, 43, 3, 13, 16

Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Yasuhiro Shibata; Sota Kurihara; Seiji Arai; Haruo Kato; Tomomi Suzuki; Yoshiyuki Miyazawa; Hidekazu Koike; Kazuto Ito; Tetsuya Nakamura; Kazuhiro Suzuki, 2017, JOURNAL OF INVESTIGATIVE SURGERY, 30, 4, 247, 251, Scientific journal

YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Takashi Nitta; Hidekazu Koike; Takeshi Miyao; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Yoshitaka Sekine; Kazuhiro Suzuki, Jan. 2017, ANTICANCER RESEARCH, 37, 1, 75, 80, Scientific journal

;;;;;;, Nov. 2016, 5, 4, 165, 170

前立腺癌に対するLH-RHアゴニスト投与後に下垂体卒中を認めた1例, 澤田 達宏; 宮澤 慶行; 金山 あずさ; 藤塚 雄司; 周東 孝浩; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩; 堀口 和彦; 山田 正信; 冨田 健介; 秋山 恵里奈; 福間 裕二; 羽鳥 基明; 大竹 伸明; 関原 哲夫, Nov. 2016, The Kitakanto Medical Journal, 66, 4, 309, 309

Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer., Haruo Kato; Yosuke Furuya; Yoshiyuki Miyazawa; Takeshi Miyao; Takahiro Syuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Nov. 2016, Anticancer research, 36, 11, 6141, 6149, Scientific journal

;;;;;;, Oct. 2016, 61, 4, 457, 457

Oct. 2016, 104, 163, 169

;;;;;;;;;, Oct. 2016, 54回, WS67, 1

;;;;;;;;;;;;, Oct. 2016, 54回, P44, 9

Asia prostate cancer study (A-CaP Study) launch symposium., Hideyuki Akaza; Yoshihiko Hirao; Choung-Soo Kim; Mototsugu Oya; Seiichiro Ozono; Dingwei Ye; Matthew Cooperberg; Shiro Hinotsu; Ji Youl Lee; Gang Zhu; Mikio Namiki; Shigeo Horie; Byung Ha Chung; Chung-Hsin Chen; Ng Chi Fai; Lukman Hakim; Edmund Chiong; Jason Letran; Rainy Umbas; Kazuhiro Suzuki; Kazuo Nishimura; Teng Aik Ong; Bannakij Lojanapiwat; Tong-Lin Wu; Wun-Jae Kim; Declan Murphy; Osamu Ogawa; Peter Carroll; Seiji Naito; Taiji Tsukamoto, Sep. 2016, Prostate international, 4, 3, 88, 96, Scientific journal

;;;;;;;;, Aug. 2016, 29, 8, 1219, 1222

;;;;;;;;;;;;;;;;;;, Aug. 2016, 66, 3, 228, 228

;;;;;;;;;;;;;;;;;;;, Aug. 2016, 66, 3, 228, 229

Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins., Yosuke Furuya; Yoshitaka Sekine; Haruo Kato; Yoshiyuki Miyazawa; Hidekazu Koike; Kazuhiro Suzuki, Jun. 2016, Prostate international, 4, 2, 56, 60, Scientific journal

[Perspective of basic research on prostate cancer]., Kazuhiro Suzuki; Hiroshi Matsui, 20 May 2016, Nihon rinsho. Japanese journal of clinical medicine, 74 Suppl 3, 12, 6, Scientific journal

[Hereditary and familial prostate cancer]., Yoshitatsu Fukabori; Nobuaki Ohtake; Hiroshi Matsui; Kazuhiro Suzuki, 20 May 2016, Nihon rinsho. Japanese journal of clinical medicine, 74 Suppl 3, 47, 51, Scientific journal

;;;;;;;;;;;, May 2016, 29, 臨増, 893, 893

;;;;;;;;;;;;, May 2016, 29, 臨増, 929, 929

;;;;;;;;;;;;;;;;;;;, May 2016, 49, Suppl.1, 719, 719

;;;;;;;;;;;;;;;;;;, May 2016, 49, Suppl.1, 761, 761

泌尿器科と合同手術で、より安全に施行しえた左上腹部巨大後腹膜腫瘍の2切除例, 平井 圭太郎; 新木 健一郎; 久保 憲生; 渡辺 亮; 五十嵐 隆通; 塚越 真理子; 石井 範洋; 星野 弘毅; 野村 昌史; 柴田 康博; 伊藤 一人; 鈴木 和浩; 桑野 博行; 調 憲, May 2016, 日本外科系連合学会誌, 41, 3, 533, 533

Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association., Takuya Koie; Chikara Ohyama; Hiroyuki Fujimoto; Hiroyuki Nishiyama; Jun Miyazaki; Shiro Hinotsu; Eiji Kikuchi; Mizuaki Sakura; Junichi Inokuchi; Tomohiko Hara; Chikara Ohyama; Hiroyuki Nishiyama; Masato Fujisawa; Hirotsugu Uemura; Hiroyuki Fujimoto; Kazuhiro Suzuki; Masatoshi Eto; Isao Hara; Akio Matsubara; Norio Nonomura; Hiroyuki Nakanishi; Takuya Koie; Hiroomi Kanayama; Tsuneharu Miki; Tomoharu Fukumori; Seiji Naito, May 2016, Japanese journal of clinical oncology, 46, 5, 468, 74, Scientific journal

;;;;;;;;;;;;, Apr. 2016, 104回, PP1, 128

;;;;;;;;;;;;, Apr. 2016, 104回, PP1, 193

;;;;;;;;;;;;, Apr. 2016, 104回, OP, 312

;;;;;;;;;;;;, Apr. 2016, 104回, OP, 324

;;;;;;;;;;;;, Apr. 2016, 104回, OP, 325

;;;;;;;;;;;;, Apr. 2016, 104回, PP3, 085

;;;;;;;;;;;;, Apr. 2016, 104回, PP3, 323

;;;;;;;;;;;;, Apr. 2016, 104回, OP, 272

SIMVASTATIN INHIBITS THE PROLIFERATION, MIGRATION AND INVASION OF ANDROGEN INDEPENDENT HUMAN PROSTATE CANCER CELLS VIA UP-REGULATION OF ANNEXIN A10, Yoshiyuki Miyazawa; Yoshitaka Sekine; Haruo Kato; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki, Apr. 2016, JOURNAL OF UROLOGY, 195, 4, E674, E674

LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST REDUCE SERUM ADRENAL ANDROGEN LEVELS IN PROSTATE CANCER PATIENTS, Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Takashi Nitta; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Apr. 2016, JOURNAL OF UROLOGY, 195, 4, E675, E676

ROLE OF ADIPONECTIN IN PROSTATE CANCER RISK AND THE PROLIFERATION OF PROSTATE CANCER., Takashi Nitta; Hidekazu Koike; Hiroshi Mastui; Takeshi Miyao; Sota Kurihara; Yoshiyuki Miyazawa; Haruo Kato; Yoshitaka Sekine; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Apr. 2016, JOURNAL OF UROLOGY, 195, 4, E28, E28

Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association, Junichi Inokuchi; Seiji Naito; Hiroyuki Fujimoto; Tomohiko Hara; Mizuaki Sakura; Hiroyuki Nishiyama; Jun Miyazaki; Eiji Kikuchi; Shiro Hinotsu; Takuya Koie; Chikara Ohyama; Hiroomi Kanayama; Tsuneharu Miki; Kazuhiro Suzuki; Masatoshi Eto; Hiroyuki Nakanishi; Tomoharu Fukumori, 01 Mar. 2016, International Journal of Urology, 23, 3, 224, 230, Scientific journal

[Screening for prostate cancer: clinical significance and future perspectives]., Kazuto Ito; Kazuhiro Suzuki, Jan. 2016, Nihon rinsho. Japanese journal of clinical medicine, 74, 1, 72, 8, Scientific journal

Germline Variants of Prostate Cancer in Japanese Families., Takahide Hayano; Hiroshi Matsui; Hirofumi Nakaoka; Nobuaki Ohtake; Kazuyoshi Hosomichi; Kazuhiro Suzuki; Ituro Inoue, 2016, PloS one, 11, 10, e0164233, Scientific journal

Impact of smoking on the age at diagnosis of upper tract urothelial carcinoma: Subanalysis of the Japanese Urological Association multi-institutional national database, Jun Miyazaki; Hiroyuki Nishiyama; Hiroyuki Fujimoto; Chikara Ohyama; Takuya Koie; Shiro Hinotsu; Eiji Kikuchi; Mizuaki Sakura; Junichi Inokuchi; Tomohiko Hara; Hiro omi Kanayama; Tsuneharu Miki; Kazuhiro Suzuki; Masatoshi Eto; Hiroyuki Nakanishi; Tomoharu Fukumori; Seiji Naito, Nov. 2015, International Journal of Urology, 22, 11, 1023, 1027, Scientific journal

Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association, Tomohiko Hara; Hiroyuki Fujimoto; Mizuaki Sakura; Junichi Inokuchi; Hiroyuki Nishiyama; Jun Miyazaki; Chikara Ohyama; Takuya Koie; Eiji Kikuchi; Shiro Hinotsu; Hiro omi Kanayama; Tsuneharu Miki; Kazuhiro Suzuki; Masatoshi Eto; Hiroyuki Nakanishi; Tomoharu Fukumori; Seiji Naito, Nov. 2015, International Journal of Urology, 22, 11, 1013, 1020, Scientific journal

;;;;;;;, Nov. 2015, 28, 3, 227, 227

;;;;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 311, 311

;;;;;;;;;, Nov. 2015, 28, 3, 186, 186

[EFFICACY OF MICROSURGICAL SUBINGUINAL VARICOCELECTOMY USING INDOCYANINE GREEN FLUORESCENCE ANGIOGRAPHY: A PILOT STUDY]., Yasuhiro Shibata; Sota Kurihara; Seiji Arai; Yoshiyuki Miyazawa; Haruo Kato; Hidekazu Koike; Kazuto Ito; Tetsuya Nakamura; Kazuhiro Suzuki, Oct. 2015, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 106, 4, 293, 8, Scientific journal

Sep. 2015, 50, 3, 386, 386

Sep. 2015, 50, 3, 472, 472

Sep. 2015, 50, 3, 779, 779

Sep. 2015, 50, 3, 941, 941

Jul. 2015, 31回, 171, 171

May 2015, 28, 臨増, 873, 873

May 2015, 65, 2, 159, 159

May 2015, 48, Suppl.1, 799, 799

May 2015, 48, Suppl.1, 937, 937

May 2015, 28, 臨増, 832, 832

May 2015, 28, 臨増, 837, 837

May 2015, 28, 臨増, 841, 841

May 2015, 28, 臨増, 855, 855

May 2015, 28, 臨増, 875, 875

May 2015, 28, 臨増, 883, 883

Apr. 2015, 103回, 467, 467

Apr. 2015, 103回, 483, 483

Apr. 2015, 103回, 501, 501

Apr. 2015, 103回, 558, 558

Apr. 2015, 103回, 562, 562

Apr. 2015, 103回, 593, 593

Apr. 2015, 103回, 598, 598

Apr. 2015, 103回, 637, 637

Apr. 2015, 103回, 706, 706

Apr. 2015, 103回, 717, 717

Apr. 2015, 103回, 732, 732

Apr. 2015, 103回, 742, 742

Apr. 2015, 28, 4, 524, 524

Apr. 2015, 28, 4, 525, 525

Apr. 2015, 103回, 532, 532

Apr. 2015, 103回, 566, 566

Apr. 2015, 103回, 647, 647

Apr. 2015, 28, 4, 524, 524

Apr. 2015, 28, 4, 524, 524

[Heavy ion radiotherapy for prostate cancer -- the role of hormone therapy]., Kazuhiro Suzuki; Hiroshi Matsui; Hidemasa Kawamura; Tatsuya Ohno, Feb. 2015, Gan to kagaku ryoho. Cancer & chemotherapy, 42, 2, 159, 63, Scientific journal

[II. Radiotherapy for prostate cancer-the role of multi-disciplinary team]., Kazuhiro Suzuki; Hiroshi Matsui; Hidemasa Kawamura; Junko Hirado; Kei Shibuya; Naoko Taniyama; Tomomi Hashimoto; Tatsuaki Kanai; Takashi NAkano; Tatsuya Ohno, Jan. 2015, Gan to kagaku ryoho. Cancer & chemotherapy, 42, 1, 32, 5, Scientific journal

[Lipid metabolism and castration resistant prostate cancer]., Kazuhiro Suzuki; Yoshitaka Sekine; Hiroshi Matsui, Dec. 2014, Nihon rinsho. Japanese journal of clinical medicine, 72, 12, 2116, 20, Scientific journal

Nov. 2014, 27, 3, 184, 184

Nov. 2014, 27, 3, 299, 299

Nov. 2014, 27, 3, 291, 291

Oct. 2014, 59, 4, 336, 336

Aug. 2014, 27, 8, 1291, 1291

Jun. 2014, 49, 3, 1183, 1183

Jun. 2014, 68, 7, 523, 526

Jun. 2014, 49, 3, 1430, 1430

Jun. 2014, 49, 3, 2644, 2644

May 2014, 27, 臨増, 793, 793

May 2014, 27, 臨増, 740, 740

May 2014, 27, 臨増, 763, 763

May 2014, 27, 臨増, 774, 774

May 2014, 27, 臨増, 793, 793

May 2014, 47, Suppl.1, 468, 468

Apr. 2014, 102回, 566, 566

Apr. 2014, 102回, 661, 661

Apr. 2014, 102回, 448, 448

Apr. 2014, 102回, 566, 566

Apr. 2014, 102回, 597, 597

Apr. 2014, 102回, 645, 645

Apr. 2014, 102回, 647, 647

Apr. 2014, 102回, 623, 623

A case of chronic myeloid leukemia found by the priapism, Yoshiyuki Miyazawa; Kensuke Tomita; Ya-Suhiro Shibata; Kazuhiro Suzuki; Masaharu Inoue; Tomoyuki Takei, 2014, Japanese Journal of Clinical Urology, 68, 7, 523, 526, Scientific journal

Clinical Outcomes of Microscopic Subinguinal Varicocelectomy for Male Infertility and Scrotal Pain Patients, Shibata Yasuhiro; Ohyama Yusuke; Arai Seiji; Suzuki Kazuhiro, 2014, The KITAKANTO Medical Journal, 64, 1, 31, 35

Nov. 2013, 26, 3, 272, 272

Nov. 2013, 26, 3, 273, 273

Nov. 2013, 26, 3, 286, 286

Oct. 2013, 58, 4, 375, 375

Sep. 2013, 48, 3, 2029, 2029

Sep. 2013, 48, 3, 2069, 2069

Aug. 2013, 26, 8, 1187, 1190

Aug. 2013, 26, 8, 1199, 1201

May 2013, 26, 臨増, 722, 722

Mar. 2013, 104, 2, 459, 459

Mar. 2013, 104, 2, 337, 337

Mar. 2013, 104, 2, 361, 361

Mar. 2013, 104, 2, 169, 169

Mar. 2013, 104, 2, 346, 346

Mar. 2013, 104, 2, 379, 379

Mar. 2013, 104, 2, 411, 411

Mar. 2013, 104, 2, 415, 415

Mar. 2013, 104, 2, 481, 481

Mar. 2013, 104, 2, 485, 485

[Clinical and basic aspects of familial prostate cancer]., Kazuhiro Suzuki; Hiroshi Matsui; Nobuaki Ohtake, Feb. 2013, Gan to kagaku ryoho. Cancer & chemotherapy, 40, 2, 159, 63, Scientific journal

Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score., Hideyuki Akaza; Shiro Hinotsu; Michiyuki Usami; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Taiji Tsukamoto; Seiji Naito; Mikio Namiki; Yoshihiko Hirao; Masaru Murai, 2013, Prostate international, 1, 2, 81, 8, Scientific journal

[Prostate cancer-the role of docetaxel on castration-resistant prostate cancer: evaluation of efficacy and subsequent treatment]., Kazuhiro Suzuki, Oct. 2012, Gan to kagaku ryoho. Cancer & chemotherapy, 39, 10, 1467, 70, Scientific journal

Septic shock following flexible transurethral lithotripsy showing favourable response after multidisciplinary treatment mainly composed of recombinant thrombomodulin: A case report, Haruo Kato; Yasuhiro Shibata; Tomomi Suzuki; Kazuto Ito; Kazuhiro Suzuki, Sep. 2012, Acta Urologica Japonica, 58, 9, 499, 502, Scientific journal

Mar. 2012, 103, 2, 279, 279

[The clinical merit of anti-RANKL antibody denosumab in prostate cancer]., Hideyuki Akaza; Taiji Tsukamoto; Kazuhiro Suzuki; Mikio Namiki; Seiichiro Ozono; Seiji Naitodept, Feb. 2012, Gan to kagaku ryoho. Cancer & chemotherapy, 39, 2, 207, 12, Scientific journal

Oncological outcomes of the prostate cancer patients registered in 2004: report from the Cancer Registration Committee of the JUA., Hiroyuki Fujimoto; Hiroyuki Nakanishi; Tsuneharu Miki; Yoshinobu Kubota; Satoru Takahashi; Kazuhiro Suzuki; Hiro-omi Kanayama; Kazuya Mikami; Yukio Homma, Dec. 2011, International journal of urology : official journal of the Japanese Urological Association, 18, 12, 876, 81, Scientific journal

High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., Yoshitaka Sekine; David Osei-Hwedieh; Kant Matsuda; Nalini Raghavachari; Delong Liu; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan T Remaley, 01 Oct. 2011, The Prostate, 71, 14, 1499, 509, Scientific journal

Sep. 2011, 87, 2, 678, 678

Aug. 2011, 61, 3, 428, 429

[Characteristics of hereditary and familial prostate cancer in Japan 2011]., Yoshitatsu Fukabori; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Jun. 2011, Nihon rinsho. Japanese journal of clinical medicine, 69 Suppl 5, 197, 202, Scientific journal

[Prostate cancer screening in Japan: current status and perspective]., Kazuhiro Suzuki, Jun. 2011, Nihon rinsho. Japanese journal of clinical medicine, 69 Suppl 5, 203, 6, Scientific journal

CHOLESTEROL GRANULOMA OF THE KIDNEY : A CASE REPORT, OKAMOTO Kohei; HATORI Motoaki; TOMITA Kensuke; YOKOYAMA Yoshinari; MAKINO Takeaki; HIRONO Masanori; MURAMATSU Kazumichi; ARAI Seiji; MORIKAWA Yasuyuki; MIYAKUBO Mai; NOMURA Masashi; KOIKE Hidekazu; MATSUI Hiroshi; SHIBATA Yasuhiro; ITO Kazuto; SUZUKI Kazuhiro, 20 May 2011, The Japanese Journal of Urology, 102, 3, 586, 590

HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion., Yoshitaka Sekine; Kazuhiro Suzuki; Alan T Remaley, No, 15 May 2011, The Prostate, 71, 7, 690, 9, Scientific journal

群馬大学での限局性前立腺癌に対する重粒子線治療・初年次報告, 加藤弘之; 石川仁; 神沼拓也; 石居隆義; 小屋順一; 島田博文; 金井達明; 北田陽子; 大野達也; 中野隆史; 鈴木和浩, May 2011, The Kitakanto Medical Journal, 61, 2, 242, Scientific journal

Feb. 2011, 24, 2, 230, 230

;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 345, 345

;;;;, 2011, The Japanese Journal of Urology, 102, 2, 310, 310

;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 529, 529

;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 539, 539

;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 438, 438

;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 416, 416

;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 412, 412

;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 481, 481

;;;;, 2011, The Japanese Journal of Urology, 102, 2, 484, 484

;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 473, 473

;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 462, 462

;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 405, 405

;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 405, 405

;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 406, 406

;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 496, 496

Suppressive effects of the antiandrogen agent, chlormadinone acetate and the 5alpha-reductase inhibitor, dutasteride on prostate weight and intraprostatic androgen levels in rats., Hideo Kobayashi; Kotaro Gotanda; Yasuhiro Shibata; Jun-ichi Watanabe; Youichi Nakano; Atsushi Shinbo; Kazuhiro Suzuki, 2011, Arzneimittel-Forschung, 61, 9, 515, 20, Scientific journal

High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism., Yoshitaka Sekine; Steve J Demosky; John A Stonik; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan T Remaley, Sep. 2010, Molecular cancer research : MCR, 8, 9, 1284, 94, Scientific journal

May 2010, 60, 2, 204, 204

May 2010, 60, 2, 205, 205

Mar. 2010, 23, 臨増, 494, 494

Mar. 2010, 23, 臨増, 522, 522

Mar. 2010, 23, 臨増, 523, 523

;;;;, 2010, The Japanese Journal of Urology, 101, 2, 303, 303

;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 515, 515

;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 413, 413

;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 416, 416

;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 260, 260

;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 370, 370

;;;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 370, 370

;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 369, 369

;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 454, 454

;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 455, 455

;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 485, 485

;, 2010, The Japanese Journal of Urology, 101, 2, 125, 125

Nov. 2009, 22, 3, 211, 211

Sep. 2009, 85, 2, 622, 622

Sep. 2009, 85, 2, 625, 625

[Clinical research on prostate cancer detected in Tone central hospital--comparison of survival rates between patients diagnosed with prostate cancer in and outside screening system]., Yoshimi Tamur; Tomoko Koya; Takahiro Morita; Yutaka Kubota; Osamu Takahashi; Isao Fujiduka; Kazuto Ito; Kazuhiro Suzuki, May 2009, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 100, 4, 525, 33, Scientific journal

Apr. 2009, 85, 1, 319, 319

Apr. 2009, 85, 1, 320, 320

Apr. 2009, 85, 1, 351, 351

Mar. 2009, 22, 臨増, 339, 339

Feb. 2009, 100, 2, 334, 334

;;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 333, 333

;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 341, 341

;;;;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 339, 339

;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 334, 334

;;;;;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 348, 348

;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 118, 118

;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 153, 153

;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 215, 215

;;;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 423, 423

;;;;;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2, 468, 468

Gene Expression Profiles of Prostate Cancer Cell Lines, LNCaP, PC-3 and DU-145, Assessed by cDNA Microarray, Okamura Keigo; Koike Hidekazu; Matsui Hiroshi; Suzuki Kazuhiro, 01 Nov. 2008, The KITAKANTO medical journal, 58, 4, 363, 369

Sep. 2008, 84, 2, 600, 600

2.前立腺癌ヨウ素125シード永久挿入時の術中・術後治療計画の比較(一般演題I,第38回群馬放射線腫瘍研究会抄録), 工藤,滋弘; 石川,仁; 岡本,雅彦; 江原,威; 吉田,大作; 原島,浩一; 櫻井,英幸; 中野,隆史; 山本,巧; 伊藤,一人; 鈴木,和浩, Aug. 2008, The KITAKANTO medical journal, 58, 3, 341, Scientific journal

Jun. 2008, 21, 6, 865, 865

がん予防食品としてのセレン強化ブロッコリースプラウト 前立腺がん細胞による検討(Selenium-enriched broccoli sprouts as an anticancer nutraceutical: study in the human prostate cancer cell lines), アブドゥラ・リズキー; 小林 健司; ファリエド・アハマド; スラジ・エカ; 伊藤 一人; 鈴木 和浩; 村上 正巳; 桑野 博行; 小山 洋, Jun. 2008, Biomedical Research on Trace Elements, 19, 2, 213, 213

May 2008, 41, Suppl.1, 631, 631

Mar. 2008, 21, 臨増, 383, 383

Mar. 2008, 21, 臨増, 372, 372

Mar. 2008, 21, 臨増, 396, 396

Mar. 2008, 21, 臨増, 397, 397

OP-220 ノモグラムランキングによる前立腺がん治療成績の客観的評価システム(前立腺腫瘍/放射線治療1,一般演題口演,第96回日本泌尿器科学会総会), 山本, 巧; 伊藤, 一人; 宮久保, 真意; 武智, 浩之; 大井, 勝; 鈴木, 和浩; 石川, 仁; 中野, 隆史; 秋元, 哲夫, Feb. 2008, The Japanese Journal of Urology, 99, 2, 326, Scientific journal

3 前立腺癌ヨウ素125シード永久挿入時の術前・術中治療計画の比較(一般演題I,第37回群馬放射線腫瘍研究会抄録), 工藤,滋弘; 石川,仁; 岡本,雅彦; 江原,威; 吉田,大作; 原島,浩一; 櫻井,英幸; 中野,隆史; 山本,巧; 伊藤,一人; 鈴木,和浩, Feb. 2008, The KITAKANTO medical journal, 58, 1, 104, Scientific journal

;;, 2008, The Japanese Journal of Urology, 99, 2, 135, 135

;;;;;;;;;;;, 2008, The Japanese Journal of Urology, 99, 2, 191, 191

;;;;;;;;;;;;, 2008, The Japanese Journal of Urology, 99, 2, 204, 204

;;;;;;, 2008, The Japanese Journal of Urology, 99, 2, 273, 273

;;;;;, 2008, The Japanese Journal of Urology, 99, 2, 391, 391

;;;;;, 2008, The Japanese Journal of Urology, 99, 2, 380, 380

;, 2008, The Japanese Journal of Urology, 99, 2, 80, 80

;;;;;;;;;;;;, 2008, The Japanese Journal of Urology, 99, 2, 398, 398

;;;;;;;;;;, 2008, The Japanese Journal of Urology, 99, 2, 404, 404

;;;;;, 2008, The Japanese Journal of Urology, 99, 2, 323, 323

Evidence-based clinical practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition)., Sadao Kamidono; Shinichi Ohshima; Yoshihiko Hirao; Kazuhiro Suzuki; Yoichi Arai; Hiroyuki Fujimoto; Shin Egawa; Hideyuki Akaza; Isao Hara; Shiro Hinotsu; Yoshiyuki Kakehi; Tomonori Hasegawa, Jan. 2008, International journal of urology : official journal of the Japanese Urological Association, 15, 1, 1, 18, Scientific journal

Nov. 2007, 20, 3, 131, 131

Sep. 2007, 42, 2, 731, 731

Sep. 2007, 42, 2, 739, 739

Sep. 2007, 42, 2, 740, 740

The 29th Meeting of the Gunma Association for Organ Transplantation, 01 Aug. 2007, The KITAKANTO medical journal, 57, 3, 259, 261

Examination of Living Donor Renal Transplantation in Gunma University Hospital in a 20-year Period, Hatori Motoaki; Hayashi Masamichi; Machida Masami; Sekihara Tetsuo; Matsuo Yasuharu; Hasumi Masaru; Tanaka Toshiyuki; Sekine Yositake; Arai Seiji; Nakazato Haruki; Shibata Yasuhiro; Yamamoto Takumi; Magari Tomohiro; Koike Hidekazu; Ito Kazuto; Kawaguchi Takuya; Kato Yuichi; Yamanaka Hidetoshi; Suzuki Kazuhiro, 01 Aug. 2007, The KITAKANTO medical journal, 57, 3, 225, 230

Exploration of target molecules for prostate cancer gene therapy., Kazuhiro Suzuki; Kiminori Nakamura; Kazunori Kato; Hirofumi Hamada; Taiji Tsukamoto, 01 Aug. 2007, The Prostate, 67, 11, 1163, 73, Scientific journal

A pediatric case of kidney transplantation in Bartter's syndrome with end-stage renal failure, SEKINE Yoshitaka; HATORI Motoaki; TAKEI Tomoyuki; KASHIWAGI Bunzo; MAGARI Tomohiro; FUKUMA Yuji; NISHII Masahiro; HAMANO Tatsuya; YAMAMOTO Takumi; SHIBATA Yasuhiro; ITO Kazuto; KUROKAWA Kohei; MACHIDA Masami; HAYASHI Masamichi; SUZUKI Kazuhiro, 28 Jul. 2007, Journal of Japanese Society for Dialysis Therapy, 40, 7, 623, 627

May 2007, 20, 臨増, 601, 601

May 2007, 40, Suppl.1, 635, 635

Examination of Cadaveric Renal Transplantation at Gunma University Hospital during 20-year Period, Hatori Motoaki; Hayashi Masamichi; Machida Masami; Sekihara Tetsuo; Matsuo Yasuharu; Hasumi Masaru; Tanaka Toshiyuki; Sekine Yositake; Arai Seiji; Nakazato Haruki; Shibata Yasuhiro; Yamamoto Takumi; Magari Tomohiro; Koike Hidekazu; Ito Kazuto; Kawaguchi Takuya; Kato Yuichi; Yamanaka Hidetoshi; Suzuki Kazuhiro, 01 May 2007, The KITAKANTO medical journal, 57, 2, 165, 168

[Prostate cancer screening at Tatebayashi City in Gunma prefecture--results of screening with PSA alone between 2003 and 2005]., Toshiyuki Nakamura; Toru Etsunaga; Yasushi Sasaki; Takashi Nitta; Yasunobu Okugi; Hiroshi Okazaki; Nobuo Katou; Takumi Yamamoto; Kazuhiro Suzuki, May 2007, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 98, 4, 619, 28, Scientific journal

WS2-2 前立腺癌に対する放射線外照射療法 (斜入4門照射) の有害事象 : 直腸出血を中心に(限局性前立腺癌に対する非観血的治療-各治療の有害事象とQOLへの影響を中心に, 第95回日本泌尿器科学会総会), 伊藤, 一人; 秋元, 哲夫; 山本, 巧; 石川, 仁; 中野, 隆史; 鈴木, 和浩, Feb. 2007, The Japanese Journal of Urology, 98, 2, 188, Scientific journal

;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 547, 547

;;;;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 549, 549

;;;;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 491, 491

;;;;, 2007, The Japanese Journal of Urology, 98, 2, 366, 366

;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 297, 297

;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 257, 257

;;;;, 2007, The Japanese Journal of Urology, 98, 2, 297, 297

;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 380, 380

;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 557, 557

;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 557, 557

;;;;, 2007, The Japanese Journal of Urology, 98, 2, 471, 471

;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 478, 478

;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 475, 475

;;;, 2007, The Japanese Journal of Urology, 98, 2, 477, 477

;;;;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 512, 512

Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., Yoshitaka Sekine; Kazuto Ito; Takumi Yamamoto; Haruki Nakazato; Yasuhiro Shibata; Motoaki Hatori; Kazuhiro Suzuki, 2007, Cancer detection and prevention, 31, 2, 149, 53, Scientific journal

Oct. 2006, 19, 3, 273, 273

Apr. 2006, 19, 臨増, 482, 482

Apr. 2006, 19, 臨増, 482, 482

;;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 476, 476

;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 465, 465

;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 325, 325

;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 325, 325

;;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 445, 445

;;;, 2006, The Japanese Journal of Urology, 97, 2, 185, 185

;;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 413, 413

;;;, 2006, The Japanese Journal of Urology, 97, 2, 348, 348

;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 351, 351

;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 304, 304

;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 493, 493

;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 491, 491

;;;;, 2006, The Japanese Journal of Urology, 97, 2, 501, 501

;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 481, 481

;;;, 2006, The Japanese Journal of Urology, 97, 2, 502, 502

;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2, 483, 483

May 2005, 18, 臨増, 535, 535

May 2005, 18, 臨増, 548, 548

May 2005, 55, 2, 188, 188

[Prostate biopsy]., Kazuhiro Suzuki; Kazuto Ito, Feb. 2005, Nihon rinsho. Japanese journal of clinical medicine, 63, 2, 253, 9, Scientific journal

;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 365, 365

;;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 359, 359

;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 264, 264

;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 211, 211

;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 129, 129

;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 298, 298

;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 297, 297

;;;;;;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 298, 298

;;;, 2005, The Japanese Journal of Urology, 96, 2, 390, 390

;;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 383, 383

;;;;;;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 150, 150

;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2, 233, 233

ACUTE SCROTUM FROM TESTICULAR INVOLVEMENT IN ACUTE LYMPHOCYTIC LEUKEMIA : A CASE REPORT, NITTA Takashi; KOIKE Hidekazu; FUKABORI Yoshitatsu; HATORI Motoaki; ONO Yoshitaka; MATSUI Hiroshi; SUZUKI Kazuhiro; YAMANAKA Hidetoshi; SHIGAWA Youko; KANAZAWA Takashi; OGAWA Chitose, 20 Jul. 2004, The Japanese Journal of Urology, 95, 5, 722, 724

[Bladder cancer and prostate cancer in hemodialysis patients]., Motoaki Hatori; Kazuhiro Suzuki; Hidetoshi Yamanaka, Jun. 2004, Nihon rinsho. Japanese journal of clinical medicine, 62 Suppl 6, 374, 7, Scientific journal

[Chronological changes of incidence rates, clinical stages and pathological differentiation of prostate cancer in Gunma Prefecture, Japan]., Seiji Nakata; Nobuaki Ohtake; Yutaka Kubota; Kazuto Ito; Kazuhiro Suzuki; Hidetoshi Yamanaka, Mar. 2004, Hinyokika kiyo. Acta urologica Japonica, 50, 3, 165, 70, Scientific journal

;;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 495, 495

;;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 496, 496

;;;, 2004, The Japanese Journal of Urology, 95, 2, 194, 194

;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 176, 176

;;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 335, 335

;;;;, 2004, The Japanese Journal of Urology, 95, 2, 351, 351

;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 340, 340

;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 550, 550

;;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 326, 326

;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 332, 332

;;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 332, 332

;;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2, 330, 330

前立腺癌に対する外照射併用高線量率組織内照射法の短期効果と急性反応, 斎藤, 淳一; 秋元, 哲夫; 北本, 佳住; 石川, 仁; 桜井, 英幸; 中野, 隆史; 黒川, 公平; 山本, 巧; 鈴木, 和浩; 山中, 英寿, May 2003, The KITAKANTO medical journal, 53, 2, 234, Scientific journal

Apr. 2003, 16, 臨増, 433, 433

Feb. 2003, 53, 1, 80, 80

Interobserver reproducibility of gleason grading of prostate carcinoma, T Oyama; W Allsbrook; K Kurokawa; Y Mikami; A Segawa; T Sano; T Nakajima; K Suzuki; K Mangold; J Epstein, Jan. 2003, LABORATORY INVESTIGATION, 83, 1, 164A, 165A

;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 133, 133

;;;;, 2003, The Japanese Journal of Urology, 94, 2, 162, 162

;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 400, 400

;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 241, 241

;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 234, 234

;;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 229, 229

;;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 318, 318

;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 375, 375

;;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 380, 380

;;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 166, 166

;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 177, 177

;;;, 2003, The Japanese Journal of Urology, 94, 2, 257, 257

;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 365, 365

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 199, 199

;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 176, 176

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 342, 342

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 347, 347

;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 347, 347

;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 340, 340

;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 352, 352

;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 324, 324

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 326, 326

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 330, 330

;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 378, 378

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 383, 383

;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 217, 217

;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 234, 234

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 256, 256

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 256, 256

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 277, 277

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 277, 277

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 277, 277

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 278, 278

;, 2002, The Japanese Journal of Urology, 93, 2, 93, 93

A Cace of Extragonadal Germ Cell Tumor in the Retroperitoneal Space., Kono Mai; Tomita Hikaru; Okamoto Kouhei; Matsui Hiroshi; Yamamoto Takumi; Nakazato Haruki; Kurokawa Kouhei; Suzuki Kazuhiro; Yamanaka Hidetoshi; Suzuki Kouichi; Suzuki Takanori, 2002, The KITAKANTO Medical Journal, 52, 3, 203, 206

;;;;, 2001, The Japanese Journal of Urology, 92, 2, 369, 369

;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 286, 286

;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 274, 274

;;;;;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 281, 281

;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 282, 282

;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 169, 169

;;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 173, 173

;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 320, 320

;;;;;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 434, 434

;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 297, 297

;;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 259, 259

;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 390, 390

;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 442, 442

Clinical Statistics on the Gunma University Hospital Department of Urology. Statistics of New Outpatients in 1999., Sasaki Yasushi; Kurokawa Kohei; Okamoto Kohei; Oki Kazunari; Sekine Yoshitaka; Tomita Hikaru; Nomura Masashi; Inoue Masaharu; Oi Masaru; Kawaguchi Takuya; Matsui Hiroshi; Hasumi Masaru; Ito Kazuto; Hatori Motoaki; Otake Nobuaki; Shiono Akihiko; Suzuki Kazuhiro; Fukabori Yoshitatsu; Yamanaka Hidetoshi, 2001, The KITAKANTO Medical Journal, 51, 2, 113, 117

;;;;;, 2000, The Japanese Journal of Urology, 91, 3, 348, 348

;;;;;;, 2000, The Japanese Journal of Urology, 91, 3, 424, 424

;;;;;;;, 2000, The Japanese Journal of Urology, 91, 3, 313, 313

;;;;;;;;;;;;, 2000, The Japanese Journal of Urology, 91, 3, 303, 303

;;;;;;, 2000, The Japanese Journal of Urology, 91, 3, 264, 264

;;;;;, 2000, The Japanese Journal of Urology, 91, 3, 272, 272

Clinical Study on 77 Cases of Testicular Tumor., Nakazato Haruki; Suzuki Kazuhiro; Ito Kazuto; Hatori Motoaki; Shiono Akihiko; Shimizu Nobuaki; Fukabori Yoshitatu; Kurokawa Kohei; Suzuki Takanori; Jinbo Susumu; Yamanaka Hidetoshi, 2000, The KITAKANTO Medical Journal, 50, 3, 259, 266

Effects of Hachimi-Jio-Gan on the function of the urinary bladder in anesthetized dogs., Suzuki Takanori; Okazaki Hiroshi; Suzuki Kouichi; Kurokawa Kohei; Higashi Hiroomi; Suzuki Kazuhiro; Yamanaka Hidetoshi, 2000, The KITAKANTO Medical Journal, 50, 1, 15, 19

1998, 89, 2, 317, 317

;;;;;;;, 1998, The Japanese Journal of Urology, 89, 2, 362, 362

;;;;;;;;;, 1998, The Japanese Journal of Urology, 89, 2, 144, 144

Clinical Statistics of the Department of Urology of Gunma University Hospital: Statistics on New Outpatients in 1996., Koike Hidekazu; Kurokawa Kohei; Sasaki Yasushi; Masuda Hiroshi; Nakazato Haruki; Shinya Hiroyuki; Shibata Yasuhiro; Nakano Katsuya; Kubota Yutaka; Suzuki Kazuhiro; Shimizu Nobuaki; Fukabori Yoshitatsu; Hayasi Masamichi; Yamanaka Hidetoshi, 1998, The KITAKANTO Medical Journal, 48, 3, 197, 201

;;;;;;;, 1997, The Japanese Journal of Urology, 88, 2, 188, 188

;;;;;;;;, 1997, The Japanese Journal of Urology, 88, 2, 334, 334

;;;;;;;;, 1997, The Japanese Journal of Urology, 88, 2, 283, 283

SURGICAL APPROACH TO THE RETROCRUAL SPACE IN RETROPERITONEAL LYMPHNODE DISSECTION : ANATOMICAL STUDY, SUZUKI KAZUHIRO; KURITA SUSUMU; KUROKAWA KOHEI; SUZUKI TAKANORI; YAMANAKA HIDETOSHI, 1996, The Kitakanto Medical Journal, 46, 1, 29, 35

TRANSURETHRAL BALLOON LASER HYPERTHERMIA FOR CHRONIC NON-BACTERIAL PROSTATITIS : LONG-TERM FOLLOW-UP RESULTS, SUZUKI TAKANORI; KUROKAWA KOHEI; SUZUKI KAZUHIRO; OKAMURA KEIGO; OHTAKE NOBUAKI; YOSHIDA TADASHI; KURITA SUSUMU; OKAZAKI HIROSHI; IMAI KYOICHI; YAMANAKA HIDETOSHI, 1996, The Kitakanto Medical Journal, 46, 1, 11, 15

A CASE OF POSTOPERATIVE MRSA PNEUMONIA : MYELOSUPPRESSION AFTER CHEMOTHERAPY FOR TESTICULAR CANCER AS A WORSENING FACTOR, SUZUKI KAZUHIRO; YOSHIDA ICHIRO; YOSHIDA TADASHI; KURITA SUSUMU; KUROKAWA KOHEI; SUZUKI TAKANORI; IMAI KYOICHI; YAMANAKA HIDETOSHI, 1996, The Kitakanto Medical Journal, 46, 5, 393, 396

;;;;;;;, 1996, The Japanese Journal of Urology, 87, 2, 291, 291

;;;;;;;;;;, 1996, The Japanese Journal of Urology, 87, 2, 625, 625

;;;;;;, 1996, The Japanese Journal of Urology, 87, 2, 601, 601

;;;;;, 1996, The Japanese Journal of Urology, 87, 2, 580, 580

;;;;, 1996, The Japanese Journal of Urology, 87, 2, 579, 579

Basic study of the difference between Nd: YAG pulsed and continuous wave lasers on thermotherapy for the prostate gland, Suzuki Takanori; Kurokawa Kohei; Suzuki Kazuhiro; Higashi Hiroomi; Yamanaka Hidetoshi, 1996, THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE, 17, 327, 330

AN ANALYSIS OF FAMILIAL PROSTATE CANCER, NAKATA Seiji; MASUDA Hiroshi; SATO Jin; SHIMIZU Nobuaki; SUZUKI Kazuhiro; IMAI Kyoichi; YAMANAKA Hidetoshi; SAITO Koki; NAKAMURA Toshiyuki; KATO Nobuo; TAKAHASHI Osamu; YAJIMA Hisanori; UMEYAMA Tomokazu; SHINOZAKI Tadatoshi; OHTAKE Obuaki; SEKIHARA Tetsuo; SARUKI Kazuhisa; SUZUKI Keiji, 20 Sep. 1995, The Japanese Journal of Urology, 86, 9, 1483, 1487

EXTRAGONADAL GERM CELL TUMOR SUCCESSFULLY TREATED BY HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE MARROW TRANSPLANTATION : A CASE REPORT, SUZUKI KAZUHIRO; TAKEZAWA YUTAKA; KUROKAWA KOHEI; JINBO SUSUMU; KURAYASHIKI RYUJI; SUZUKI TAKANORI; IMAI KYOICHI; YAMANAKA HIDETOSHI, 1995, The Kitakanto Medical Journal, 45, 6, 579, 582

;;;;;, 1995, The Japanese Journal of Urology, 86, 3, 428, 428

1995, 86, 1, 103, 104

1995, 86, 1, 136, 136

;;;;;;, 1995, The Japanese Journal of Urology, 86, 3, 714, 714

;;;, 1995, The Japanese Journal of Urology, 86, 3, 518, 518

Clinical Experience of Transurethral Balloon Laser Thermotherapy for the Benign Prostatic Hypertrophy Patients, KUROKAWA Kohei; SUZUKI Takanori; SUZUKI Kazuhiro; MATSUMOTO Kazuhisa; HASHIMOTO Katsuyoshi; ONO Yoshihiro; KUBOTA Yutaka; SAITO Yoshitaka; YAMANAKA Hidetoshi, 1995, THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE, 16, 2, 19, 24

Experimental Research of Transurethral Balloon Laser Therapy for Prostatic Diseases., ;;;, 1994, Thermal Medicine, 10, 2, 121, 125

INTERSTITIAL TEMPERATURE MEASUREMENT DURING BALLOON LASERTHERAPY (PROSTALASE™) OF THE CANINE PROSTATE, Kurokawa Kohei; Suzuki Takanori; Suzuki Kazuhiro; Yamanaka Hidetoshi, 1994, The Japanese Journal of Urology, 85, 8, 1243, 1247

Effects of antiandrogen TZP-4238 on the prostatic androgen receptor and prostatic androgen in rat, Honma Seijiro; Suzuki Kazuhiro; Takezawa Yutaka; Minato Kouichi; Fukabori Yoshitatsu; Yamanaka Hidetoshi, 1994, Folia Endocrinologica Japonica, 70, 8, 925, 940

Basic and clinical studies of transurethral balloon laser therapy for prostate diseases, Suzuki Takanori; Kurokawa Kohei; Suzuki Kazuhiro; Yamanaka Hidetoshi, 1994, THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE, 15, 285, 286

Interstitial temperature measurement during balloon laserthermia (PROSTALASE^TM) of the canine prostate, Kurokawa Kohei; Suzuki Takanori; Suzuki Kazuhiro; Yamanaka Hidetoshi, 1993, THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE, 14, 341, 342

1992, 83, 6, 883, 883

ENDOCRINE ENVIRONMENT OF BENIGN PROSTATIC HYPERPLASIA:Relationships of Sex Steroid Hormone Levels with Age and the Size of the Prostate, Suzuki Kazuhiro; Inaba Shigeki; Takeuchi Hiroyuki; Takezawa Yutaka; Fukabori Yoshitatsu; Suzuki Takanori; Imai Kyoichi; Yamanaka Hidetoshi; Honma Seijiro, 1992, The Japanese Journal of Urology, 83, 5, 664, 671

A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS., Miyazawa Y, Nakamura T, Takezawa Y, Shimizu N, Matsuo Y, Ogura H, Takei T, Sekine Y, Arai S, Suzuki K., No, Yes, No, 2023, Prostate, 83, 8, 759, 764, Scientific journal

Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin., Miyazawa Y, Shimizu T, Sekine Y, Arai S, Ohtsu A, Fujizuka Y, Nomura M, Koike H, Matsui H, Suzuki K., No, Yes, No, 2022, IJU Case Rep, 6, 1, 37, 40, Scientific journal

Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer., Kazama H, Kawaguchi O, Seto T, Suzuki K, Matsuyama H, Matsubara N, Tajima Y, Fukao T., No, No, No, 2022, BMC Cancer., 22, 1, 470

Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells., Ohtsu A, Arai S, Sawada T, Kato M, Maeno Y, Miyazawa Y, Fujizuka Y, Sekine Y, Koike H, Matsui H, Suzuki K., No, No, No, 2022, Biochem Biophys Res Commun., 628, 76, 83, Scientific journal

Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study., Uemura H, Kobayashi K, Yokomizo A, Hinotsu S, Horie S, Kakehi Y, Nonomura N, Ogawa O, Oya M, Suzuki K, Saito A, Asakawa K, Uno S, Naito S., No, No, No, Int J Clin Oncol, 27, 10, 1632, 1643, Scientific journal

Variants in HOXB13, G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men., Kurihara S, Matsui H, Ohtake N, Aoki M, Sekine Y, Arai S, Koike H, Suzuki K, Miyazawa Y, No, Yes, No, 2022, Cancer Diagn Progn, 2, 5, 542, 548, Doctoral thesis

Carbon-ion radiotherapy for inoperable upper tract ureteral cancer., Mizukami T, Kawamura H, Kubo N, Sato H, Kawahara M, Adachi A, Matsui H, Suzuki K, Saitoh JI, Nakano T, Ohno T., No, No, No, 2023, Asia Pac J Clin Oncol, Apr 23. doi: 10.1111/ajco.13960., Scientific journal

Changes in Renal Function of Patients With Prostate Cancer: Focus on Androgen Deprivation Therapy., Miyazawa Y, Sekine Y, Arai S, Nomura M, Koike H, Matsui H, Suzuki K., No, Yes, No, 2022, Cancer Diagn Progn., 2, 6, 686, 690, Scientific journal

Summary of the clinical practice manual for late-onset hypogonadism, de H, Akehi Y, Fukuhara S, Ohira S, Ogawa S, Kataoka T, Kumagai H, Kobayashi K, Komiya A, Shigehara K, Syuto T, Soh J, Tanabe M, Taniguchi H, Chiba K, Matsushita K, Mitsui Y, Yoneyama T, Shirakawa T, Fujii Y, Kumano H, Ueshiba H, Amano T, Sasaki H, Maeda S, Mizokami A, Suzuki K, Horie S, No, No, No, 2023, Int J Urol, Feb 9. doi: 10.1111/iju.15160., Scientific journal

Combination therapy with novel androgen recetptor antagonists and statin for castration- resistant prostate cancer, Nakayama H, Sekine Y, Oka D, Miyazawa Y, Arai S, Koike H, Matsui H, Shibata Y, Suzuki K, No, Yes, No, 2022, Prostate, 82, 3, 314, 322, Doctoral thesis

Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration, ONO YOSHIHIRO ／ SUZUKI KAZUHIRO ／ YUASA HISAKO ／ KUROKAWA KOHEI ／ FUKABORI YOSHITATSU ／ YAMANAKA HIDETOSHI, No, Sep. 2003, Tohoku Journal of Experimental Medicine

Estrogen treatment of prostate cancer increases tyiglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques, USUI SHINICHI ／ SUZUKI KAZUHIRO ／ YAMANAKA HIDETOSHI ／ NAKANO TAKAMITSU ／ NAKAJIMA KATSUYUKI ／ HARA YUKICHI ／ OKAZAKI MITSUYO, No, Mar. 2002, Clin Chem Acta

A novel immunosuppressive drug,FTY720,prevents the cancer progerssion indudced by cyclosporine, TANAKA TOSHIYUKI ／ TAKAHARA SHIRO ／ HATORI MOTOAKI ／ SUZUKI KAZUHIRO ／ WANG J-D ／ ICHIMARU NAOTSUGU ／ SUZUKI SEIICHI ／ MOROZUMI KUNIO ／ OKUYAMA AKIHIKO ／ YAMANAKA HIDETOSHI, No, Jul. 2002, Cancer Letters

Tumor-associated tissue eosinophilia of penile cancer, ONO YOSHIHIRO ／ OZAWA MASASHI ／ TAMURA YOSHIMI ／ suzuki takanori ／ SUZUKI KAZUHIRO ／ KUROKAWA KOHEI ／ FUKABORI YOSHITATSU ／ YAMANAKA HIDETOSHI, No, Sep. 2002, Int J Urol

Incidence of Bladder cancer discovered by urethrocystoscopy at prostate biopsy: extraordinary high incidence of tiny bladder cancer in elderly males., Okazaki H / suzuki takanori / KUROKAWA KOHEI / ITO KAZUTO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, No, May 2004, Tohoku J Exp Med

Usefulness of prostate-specific antigen velocity in screening for prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / FUKABORI YOSHITATSU / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Yes, Jun. 2002, Int J Urol

Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, SUZUKI KAZUHIRO / ITO KAZUTO / YAMAMOTO TAKUMI / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / KOIKE HIDEKAZU / MATSUI HIROSHI / ONO YOSHIHIRO / HASUMI MASARU / NAKAZATO HARUKI / OKUGI HIRONOBU / SEKINE YOSHITAKA / OOKI KAZUNARI, No, Jun. 2002, Int J Cancer

Prognostic significance of plasma placental growth factor levels in renal cell cancer:An association with clinical characteristics and vascular endothelial growth factor levels, MATSUMOTO KAZUHISA ／ SUZUKI KAZUHIRO ／ KOIKE HIDEKAZU ／ OKAMURA KEIGO ／ TSUCHIYA KIYOTAKA ／ UCHIDA TATSUYA ／ TAKEZAWA YUTAKA ／ kobayashi mikio ／ YAMANAKA HIDETOSHI, No, 2003, ANTICANCER RESEARCH

Rapidly progressive malignant epithelioid angiomyolipoma of the kidney, YAMAMOTO TAKUMI / ITO KAZUTO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, No, Jul. 2002, J Urol

Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population., NAKAZATO HARUKI ／ SUZUKI KAZUHIRO ／ MATSUI HIROSHI ／ OHTAKE NOBUAKI ／ NAKATA SEIJI ／ YAMANAKA HIDETOSHI, Yes, 2003, Br J Cancer

Gene expression profiles of human BPH(II):Optimization of laser-capture microdissection and utilization of cDNA microarray., MATSUI HIROSHI ／ SUZUKI KAZUHIRO ／ HASUMI MASARU ／ KOIKE HIDEKAZU ／ OKUGI HIRONOBU ／ NAKAZATO HARUKI ／ YAMANAKA HIDETOSHI, No, 2003, Anticancer Research

Usefulness of PSA screening in outpatients with bladder cancer: Preliminary results, KUROKAWA KOHEI / SUZUKI KAZUHIRO / OKAZAKI HIROSHI / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, No, May 2002, Int J Urol

Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR, SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / HASUMI MASARU / ONO YOSHIHIRO / NAKAZATO HARUKI / KOIKE HIDEKAZU / ITO KAZUTO / FUKABORI YOSHITATSU / KUROKAWA KOHEI, No, Nov. 2001, Anticancer Res

Yes, May 2001, 14（臨増）: 441-443

Yes, Aug. 2001, 14(8): 868-871

Yes, Mar. 2001, 9(1): 66-68

No, Mar. 2001, 9(1): 69-70

No, Sep. 2003, 16(9),1005-1010

Comparative study on the prevalence of clinically detectable prostate cancer in cases with and without bladder cancer, KUROKAWA KOHEI / ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, No, Feb. 2004, Urology

Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4 ng/ml, OHI MASARU / ITO KAZUTO / SUZUKI KAZUHIRO / YAMAMOTO TAKUMI / YAMANAKA HIDETOSHI, No, Jan. 2004, Eur Urol

Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate, ONO YOSHIHIRO / SUZUKI KAZUHIRO / KASHIWAGI BUNZOU / SHIBATA YASUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, No, Jan. 2004, Int J Androl

Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, MATSUMOTO KAZUHISA / SUZUKI KAZUHIRO / KOIKE HIDEKAZU / HASUMI MASARU / MATSUI HIROSHI / OKUGI HIRONOBU / SHIBATA YASUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI, No, Sep. 2003, Anticancer Res

The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer, HASUMI MASARU / SUZUKI KAZUHIRO / MATSUI HIROSHI / YAMAMOTO TAKUMI / ITO KAZUTO / KUROKAWA KOHEI / AOKI JUN / ENDO KEIGO / YAMANAKA HIDETOSHI, No, Sep. 2003, Anticancer Res

Association of genetic polymorphisms of Glutathione-S-transpherase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, NAKAZATO HARUKI / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / OHTAKE NOBUAKI / TAKEI TOMOYUKI / NAKATA SEIJI / HASUMI MASARU, No, May 2003, Anticancer Res

A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / MATSUI HIROSHI / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / NAKAZATO HARUKI / OKUGI HIRONOBU / KOIKE HIDEKAZU / ONO YOSHIHIRO, No, Jul. 2003, J Biomed Sci

No, 2001, 14,No.臨時増刊(451-453)

An evaluation of the Banff 97 classification after kidney transplantation, TANAKA TOSHIYUKI ／ KYO MASAHIRO ／ KOKADO YUKITO ／ TAKAHARA SHIRO ／ HATORI MOTOAKI ／ SUZUKI KAZUHIRO ／ HASUMI MASARU ／ TOKI KIYOHIDE ／ ICHIMARU NAOTSUGU ／ OKUYAMA AKIHIKO ／ YAMANAKA HIDETOSHI, No, 2003, Transplantation Proceedings

Hands-free hook for endourological procedures, ONO YOSHIHIRO ／ SUZUKI KAZUHIRO, No, Oct. 2003, Int J Urol

Malignant fibrous histiocytoma of the right spermatic cord: a case report., Sekine Y / Saruki K / Morita T / NAKAZATO HARUKI / YOKOO HIDEAKI / Yamanaka H / Ohki K / Okamoto K / Nomura M / Tomita H / Ohtake N / SUZUKI KAZUHIRO / KUROKAWA KOHEI / Mashimo M, No, 2001, Int J Urol

Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI / NAKAZATO HARUKI / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / KASHIWAGI BUNZOU / NISHII MASAHIRO / OHTAKE NIBUAKI / NAKATA SEIJI, No, Oct. 2003, Cancer

Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, HASUMI MASARU / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / ITO KAZUTO / YAMANAKA HIDETOSHI, No, Oct. 2003, Cancer Lett

Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less, ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Yes, Sep. 2003, Prostate

Natural history of PSA increase with and without prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Yes, Jul. 2003, Urology

Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, SUZUKI KAZUHIRO / HATORI MOTOAKI / ITO KAZUTO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / NAKAZATO HARUKI / KOIKE HIDEKAZU / OKUGI HIRONOBU / HASUMI MASARU / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI, No, Jun. 2003, Cancer Lett

Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL., ITO KAZUTO / YAMAMOTO TAKUMI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Yes, Apr. 2003, Urology

Preliminary results of a monitoring system to confirm the preservation of cavernous nerves, KUROKAWA KOHEI / suzuki takanori / SUZUKI KAZUHIRO / TERADA N / ITO KAZUTO / YAMANAKA HIDETOSHI, No, Mar. 2003, Int J Urol

Cumulative probability of PSA increase above 4.0 ng/ml in population based screening for prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Yes, Apr. 2004, Int J Cancer

Association of the genetic polymorphism of the CYP19 intron 4 [TTTA]n repeat with familial prostate cancer risk in a Japanese population., SUZUKI KAZUHIRO / NAKAZATO HARUKI / MATSUI HIROSI / KOIKE HIDEKAZU / OKUGI HIRONOBU / OHTAKE NOBUAKI / NAKATA SEIJI / HASUMI MASARU / YAMANAKA HIDETOSHI, Yes, 2003, Anticancer Research

Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / MATSUI HIROSHI / ONO YOSHIHIRO / NAKAZATO HARUKI / HASUMI MASARU / KOIKE HIDEKAZU, No, Nov. 2002, Anticancer Res

The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with PSA levels of 4.1 to 10.0 ng/ml, ITO KAZUTO / YAMAMOTO TAKUMI / KUROKAWA KOHEI / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Yes, Nov. 2002, Cancer

MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer, HASUMI MASARU / SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, No, Apr. 2002, Anticancer Res

Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/ml or less, YAMAMOTO TAKUMI / ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, No, Dec. 2001, Urology

Intermittent deep coma in a hemodialysis patient with liver cirrhosis:A case report, MATSUMOTO KAZUHISA / HAYASHI MASAMICHI / KOSAKU NOZOMU / YAMAMOTO TAKUMI / HATORI MOTOAKI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / ONO YASUHIRO, No, 2003, Kitakanto Med J

Yes, 2004, 58,No.7(455-459)

Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: is it possible to identify patients likely to have good treatment outcomes?, KUROKAWA KOHEI / ITO KAZUTO / SUZUKI KAZUHIRO / YAMAMOTO TAKUMI / AKIMOTO TETSUO / YAMANAKA HIDETOSHI, No, Nov. 2002, Jpn J Clin Oncol

Yes, Jan. 2002, 50,No.1(83-87)

Yes, Mar. 2002, 10,No.3(245-248)

Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population., SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / MATSUI HIROSHI / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / KOIKE HIDEKAZU / NAKAZATO HARUKI / OKUGI HIRONOBU / HASUMI MASARU, Yes, May 2003, Int J Urol

No, Jan. 2001, 92,No.(6-12）

Role of androgen on blood flow and capillary structure in rat seminal vesicle, ONO YOSHIHIRO / SUZUKI KAZUHIRO / KASHIWAGI BUNZOU / SHIBATA YASUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, No, Feb. 2004, Tohoku J Exp Med

Yes, Dec. 2003, 36,No.12(1731-1736)

No, Mar. 2004, 37,No.3(249-252)

Yes, Jun. 2004, 37,No.6(1437-1442)

Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer., Shigehito Miyamoto / ITO KAZUTO / KUROKAWA KOHEI / SUZUKI KAZUHIRO / 鈴木慶二 / YAMANAKA HIDETOSHI, No, Jun. 2006, Int J Urol

Yes, Apr. 2003, 57,No.4(310-315)

No, 2004, 22,No.9(88-94)

Yes, Oct. 2004, 9,No.10(908-915)

The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less, ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Yes, Feb. 2004, J Urol

No, 2005, 18(8):1000-1002

No, 2005, 18(8): 997-999

Yes, 2004, 11: 50-53

Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia, SHIBATA YASUHIRO / KASHIWAGI BUNZOU / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / ARAI SEIJI, Yes, Aug. 2005, Urology

No, 2004, 11(2): 37-39

Yes, 2004, 11,No.2(62-64)

Yes, 2005, 63,No.2(253-259)

Yes, Sep. 2004, 17,No.9(971-976)

Fatal leukemia in interleukin-15 transgenic mice., Fehniger T.A. / SUZUKI KAZUHIRO / VanDeusen J.B. / Cooper M.A. / Freud A.G. / Caligiuri M.A., No, 2001, Blood Cells, Molecules, and Disease

Yes, Mar. 2006, 14(1): 43-45

Yes, Jan. 2003, 10(2):118-122

Yes, Jan. 2003, 10(2):87-90

No, Jan. 2003, 10(2)：126-129

No, 2004, 50:165-170

A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States, Oyama T / Allsbrook WC / Kurokawa K / Matsuda H / SEGAWA ATSUKI / SANO TAKAAKI / SUZUKI KAZUHIRO / Epstein LI, No, Aug. 2005, Arch Pathol Lab Med

The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats, SHIBATA YASUHIRO / KASHIWAGI BUNZOU / ONO YOSHIHIRO / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / HONMA SEIJIRO / YAMANAKA HIDETOSHI, Yes, Feb. 2004, Urological Research

Yes, Jan. 2004, 50,No.1(7-14)

Yes, 2004, 53,No.10(2741-2742)

Yes, 2004, 56,No.5(758-762）

Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo., SHIBATA YASUHIRO / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / 本間誠次郎, Yes, 2004, Endocrinology

No, Nov. 2002, 15,No.11(1237-1240)

Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer., KOIKE HIDEKAZU / ITO KAZUTO / OYAMA TETSUNARI / YAMANAKA HIDETOSHI / SUZUKI KAZUHIRO, No, Apr. 2005, Br J Cancer.

Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity., AKIMOTO TETSUO / ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / NAKANO TAKASHI, No, Oct. 2005, Int J Radiat Oncol Biol Phys.

No, 2002, 60,No.11(469-473)

No, Oct. 2002, 18,No.10(1377-1381)

No, Jul. 2002, 52,No.4(271-277)

Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: Establishment of a new highly sensitive simultaneous andorgen measurement method, KASHIWAGI BUNZOU / SHIBATA YASUHIRO / ONO YOSHIHIRO / SUZUKI RYOTA / HONMA SEIJIRO / SUZUKI KAZUHIRO, No, Oct. 2005, Journal of Andrology

Effect of androgen concentration on seminal vesicle blood flow in rat-establishment of new highly sensitive simultaneous androgen measurement method, KASHIWAGI BUNZOU / SHIBATA YASUHIRO / SUZUKI KAZUHIRO / HONMA SEIJIRO / ONO YOSHIHIRO / YAMANAKA HIDETOSHI, No, Jun. 2005, Urology

No, Oct. 2001, 47,No.10(861-866）

No, 2005, 12: 148-150

No, Dec. 2002, 56,No.13(1119-1123)

No, Jul. 2002, 52,No.4(267-270)

No, May 2002, 52,No.3(203-206)

No, Jul. 2002, 52,No.4(279-282)

Yes, 2003, 10,No.2(192-194)

Yes, 2004, 17, No.12 (1251-1254)

Yes, 2004, 62, 増刊号6 (374-377)

A simple and reliable monitoring system to confirm the preservation of the cavernous nerves, KUROKAWA KOHEI / suzuki takanori / SUZUKI KAZUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, No, May 2001, Int J Urol

No, Nov. 2002, 35,No.11(1447-1451)

No, Aug. 2002, 15No.8(934-937)

NK cell-mediated anti-tumor immune response to human prostate Cancer cell, PC-3 : immunogene therapy using a highly secretable form of interleukin-15 gene transfer., SUZUKI KAZUHIRO / NAKAZATO HARUKI / MATSUI HIROSHI / HASUMI MASARU / SHIBATA YASUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Yes, Apr. 2001, Journal of Leucocyte Biology

Fatal leukemia in inter leukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD 8 T cells, Fehniger, T.A. / Caligiuri M.A. / SUZUKI KAZUHIRO / Ponnappan A. / VanDeusen J.B. / Cooper M.A. / Florea S.M. / Freud A.G. / Robinson M.L. / Durbin J, No, 2001, J Exp Med

No, 2002, 10,No.1(18-19)

No, Feb. 2002, 48,No.2(85-87)

Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population., Hironobu Okugi, Haruki Nakazato, Hiroshi Matsui, Nobuaki Ohtake, Seiji Nakata, Kazuhiro Suzuki, No, 2006, Cancer Detection and Prevention

No, Mar. 2002, 10,No.1(29-30)

Yes, 2006, 16, 3, 13-15

A case of emphyematous pyelonephritis in a renal allograft, Seiji Arai, Takeaki Makino, Masaru Hasumi, Yasuhiro Shibata, Motoaki Hatori, Kazuhiro Suzuki, No, 2006, Transplantation

No, 2005, 13, 1, 89-91

Yes, 2006, 55, 11, 2705

Yes, 2006, 464-468

Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues., Hironobu Okugi, Hidekazu Koike, Yoshitaka Sekine, Hiroshi Matsui, Kauzhiro Suzuki, No, 2006, Asia-Pacific Journal of Clinical Oncology

Yes, 2005, 140-153

Yes, 2005, 22, 4, 206-216

Yes, 2005, 42, 12, 539-541

Yes, 2005, 243

No, 2006, 56, 3, 231-235

Long term follow-up of mass screening for prostate carcinoma in men with initial prostate-specific antigen levels of 4.0ng/ml or less, ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Yes, Feb. 2001, Cancer

Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents Chlormadinone acetate and Finasteride, SHIBATA YASUHIRO / FUKABORI YOSHITATSU / ITO KAZUTO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, No, Jan. 2001, J Urol

Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / NAKAZATO HARUKI / HASUMI MASARU / MATSUI HIROSHI / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, No, Jun. 2001, Int J Androl

Positive effect of prostaglandin on regulation of prostatic blood flow., Kashiwagi B, Shibata Y, Ohki K, Arai S, Honma S, Suzuki K., No, 2006, Urology

No, Aug. 2002, 15,No.8(928-930)

Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo., Shibata Y, Kashiwagi B, Arai S, Magari T, Suzuki K, Honma S., No, 2006, Urology

Cyclin D1 gene polymorphism and familial prostate cancer : The AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage., KOIKE HIDEKAZU / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / TAKEI TOMOYUKI / NAKATA SEIJI / SATHO T / OHTAKE NOBUAKI, Yes, Nov. 2003, Anticancer Research

Lead time of prostate cancer detected in population-based screening for prostate cancer in Japan., Ito K, Yamamoto T, Miyakubo M, Takechi H, Ohi M, Shibata Y, Suzuki K., No, Oct. 2007, J Urol , 178, 1258-1264

Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., Sekine Y, Ito K, Yamamoto T, Nakazato H, Shibata Y, Hatori M, Suzuki K., No, 2007

Editorial Comment, Kazuhiro Suzuki, Yes, Feb. 2008, Int J Urol

Editorial Comment, Kazuhiro Suzuki, Yes, Feb. 2008, Int J Urol, 15

Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells. , Sekine Y, Koike H, Nakano T, Nakajima K, Suzuki K, No, Aug. 2007, Clin Chim Acta

No, Jan. 2008, 15, 2, 125-127

Yes, Mar. 2000, ８４, ３, ３０９－３１４

No, Mar. 2007, ９８, １－３１

Pilot study of the optimum hematocrit for patients in the predialysis stage after renal transplantation , Kawaguchi T, Moriyama T, Suzuki K, Hatori M, Tanaka T, Takahara S, Yamanaka H., No, Jun. 2004, Transplantation Proc

Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility ot familial prostate cancer in a Japanese population, Tatsuya Hamano, Hiroshi Matsui, Nobuaki Ohtake, Seiji Nakata, Kazuhiro Suzuki, No, Feb. 2008, Asia-Pacific Journal of Clinical Oncology

Yes, Apr. 2008, 6, 2, 74-80

No, Mar. 2007, 15, 1, 93-95

No, Dec. 2007, 20, 12, 1525-1529

No, Dec. 2007, 65, 10, 203-206

Yes, Dec. 2007, 65, 10, 187-293

No, Dec. 2007, ６５, １０, 182-186

Yes, Jul. 2007, 57, 25-27

Yes, Oct. 2007, ５, ５, ７７－８２

Yes, Jun. 2007, 20, 6, 737-741

Effects of Aromatase Inhibitor, TZA-2209, on the Prostate of Androstenedione-treated Castrated Dogs : Changes in Prostate Volume and Histopathological Findings, SUZUKI KAZUHIRO / ITO KAZUTO / suzuki takanori / YAMANAKA HIDETOSHI, No, May 1996, Prostate

Endocrine Environment of Benign Prostatic Hyperplasia : Prostate Size and Volume are Correlated with Serum Estrogen Concentration, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / suzuki takanori / YAMANAKA HIDETOSHI, No, Mar. 1995, Scand J Urol Nephrol

Effects of New Steroidal Antiandrogen, TZP-4238(172-acetoxy-6-chloro-2-oxa-4, 6-pregnadine-3, 20-dione), on Spontaneously Developed Canine Benign Prostatic Hyperplasia, TAKEZAWA YUTAKA / ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, No, 1995, Prostate

Yes, 2000, 13/8,997-1001

Effects of new steroidal aromatase inhibitor, TZA-2237, and/or Chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia, ITO KAZUTO / FUKABORI YOSHITATSU / SHIBATA YASUHIRO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Yes, Oct. 2000, Eur J Endocrinol

Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Yes, Aug. 2000, Urology

Correlation of prostate-specific antigen before prostate cancer detection and clinicopathological features : Evaluation of mass screening populations, ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Yes, May 2000, Urology

Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / suzuki takanori / YAMANAKA HIDETOSHI, No, 1998, Int Urol Nephrol

IL-15 costimulates the generalized shuartzman reaction and innate immune IFN-γ production in vivo, SUZUKI KAZUHIRO, 2000, J Immunol

Differential cytokine and chemokino gene expression by human NK cells following activation with IL-18 or IL-15 combination with IL-12 : Imprication for the innata immune response, SUZUKI KAZUHIRO, 1999, J. Immunol

Effect of dual inhibition of 5-alpha-reductase and aromatase on spontareously developed canine prostate hypertrophy, SUZUKI KAZUHIRO, 1998, Prostate

Estimation of canine prostatic volume : Nomesram based on prostatic cubic volume, SUZUKI KAZUHIRO, 1998, 1st Urol Nephrol

Expression and degredation of rat androgen reoptor following castration testosterone replacement and antiandrogens administration analysis by western blot and immnnohistochemishy, SUZUKI KAZUHIRO, 1997, Tohoku J Ey Med

Effect of aromotase inhibitor, TZA-2209, on the prostate of androsternedione-treated castrated dogs : chayes in prostate volume and histopathological findings, SUZUKI KAZUHIRO, Yes, 1996, Prostate

Synergistic Effects of Estrogen and Androgen on the Prostate : Effects of Estrogen on Androgen-and Estrogen-receptors, Brd V Uptake, Immunohistochemical Study of AR, and Responses to Antiandrogens, SUZUKI KAZUHIRO / ITO KAZUTO / suzuki takanori / YAMANAKA HIDETOSHI, No, Mar. 1995, Prostate

Expression and Degradation of Rat Androgen Receptor Following Castration, testosterone Replacement and Antiandrogens Administration : Analysis by Western Blot and Immunohistochemistry, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / suzuki takanori / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, No, Nov. 1997, Tohoku J Exp Med

Changes in the endocrine environment of the human prostate transition zone with aging : Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition, SHIBATA YASUHIRO / ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, No, Jan. 2000, Prostate

Yes, May 2010, ２３, ５, ７１９

Yes, May 2009, 138, 2, 251

Yes, Dec. 2008, ２１, １２, １５８５

Epidemiology of prostate cancer and benign prostatic hyperplasia, Kazuhiro Suzuki, Yes, Dec. 2009, JMAJ

Development of an enzyme-linked immunosorbent assay for metallothionein-I and -II in plasma of humans and experimental animals., Nakajima K, Kodaira T, Kato M, Nakazato K, Tokita Y, Kikuchi H, Sekine H, Suzuki K, Nagamine T., No, May 2010, Clin Chim Acta

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells., Abdulah R, Faried A, Kobayashi K, Yamazaki C, Suradji EW, Ito K, Suzuki K, Murakami M, Kuwano H, Koyama H., No, Nov. 2009, BMC Cancer

New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry., Arai S, Miyashiro Y, Shibata Y, Kashiwagi B, Tomaru Y, Kobayashi M, Watanabe Y, Honma S, Suzuki K., No, Jan. 2010, Steroids

Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer., Okamura K, Koike H, Sekine Y, Matsui H, Suzuki K., No, Aug. 2009, Cancer Epidemiolo

Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor., Sekine Y, Koike H, Nakano T, Nakajima K, Takahashi S, Suzuki K., No, Jul. 2009, Cancer Epidemiol

The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha1-adrenergic receptor antagonist work well for ureteral stones?, Ohki K, Ohno Y, Suzuki K., No, Jan. 2010, Int Urol Nephrol

Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy., Miyakubo M, Ito K, Yamamoto T, Takechi H, Ohi M, Suzuki K., No, Jun. 2009, Int J Urol

Induction of type 1 interferon receptor by zinc in U937 cells., Nagamine T, Nakajima K, Takada H, Sekine Y, Suzuki K., No, Jun. 2009, Cytokine

Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia., Nagai Y, Hasegawa M, Shinmi K, Kishi C, Tsushima Y, Endo K, Okabe K, Suzuki K, Ishikawa O., No, Jun. 2008, Acta Derm Venereol

Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Sekine Y, Furuya Y, Nishii M, Koike H, Matsui H, Suzuki K., No, Jul. 2008, Biochem Biophys Res Commun.

Changes in baseline PSA levels in Japanese men from 1988 to 2003., Ohi M, Ito K, Yamamoto T, Miyakubo M, Takechi H, Kubota Y, Suzuki K., No, Jul. 2008, Urology

Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds., Yamamoto T, Ito K, Miyakubo M, Takechi H, Suzuki K, Akimoto T, Ishikawa H, Nakano T., Yes, Oct. 2008, Urology

Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease., Hamano T, Matsui H, Sekine Y, Ohtake N, Nakata S, Suzuki K., No, Aug. 2010, Journal of Urology

Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer., Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K., No, Dec. 2008, Urology

Yes, Feb. 2009, ８１, ２, ２００

Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population., Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, Nakata S, Yamanaka H, Suzuki K., No, Apr. 2008, Int Urol Nephrol

Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan., Takechi H, Ito K, Yamamoto T, Miyakubo M, Ohi M, Suzuki K., No, Nov. 2008, Urology

Yes, Nov. 2009, 58, 11, 2351-352

Yes, Apr. 2009, 7, 2, 10-16

Yes, Nov. 2009, 16, 11, 1064

Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related induces in men with total PSA in the 2.0-10.0ng/ml range., No, 2012, World J Urol

Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate., No, 2012, Int J Radiat Oncol Biol Phys

Serous borderline tumor of the paratestis in a child., No, 2012, BJUI.org

Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme., No, 2012, Prostate Cancer and Prostatic Disease

Luteinizing horomone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: Implications for the effect of LH on the adrenal glands., No, 2012, J Androl

Lower urinary tract symptoms of neurological origin in urological practice., No, 2012, Clin Auton Res

Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., No, 2012

Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation., No, 2012, Biochem Biophys Res Commun

Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy., No, 2012, Prostate Cancer and Prostatic Disease

Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., No, 2011, Steroids

Yes, 2010

Yes, 2011

Yes, 2011

Yes, 2011

Yes, 2011

Yes, 2011

No, 2011

Yes, 2011

Yes, 2011

Yes, 2012

Yes, 2012

Yes, 2012

No, 2012

Role of squalene synthase in prostate cancer risk and the biological aggressiveness on human prostate cancer, No, 2012, Prostate Cancer and Prostatic Disease

Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., No, 2011, J Urol

High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., No, 2011, The Prostate

Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010., No, 2010, Int J Urol

The investigation of ureteral sympathetic innevation, using semi-serial sections: why dose the alpha1-adrenergic receptor antagonist work well for ureteral stones?, No, 2010, Int Urol Nephrol

Yes, 2010

Yes, 2010

Yes, 2010

Yes, 2010

Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Miyazawa Y, Kato H, Arai S, Furuya Y, Sekine Y, Nomura M, Koike H, Matsui H, Shibata Y, Ito K, Suzuki K, No, 2015, Basic and Clinical Andrology

Suicide attempt with an overdose of sunitinib, Arai, Seiji; Matsui, Hiroshi; Ohki, Ryo; Miyazawa, Yoshiyuki; Koike, Hidekazu; Hashita, Tadahiro; Katsuyama, Yoshihiko; Sekine, Yoshitaka; Nomura, Masashi; Shibata, Yasuhiro; Hatori, Motoaki; Ito, Kazuto; Yamamoto, Koujirou; Ohmori, Shigeru; Suzuki, Kazuhiro, No, Oct. 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Chlormadinone acetate is effective for hot flush during androgen deprivation therapy, Koike, Hidekazu; Morikawa, Yasuyuki; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, No, 2013, Prostate International

Androgen receptor coactivator p120 subtype beta is highly expressed in prostate cancer, Muramatasu, Kazumichi; Matsui, Hiroshi; Sekine, Yoshitaka; Koike, Hidekazu; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, No, 2013, Prostate International

Simple method for preventing inguinal hernias after radical retropubic prostatectomy, Koike, Hidekazu; Matsui, Hiroshi; Morikawa, Yasuyuki; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, No, 2013, Prostate International

Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues, Arai, S.; Shibata, Y.; Nakamura, Y.; Kashiwagi, B.; Uei, T.; Tomaru, Y.; Miyashiro, Y.; Honma, S.; Hashimoto, K.; Sekine, Y.; Ito, K.; Sasano, H.; Suzuki, K., No, 2013, ANDROLOGY

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, No, 2017, BMC UROLOGY

Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Fujizuka, Yuji; Ito, Kazuto; Oki, Ryo; Suzuki, Rie; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, No, 2017, INTERNATIONAL JOURNAL OF UROLOGY

Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, No, 2017, ANTICANCER RESEARCH

Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Kato, Haruo; Furuya, Yosuke; Koike, Hidekazu; Suzuki, Kazuhiro, No, 2017, PROSTATE

Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Shibata, Yasuhiro; Kurihara, Sota; Arai, Seiji; Kato, Haruo; Suzuki, Tomomi; Miyazawa, Yoshiyuki; Koike, Hidekazu; Ito, Kazuto; Nakamura, Tetsuya; Suzuki, Kazuhiro, No, 2017, JOURNAL OF INVESTIGATIVE SURGERY

YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Nitta, Takashi; Koike, Hidekazu; Miyao, Takeshi; Miyazawa, Yoshiyuki; Kato, Haruo; Furuya, Yosuke; Sekine, Yoshitaka; Suzuki, Kazuhiro, No, 2017, ANTICANCER RESEARCH

Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Kato, Haruo; Furuya, Yosuke; Miyazawa, Yoshiyuki; Miyao, Takeshi; Syuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, No, Nov. 2016, ANTICANCER RESEARCH

Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naive prostate cancer, Miyoshi, Yasuhide; Uemura, Hiroji; Umemoto, Susumu; Sakamaki, Kentaro; Taguri, Masataka; Suzuki, Kazuhiro; Shibata, Yasuhiro; Masumori, Naoya; Ichikawa, Tomohiko; Mizokami, Atsushi; Sugimura, Yoshiki; Nonomura, Norio; Sakai, Hideki; Honma, Seijiro; Harada, Masaoki; Kubota, Yoshinobu, No, 2016, PROSTATE

Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan, Suzuki, Kazuhiro; Namiki, Mikio; Fujimoto, Tsukasa; Takabayashi, Nobuyoshi; Kudou, Kentarou; Akaza, Hideyuki, Yes, Dec. 2015, JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Ishikawa, Hitoshi; Katoh, Hiroyuki; Kaminuma, Takuya; Kawamura, Hidemasa; Ito, Kazuto; Matsui, Hiroshi; Hirato, Junko; Shimizu, Nobuaki; Takezawa, Yutaka; Tsuji, Hiroshi; Suzuki, Kazuhiro; Ohno, Tatsuya; Nakano, Takashi, No, Oct. 2015, ANTICANCER RESEARCH

Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer, Nozawa, Masahiro; Mukai, Hirofumi; Takahashi, Shunji; Uemura, Hiroji; Kosaka, Takeo; Onozawa, Yusuke; Miyazaki, Jun; Suzuki, Kazuhiro; Okihara, Koji; Arai, Yoichi; Kamba, Tomomi; Kato, Masashi; Nakai, Yasutomo; Furuse, Hiroshi; Kume, Haruki; Ide, Hisamitsu; Kitamura, Hiroshi; Yokomizo, Akira; Kimura, Takahiro; Tomita, Yoshihiko; Ohno, Keiji; Kakehi, Yoshiyuki, No, Oct. 2015, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY

Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association, Kanayama, Hiro-omi; Fukumori, Tomoharu; Fujimoto, Hiroyuki; Nakanishi, Hiroyuki; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Miki, Tsuneharu; Kamoi, Kazumi; Kubota, Yoshinobu; Takahashi, Satoru; Homma, Yukio; Naito, Seiji, No, 2015, INTERNATIONAL JOURNAL OF UROLOGY

Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Kato, Haruo; Sekine, Yoshitaka; Furuya, Yosuke; Miyazawa, Yoshiyuki; Koike, Hidekazu; Suzuki, Kazuhiro, No, 2015, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial, Saad, Fred; Fizazi, Karim; Jinga, Viorel; Efstathiou, Eleni; Fong, Peter C.; Hart, Lowell L.; Jones, Robert; McDermott, Raymond; Wirth, Manfred; Suzuki, Kazuhiro; MacLean, David B.; Wang, Ling; Akaza, Hideyuki; Nelson, Joel; Scher, Howard I.; Dreicer, Robert; Webb, Iain J.; de Wit, Ronald, No, 2015, LANCET ONCOLOGY

Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata, Yasuhiro; Arai, Seiji; Miyazawa, Yoshiyuki; Shuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Ito, Kazuto; Suzuki, Kazuhiro, No, 2017, PROSTATE

A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Suzuki, Kazuhiro; Ozono, Seiichiro; Yamaguchi, Akito; Koike, Hidekazu; Matsui, Hiroshi; Nagata, Masao; Takubo, Takatoshi; Miyashita, Kana; Matsushima, Takafumi; Akaza, Hideyuki, Yes, 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY

Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan, Onozawa, Mizuki; Hinotsu, Shiro; Tsukamoto, Taiji; Oya, Mototsugu; Ogawa, Osamu; Kitamura, Tadaichi; Suzuki, Kazuhiro; Naito, Seiji; Namiki, Mikio; Nishimura, Kazuo; Hirao, Yoshihiko; Akaza, Hideyuki, No, Oct. 2014, JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer, Matsuyama, Hideyasu; Shimabukuro, Tomoyuki; Hara, Isao; Kohjimoto, Yasuo; Suzuki, Kazuhiro; Koike, Hidekazu; Uemura, Hirotsugu; Hayashi, Taiji; Ueno, Munehisa; Kodaira, Kiichiro; Tomita, Yoshihiko; Sakurai, Toshihiko; Shimizu, Nobuaki, No, Oct. 2014, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY

YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Koike, Hidekazu; Nitta, Takashi; Sekine, Yoshitaka; Arai, Seiji; Furuya, Yosuke; Nomura, Masashi; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Oyama, Tetsunari; Suzuki, Kazuhiro, No, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients, Miyoshi, Yasuhide; Uemura, Hiroji; Umemoto, Susumu; Sakamaki, Kentaro; Morita, Satoshi; Suzuki, Kazuhiro; Shibata, Yasuhiro; Masumori, Naoya; Ichikawa, Tomohiko; Mizokami, Atsushi; Sugimura, Yoshiki; Nonomura, Norio; Sakai, Hideki; Honma, Seijiro; Harada, Masaoki; Kubota, Yoshinobu, No, 2014, BMC CANCER

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Ishizuka, Tamotsu; Hisada, Takeshi; Hatori, Motoaki; Koike, Akio; Hanabuchi, Kikuo; Matsuzaki, Shinichi; Kamide, Yosuke; Utsugi, Mitsuyoshi; Aoki, Haruka; Yoshino, Reiko; Yanagitani, Noriko; Koga, Yasuhiko; Ono, Akihiro; Kaira, Kyoichi; Sunaga, Noriaki; Dobashi, Kunio; Tsuburai, Takahiro; Akiyama, Kazuo; Yamada, Masanobu; Suzuki, Kazuhiro; Mori, Masatomo, No, 2014, INFLAMMATION RESEARCH

Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Miki, Tsuneharu; Kamoi, Kazumi; Fujimoto, Hiroyuki; Kanayama, Hiro-omi; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Naito, Seiji; Fukumori, Tomoharu; Kubota, Yoshinobu; Takahashi, Satoru; Mikami, Kazuya; Homma, Yukio, No, 2014, INTERNATIONAL JOURNAL OF UROLOGY

Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort, Inamoto, Teruo; Azuma, Haruhito; Hinotsu, Shiro; Tsukamoto, Taiji; Oya, Mototsugu; Ogawa, Osamu; Kitamura, Tadaichi; Kazuhiro, Suzuki; Naito, Seiji; Namiki, Mikio; Nishimura, Kazuo; Hirao, Yoshihiko; Usami, Michiyuki; Murai, Masaru; Akaza, Hideyuki, No, 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Magari, Tomohiro; Shibata, Yasuhiro; Arai, Seiji; Kashiwagi, Bunzo; Suzuki, Keiji; Suzuki, Kazuhiro, No, 2014, ASIAN JOURNAL OF ANDROLOGY

Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Fujimoto, Hiroyuki; Nakanishi, Hiroyuki; Miki, Tsuneharu; Kanayama, Hiro-omi; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Naito, Seiji; Fukumori, Tomoharu; Kubota, Yoshinobu; Takahashi, Satoru; Homma, Yukio; Kamoi, Kazumi, No, 2014, INTERNATIONAL JOURNAL OF UROLOGY

Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer, Mukai, Hirofumi; Takahashi, Shunji; Nozawa, Masahiro; Onozawa, Yusuke; Miyazaki, Jun; Ohno, Keiji; Suzuki, Kazuhiro, No, 2014, CANCER CHEMOTHERAPY AND PHARMACOLOGY

Chronic expanding hematoma in the retroperitoneal space: a case report, Syuto, Takahiro; Hatori, Motoaki; Masashi, Nomura; Sekine, Yoshitaka; Suzuki, Kazuhiro, No, Nov. 2013, BMC UROLOGY

High-Density Lipoprotein and Prostate Cancer: An Overview, Kotani, Kazuhiko; Sekine, Yoshitaka; Ishikawa, Shizukiyo; Ikpot, Imoh Z.; Suzuki, Kazuhiro; Remaley, Alan T., No, 2013, JOURNAL OF EPIDEMIOLOGY

Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy, Shibata, Y.; Suzuki, K.; Arai, S.; Miyoshi, Y.; Umemoto, S.; Masumori, N.; Kamiya, N.; Ichikawa, T.; Kitagawa, Y.; Mizokami, A.; Sugimura, Y.; Nonomura, N.; Sakai, H.; Honma, S.; Kubota, Y., No, 2013, ANDROLOGY

Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito, Kazuto; Miyakubo, Mai; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, No, 2013, WORLD JOURNAL OF UROLOGY

Lower urinary tract symptoms of neurological origin in urological practice, Magari, Tomohiro; Fukabori, Yoshitatsu; Ogura, Haruyuki; Suzuki, Kazuhiro, No, 2013, CLINICAL AUTONOMIC RESEARCH

Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation, Magari, Tomohiro; Shibata, Yasuhiro; Arai, Sew; Kashiwagi, Bunzo; Suzuki, Kazuhiro, No, 2013, SCANDINAVIAN JOURNAL OF UROLOGY

;;;, Apr. 2022, 9, 1, 1

;;;, Apr. 2022, 5, 1, 05

;;;;;;, Apr. 2022, 9, 1, 35

Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer., Kazama Hirotaka;Kawaguchi Osamu;Seto Takeshi;Suzuki Kazuhiro;Matsuyama Hideyasu;Matsubara Nobuaki;Tajima Yuki;Fukao Taro, Apr. 2022, BMC cancer, 22, 1

;;;, Apr. 2022, 9, 1, 1

;;;;;;, Apr. 2022, 9, 1, 35

;;;;, Apr. 2022, 98, 1, 312

;;;, Apr. 2022, 5, 1, 05

;;;;;;;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 469

;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 516

;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 674

;;;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 775

;;;;;;, Jul. 2022, 31回, 34

;, Jul. 2022, 16, 1, 25

;;;;;;;;, Aug. 2022, 16, 2, 149

;;;;;, Aug. 2022, 35, 8, 860

;;;;, Aug. 2022, 35, 8, 909

;;, Oct. 2015, 28, 10, 1631

Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer, Nakayama, Hiroshi;Sekine, Yoshitaka;Oka, Daisuke;Miyazawa, Yoshiyuki;Arai, Seiji;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2022, PROSTATE, 82, 3, 314, 322

A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS., Miyazawa, Yoshiyuki;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Arai, Seiji;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2022, JOURNAL OF CLINICAL ONCOLOGY, 40, 6

Comparative study of RARP and carbon ion radiotherapy sexual functional changes for prostate cancer using the propensity score matching method., Miyazawa, Yoshiyuki;Oka, Daisuke;Koike, Hidekazu;Kawamura, Hidemasa;Miyasaka, Yuhei;Syuto, Takahiro;Arai, Seiji;Sekine, Yoshitaka;Matsui, Hiroshi;Ohno, Tatsuya;Suzuki, Kazuhiro, 2022, JOURNAL OF CLINICAL ONCOLOGY, 40, 6

Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer, Kazama, Hirotaka;Kawaguchi, Osamu;Seto, Takeshi;Suzuki, Kazuhiro;Matsuyama, Hideyasu;Matsubara, Nobuaki;Tajima, Yuki;Fukao, Taro, 2022, BMC CANCER, 22, 1

Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study, Uemura, Hiroji;Kobayashi, Kazuki;Yokomizo, Akira;Hinotsu, Shiro;Horie, Shigeo;Kakehi, Yoshiyuki;Nonomura, Norio;Ogawa, Osamu;Oya, Mototsugu;Suzuki, Kazuhiro;Saito, Atsushi;Asakawa, Keiko;Uno, Satoshi;Naito, Seiji, 2022, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 27, 10, 1632, 1643

Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Kato, Mai;Maeno, Yuta;Miyazawa, Yoshiyuki;Fujizuka, Yuji;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2022, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 628, 76, 83

Brefeldin A mediates integrated stress response and in combination with Navitoclax induces apoptosis in prostate cancer cells., Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2022, CANCER RESEARCH, 82, 12

Brefeldin A mediates integrated stress response and in combination with Navitoclax induces apoptosis in prostate cancer cells, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2022, CANCER RESEARCH, 82, 12

A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS, Miyazawa, Yoshiyuki;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Sekine, Yoshitaka;Arai, Seiji;Suzuki, Kazuhiro, 2023, PROSTATE, 83, 8, 759, 764

Summary of the clinical practice manual for late-onset hypogonadism, Ide, Hisamitsu;Akehi, Yuko;Fukuhara, Shinichiro;Ohira, Shin;Ogawa, Sumito;Kataoka, Tomoya;Kumagai, Hiroshi;Kobayashi, Ko;Komiya, Akira;Shigehara, Kazuyoshi;Syuto, Takahiro;Soh, Jintetu;Tanabe, Makito;Taniguchi, Hisanori;Chiba, Koji;Matsushita, Kazuhito;Mitsui, Yozo;Yoneyama, Takahiro;Shirakawa, Tomoya;Fujii, Yasuhisa;Kumano, Hiroaki;Ueshiba, Hajime;Amano, Toshiyasu;Sasaki, Haruaki;Maeda, Seiji;Mizokami, Atsushi;Suzuki, Kazuhiro;Horie, Shigeo, 2023, INTERNATIONAL JOURNAL OF UROLOGY, 30, 5, 422, 430

Carbon-ion radiotherapy for inoperable upper tract ureteral cancer, Mizukami, Tatsuji;Kawamura, Hidemasa;Kubo, Nobuteru;Sato, Hiro;Kawahara, Masahiro;Adachi, Akiko;Matsui, Hiroshi;Suzuki, Kazuhiro;Saitoh, Jun-ichi;Nakano, Takashi;Ohno, Tatsuya, 2023, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report, Ohtsu, Akira;Arai, Seiji;Fujizuka, Yuji;Fukuda, Reon;Hori, Keisuke;Morimura, Yuki;Kawahara, Rintaro;Shiraishi, Takuya;Ogawa, Hiroomi;Miyazawa, Yoshiyuki;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2023, BMC UROLOGY, 23, 1

The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide, Miyazawa, Yoshiyuki;Hori, Keisuke;Tsuji, Yusuke;Sekine, Yoshitaka;Arai, Seiji;Fujizuka, Yuji;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2023, INTERNATIONAL JOURNAL OF UROLOGY

Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan, Matsuyama, Hideyasu;Matsubara, Nobuaki;Kazama, Hirotaka;Seto, Takeshi;Sunaga, Yoshinori;Suzuki, Kazuhiro, 2023, BMC CANCER, 23, 1

Moving beyond negative campaign for PSA-based screening for prostate cancer, Ito, Kazuto;Sekine, Yoshitaka;Suzuki, Kazuhiro;Kurosawa, Isao, 2023, CANCER SCIENCE, 114, 1536, 1536

Baseline characteristics may impact treatment duration of cabazitaxel in patients with mCRPC: a subanalysis of data from a post-marketing surveillance, Matsubara, Nobuaki;Matsuyama, Hideyasu;Kazama, Hirotaka;Seto, Takeshi;Sunaga, Yoshinori;Suzuki, Kazuhiro, 2023, JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Feb. 2016, 31, 24

Predictive models of long-term survival outcomes following radical cystectomy., Ohtsu Akira;Arai Seiji;Fujizuka Yuji;Miyazawa Yoshiyuki;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Oct. 2023, Cancer medicine, 12, 23

Successful embolization of subcutaneous mesenteric varices within an ileal conduit in a patient with liver cirrhosis., Sakurai Ayaka;Ohtsu Akira;Arai Seiji;Aoki Masanori;Ikeya Miho;Tokue Hiroyuki;Hori Keisuke;Fujizuka Yuji;Sekine Yoshitaka;Koike Hidekazu;Suzuki Kazuhiro, Sep. 2023, IJU case reports, 6, 6

L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity., Rii Junryo;Sakamoto Shinichi;Mizokami Atsushi;Xu Minhui;Fujimoto Ayumi;Saito Shinpei;Koike Hidekazu;Tamura Takaaki;Arai Takayuki;Yamada Yasutaka;Goto Yusuke;Sazuka Tomokazu;Imamura Yusuke;Suzuki Kazuhiro;Kanai Yoshikatsu;Anzai Naohiko;Ichikawa Tomohiko, Jan. 2024, Cancer science, 115, 3

Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial., Yokomizo Akira;Koga Hirofumi;Ito Kazuto;Takezawa Yutaka;Komiyama Motokiyo;Nishimura Kazuo;Yonese Junji;Hashine Katsuyoshi;Masumori Naoya;Arai Gaku;Saito Shiro;Shinohara Mitsuru;Shimizu Nobuaki;Yamauchi Atsushi;Satoh Takefumi;Tochigi Tatsuo;Kobayashi Mikio;Fujimoto Hiroyuki;Kakimoto Ken-Ichi;Fukui Iwao;Tsukamoto Taiji;Nozaki Miwako;Karasawa Katsuyuki;Hasumi Masaru;Ohtani Mikinobu;Ishiyama Hiromichi;Kuwahara Masaaki;Harada Masaoki;Ohashi Yasuo;Kotake Toshihiko;Kakizoe Tadao;Suzuki Kazuhiro;Naito Seiji;Yamanaka Hidetoshi; , May 2021, Cancer medicine, 10, 10

Carbon ion radiotherapy for prostate cancer with bladder invasion., Miyasaka Yuhei;Kawamura Hidemasa;Sato Hiro;Kubo Nobuteru;Mizukami Tatsuji;Matsui Hiroshi;Miyazawa Yoshiyuki;Ito Kazuto;Nakano Takashi;Suzuki Kazuhiro;Ohno Tatsuya, Aug. 2021, BMC urology, 21, 1

Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer., Sekine Yoshitaka;Nakayama Hiroshi;Miyazawa Yoshiyuki;Arai Seiji;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Oct. 2021, Oncology letters, 22, 6

Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer., Nakayama Hiroshi;Sekine Yoshitaka;Oka Daisuke;Miyazawa Yoshiyuki;Arai Seiji;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, Nov. 2021, The Prostate, 82, 3

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study., Uemura Hiroji;Kobayashi Kazuki;Yokomizo Akira;Hinotsu Shiro;Horie Shigeo;Kakehi Yoshiyuki;Naito Seiji;Nonomura Norio;Ogawa Osamu;Oya Mototsugu;Suzuki Kazuhiro;Saito Atsushi;Uno Satoshi;Akaza Hideyuki, Aug. 2021, BJUI compass, 3, 1

Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells., Ohtsu Akira;Arai Seiji;Sawada Tatsuhiro;Kato Mai;Maeno Yuta;Miyazawa Yoshiyuki;Fujizuka Yuji;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, Aug. 2022, Biochemical and biophysical research communications, 628

Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin., Miyazawa Yoshiyuki;Shimizu Takanori;Sekine Yoshitaka;Arai Seiji;Ohtsu Akira;Fujizuka Yuji;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, Oct. 2022, IJU case reports, 6, 1

Summary of the clinical practice manual for late-onset hypogonadism., Ide Hisamitsu;Akehi Yuko;Fukuhara Shinichiro;Ohira Shin;Ogawa Sumito;Kataoka Tomoya;Kumagai Hiroshi;Kobayashi Ko;Komiya Akira;Shigehara Kazuyoshi;Syuto Takahiro;Soh Jintetu;Tanabe Makito;Taniguchi Hisanori;Chiba Koji;Matsushita Kazuhito;Mitsui Yozo;Yoneyama Takahiro;Shirakawa Tomoya;Fujii Yasuhisa;Kumano Hiroaki;Ueshiba Hajime;Amano Toshiyasu;Sasaki Haruaki;Maeda Seiji;Mizokami Atsushi;Suzuki Kazuhiro;Horie Shigeo, Feb. 2023, International journal of urology : official journal of the Japanese Urological Association, 30, 5

Carbon-ion radiotherapy for inoperable upper tract ureteral cancer., Mizukami Tatsuji;Kawamura Hidemasa;Kubo Nobuteru;Sato Hiro;Kawahara Masahiro;Adachi Akiko;Matsui Hiroshi;Suzuki Kazuhiro;Saitoh Jun-Ichi;Nakano Takashi;Ohno Tatsuya, Apr. 2023, Asia-Pacific journal of clinical oncology

Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan., Matsuyama Hideyasu;Matsubara Nobuaki;Kazama Hirotaka;Seto Takeshi;Sunaga Yoshinori;Suzuki Kazuhiro, Jun. 2023, BMC cancer, 23, 1

Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin., Katsumi Shigeaki;Araki Takuya;Yashima Hideaki;Miyazawa Yoshiyuki;Suzuki Kazuhiro;Yamamoto Koujirou, Jul. 2023, Case reports in oncology, 16, 1

Hormonal therapy for localized prostate cancer in Japan: The outcome of J-CaP database, Hinotsu, Shiro;Akaza, Hideyuki;Ogawa, Osamu;Oya, Mototsugu;Kitamura, Tadaichi;Suzuki, Kazuhiro;Tsukamoto, Taiji;Naito, Seiji;Namiki, Mikio;Nishimura, Kazuo;Hirao, Yoshihiko;J-CaP Study Grp, 2012, JOURNAL OF CLINICAL ONCOLOGY, 30, 5

Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer, Miyamoto, Shigehito;Ito, Kazuto;Kurokawa, Kohei;Suzuki, Kazuhiro;Suzuki, Keiji;Yamanaka, Hidetoshi, 2006, INTERNATIONAL JOURNAL OF UROLOGY, 13, 6, 767, 772

Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population, Okugi, Hironobu;Nakazato, Haruki;Matsui, Hiroshi;Ohtake, Nobuaki;Nakata, Seiji;Suzuki, Kazuhiro, 2006, CANCER DETECTION AND PREVENTION, 30, 3, 262, 268

Positive effect of prostaglandin on regulation of prostatic blood flow, Kashiwagi, Bunzo;Shibata, Yasuhiro;Ohki, Kazunari;Arai, Seiji;Honma, Seijiro;Suzuki, Kazuhiro, 2006, UROLOGY, 68, 3, 682, 686

Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo, Shibata, Yasuhiro;Kashiwagi, Bunzo;Arai, Seiji;Magari, Tomohiro;Suzuki, Kazuhiro;Honma, Seijiro, 2006, UROLOGY, 68, 5, 1127, 1131

Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan, Sekine, Yoshitaka;Ito, Kazuto;Yamamoto, Takumi;Nakazato, Haruki;Shibata, Yasuhiro;Hatori, Motoaki;Suzuki, Kazuhiro, 2007, CANCER DETECTION AND PREVENTION, 31, 2, 149, 153

Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells, Sekine, Yoshitaka;Koike, Hidekazu;Nakano, Takamitsu;Nakajima, Katsuyuki;Suzuki, Kazuhiro, 2007, CLINICA CHIMICA ACTA, 383, 1-2, 78, 84

Lead time of prostate cancer detected in population based screening for prostate cancer in Japan, Ito, Kazuto;Yamamoto, Takumi;Miyakubo, Mai;Takechi, Hiroyuki;Ohi, Masaru;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2007, JOURNAL OF UROLOGY, 178, 4, 1258, 1263

The Second Joint Meeting of American Urological Association (AUA)/Japanese Urological Association (JUA) International Program on the 102nd Annual Meeting of American Urological Association at Anaheim 2007, Ogan, Kenneth;Kawai, Koji;Gill, Inderbir Singh;Naito, Seiji;Isaacs, Williams B.;Suzuki, Kazuhiro;Kibel, Adam S.;Kakehi, Yoshiyuki;Yoshimura, Naoki;Yokoyama, Osamu;Chancellor, Michael B.;Takahashi, Satoru, 2007, INTERNATIONAL JOURNAL OF UROLOGY, 14, 12, 1116, 1116

Familial prostate cancer in Japan, Suzuki, Kazuhiro, 2007, INTERNATIONAL JOURNAL OF UROLOGY, 14, 12, 1120, 1120

Evidence-based clinical practice guidelines for prostate cancer (Summary JUA 2006 edition), Kamidono, Sadao;Ohshima, Shinichi;Hirao, Yoshihiko;Suzuki, Kazuhiro;Arai, Yoichi;Fujimoto, Hiroyuki;Egawa, Shin;Akaza, Hideyuki;Hara, Isao;Hinotsu, Shiro;Kakehi, Yoshiyuki;Hasegawa, Tomonori, 2008, INTERNATIONAL JOURNAL OF UROLOGY, 15, 1, 1, 18

Willingness to pay for mass screening for prostate cancer: A contingent valuation survey - Comment, Suzuki, Kazuhiro, 2008, INTERNATIONAL JOURNAL OF UROLOGY, 15, 1, 105, 105

Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan - Comment, Suzuki, Kazuhiro, 2008, INTERNATIONAL JOURNAL OF UROLOGY, 15, 2, 161, 161

Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Hamano, Tatsuya;Matsui, Hiroshi;Ohtake, Nobuaki;Nakata, Seiji;Suzuki, Kazuhiro, 2008, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26

Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor, Sekine, Yoshitaka;Furuya, Yosuke;Nishii, Masahiro;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2008, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 372, 2, 356, 361

Changes in baseline PSA levels in Japanese men from 1988 to 2003, Ohi, Masaru;Ito, Kazuto;Yamamoto, Takumi;Miyakubo, Mai;Takechi, Hiroyuki;Kubota, Yutaka;Suzuki, Kazuhiro, 2008, UROLOGY, 72, 1, 95, 98

Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds, Yamamoto, Takumi;Ito, Kazuto;Miyakubo, Mal;Takechi, Hiroyuki;Suzuki, Kazuhiro;Akimoto, Tetsuo;Ishikawa, Hitoshi;Nakano, Takashi, 2008, UROLOGY, 72, 4, 892, 897

Prostate-Specific Antigen Kinetics in Screen-Detected Prostate Cancer in Japan, Takechi, Hiroyuki;Ito, Kazuto;Yamamoto, Takumi;Miyakubo, Mai;Ohi, Masaru;Suzuki, Kazuhiro, 2008, UROLOGY, 72, 5, 1111, 1115

Nephrogenic Systemic Fibrosis with Multiple Calcification and Osseous Metaplasia, Nagai, Yayoi;Hasegawa, Michiko;Shinmi, Kahori;Kishi, Chikako;Tsushima, Yoshito;Endo, Keigo;Okabe, Kazuhiko;Suzuki, Kazuhiro;Ishikawa, Osamu, 2008, ACTA DERMATO-VENEREOLOGICA, 88, 6, 597, 600

Gene Expression of Survivin and Its Spliced Isoforms Associated With Proliferation and Aggressive Phenotypes of Prostate Cancer, Koike, Hidekazu;Sekine, Yoshitaka;Kamiya, Makoto;Nakazato, Haruki;Suzuki, Kazuhiro, 2008, UROLOGY, 72, 6, 1229, 1233

Proprostate-specific antigen: Its usefulness in the era of multiple-core prostate biopsy, Miyakubo, Mai;Ito, Kazuto;Yamamoto, Takumi;Takechi, Hiroyuki;Ohi, Masaru;Suzuki, Kazuhiro, 2009, INTERNATIONAL JOURNAL OF UROLOGY, 16, 6, 561, 565

Induction of type 1 interferon receptor by zinc in U937 cells, Nagamine, Takeaki;Nakajima, Kastuyuki;Takada, Hisashi;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2009, CYTOKINE, 46, 3, 346, 350

Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor, Sekine, Yoshitaka;Koike, Hidekazu;Nakano, Takamitsu;Nakajima, Katsuyuki;Takahashi, Sadao;Suzuki, Kazuhiro, 2009, CANCER EPIDEMIOLOGY, 33, 1, 16, 23

Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Okamura, Keigo;Koike, Hidekazu;Sekine, Yoshitaka;Matsui, Hiroshi;Suzuki, Kazuhiro, 2009, CANCER EPIDEMIOLOGY, 33, 2, 137, 141

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells, Abdulah, Rizky;Faried, Ahmad;Kobayashi, Kenji;Yamazaki, Chiho;Suradji, Eka W.;Ito, Kazuto;Suzuki, Kazuhiro;Murakami, Masami;Kuwano, Hiroyuki;Koyama, Hiroshi, 2009, BMC CANCER, 9

New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry, Arai, Seiji;Miyashiro, Yoshimichi;Shibata, Yasuhiro;Kashiwagi, Bunzo;Tomaru, Yukio;Kobayashi, Mikio;Watanabe, Yoko;Honma, Seijiro;Suzuki, Kazuhiro, 2010, STEROIDS, 75, 1, 13, 19

The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the α1-adrenergic receptor antagonist work well for ureteral stones?, Ohki, Kazunari;Ohno, Yosihiro;Suzuki, Kazuhiro, 2010, INTERNATIONAL UROLOGY AND NEPHROLOGY, 42, 1, 113, 117

Association of SNP rs1447295 and Microsatellite Marker DG8S737 With Familial Prostate Cancer and High Grade Disease, Hamano, Tatsuya;Matsui, Hiroshi;Sekine, Yoshitaka;Ohtake, Nobuaki;Nakata, Seiji;Suzuki, Kazuhiro, 2010, JOURNAL OF UROLOGY, 184, 2, 738, 742

High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen-Independent Cancer Cells by an ABCA1-Dependent Mechanism, Sekine, Yoshitaka;Demosky, Steve J.;Stonik, John A.;Furuya, Yosuke;Koike, Hidekazu;Suzuki, Kazuhiro;Remaley, Alan T., 2010, MOLECULAR CANCER RESEARCH, 8, 9, 1284, 1294

Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010, Naito, Seiji;Kakehi, Yoshiyuki;Okuyama, Akihiko;Imamura, Tomoaki;Yasunaga, Hideo;Akaza, Hideyuki;Hinotsu, Shiro;Arai, Yoichi;Dokiya, Takushi;Egawa, Shin;Suzuki, Kazuhiro;Koga, Hirofumi;Masumori, Naoya;Akakura, Koichiro;Kawashima, Kiyotaka;Okihara, Koji;Ito, Kazuto;Comm Estab Guidelines Screening Pr;Japanese Urological Assoc, 2010, INTERNATIONAL JOURNAL OF UROLOGY, 17, 10, 830, 838

Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues, Arai, Seiji;Miyashiro, Yoshimichi;Shibata, Yasuhiro;Tomaru, Yukio;Kobayashi, Mikio;Honma, Seijiro;Suzuki, Kazuhiro, 2011, STEROIDS, 76, 3, 301, 308

Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D₃ Induced Cell Growth Inhibition in Prostate Cancer, Koike, Hidekazu;Morikawa, Yasuyuki;Sekine, Yoshitaka;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2011, JOURNAL OF UROLOGY, 185, 4, 1497, 1503

HDL and Sphingosine-1-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and S1P Receptors, and Promote Cell Migration and Invasion, Sekine, Yoshitaka;Suzuki, Kazuhiro;Remaley, Alan T., 2011, PROSTATE, 71, 7, 690, 699

HDL and Sphingosine-I-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and SIP Receptors, and Promote Cell Migration and Invasion (vol 71, pg 690, 2011), Sekine, Yoshitaka;Suzuki, Kazuhiro;Remaley, Alan T., 2011, PROSTATE, 71, 13, 1480, 1480

High Fat Diet Reduces the Expression of Glutathione Peroxidase 3 in Mouse Prostate, Sekine, Yoshitaka;Osei-Hwedieh, David;Matsuda, Kant;Raghavachari, Nalini;Liu, Delong;Furuya, Yosuke;Koike, Hidekazu;Suzuki, Kazuhiro;Remaley, Alan T., 2011, PROSTATE, 71, 14, 1499, 1509

Suppressive effects of the antiandrogen agent, chlormadinone acetate and the 5α-reductase inhibitor, dutasteride on prostate weight and intraprostatic androgen levels in rats, Kobayashi, Hideo;Gotanda, Kotaro;Shibata, Yasuhiro;Watanabe, Jun-ichi;Nakano, Youichi;Shinbo, Atsushi;Suzuki, Kazuhiro, 2011, ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 61, 9, 515, 520

Oncological outcomes of the prostate cancer patients registered in 2004: Report from the Cancer Registration Committee of the JUA, Fujimoto, Hiroyuki;Nakanishi, Hiroyuki;Miki, Tsuneharu;Kubota, Yoshinobu;Takahashi, Satoru;Suzuki, Kazuhiro;Kanayama, Hiro-omi;Mikami, Kazuya;Homma, Yukio, 2011, INTERNATIONAL JOURNAL OF UROLOGY, 18, 12, 876, 881

Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Morikawa, Yasuyuki;Koike, Hidekazu;Sekine, Yoshitaka;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2012, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 419, 3, 584, 589

Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Nishii, Masahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Oyama, Tetsunari;Suzuki, Kazuhiro, 2012, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238

Lower urinary tract symptoms of neurological origin in urological practice, Magari, Tomohiro;Fukabori, Yoshitatsu;Ogura, Haruyuki;Suzuki, Kazuhiro, 2013, CLINICAL AUTONOMIC RESEARCH, 23, 2, 67, 72

Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito, Kazuto;Miyakubo, Mai;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2013, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311

Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation, Magari, Tomohiro;Shibata, Yasuhiro;Arai, Sew;Kashiwagi, Bunzo;Suzuki, Kazuhiro, 2013, SCANDINAVIAN JOURNAL OF UROLOGY, 47, 3, 236, 241

High-Density Lipoprotein and Prostate Cancer: An Overview, Kotani, Kazuhiko;Sekine, Yoshitaka;Ishikawa, Shizukiyo;Ikpot, Imoh Z.;Suzuki, Kazuhiro;Remaley, Alan T., 2013, JOURNAL OF EPIDEMIOLOGY, 23, 5, 313, 319

Chronic expanding hematoma in the retroperitoneal space: a case report, Syuto, Takahiro;Hatori, Motoaki;Masashi, Nomura;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2013, BMC UROLOGY, 13

Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer, Mukai, Hirofumi;Takahashi, Shunji;Nozawa, Masahiro;Onozawa, Yusuke;Miyazaki, Jun;Ohno, Keiji;Suzuki, Kazuhiro;TED 11576 Invest, 2014, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 4, 703, 710

Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Fujimoto, Hiroyuki;Nakanishi, Hiroyuki;Miki, Tsuneharu;Kanayama, Hiro-omi;Ohyama, Chikara;Suzuki, Kazuhiro;Nishiyama, Hiroyuki;Eto, Masatoshi;Naito, Seiji;Fukumori, Tomoharu;Kubota, Yoshinobu;Takahashi, Satoru;Homma, Yukio;Kamoi, Kazumi, 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 5, 527, 534

Phase I clinical study of cabazitaxel plus prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in a Japanese population., Takahashi, Shunji;Mukai, Hirofumi;Uemura, Hirotsugu;Uemura, Hiroji;Kosaka, Takeo;Nishiyama, Hiroyuki;Suzuki, Kazuhiro;Kakehi, Yoshiyuki;Okihara, Koji;Namiki, Shunichi;Ogawa, Osamu;Kato, Masashi;Nakai, Yasutomo;Ohno, Keiji;TED11576 Investigators, 2014, JOURNAL OF CLINICAL ONCOLOGY, 32, 4

Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Magari, Tomohiro;Shibata, Yasuhiro;Arai, Seiji;Kashiwagi, Bunzo;Suzuki, Keiji;Suzuki, Kazuhiro, 2014, ASIAN JOURNAL OF ANDROLOGY, 16, 3, 457, 460

Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Miki, Tsuneharu;Kamoi, Kazumi;Fujimoto, Hiroyuki;Kanayama, Hiro-omi;Ohyama, Chikara;Suzuki, Kazuhiro;Nishiyama, Hiroyuki;Eto, Masatoshi;Naito, Seiji;Fukumori, Tomoharu;Kubota, Yoshinobu;Takahashi, Satoru;Mikami, Kazuya;Homma, Yukio, 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 8, S1, S6

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Ishizuka, Tamotsu;Hisada, Takeshi;Hatori, Motoaki;Koike, Akio;Hanabuchi, Kikuo;Matsuzaki, Shinichi;Kamide, Yosuke;Utsugi, Mitsuyoshi;Aoki, Haruka;Yoshino, Reiko;Yanagitani, Noriko;Koga, Yasuhiko;Ono, Akihiro;Kaira, Kyoichi;Sunaga, Noriaki;Dobashi, Kunio;Tsuburai, Takahiro;Akiyama, Kazuo;Yamada, Masanobu;Suzuki, Kazuhiro;Mori, Masatomo, 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796

YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Koike, Hidekazu;Nitta, Takashi;Sekine, Yoshitaka;Arai, Seiji;Furuya, Yosuke;Nomura, Masashi;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Oyama, Tetsunari;Suzuki, Kazuhiro, 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713

High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients, Miyoshi, Yasuhide;Uemura, Hiroji;Umemoto, Susumu;Sakamaki, Kentaro;Morita, Satoshi;Suzuki, Kazuhiro;Shibata, Yasuhiro;Masumori, Naoya;Ichikawa, Tomohiko;Mizokami, Atsushi;Sugimura, Yoshiki;Nonomura, Norio;Sakai, Hideki;Honma, Seijiro;Harada, Masaoki;Kubota, Yoshinobu, 2014, BMC CANCER, 14

Suicide attempt with an overdose of sunitinib, Arai, Seiji;Matsui, Hiroshi;Ohki, Ryo;Miyazawa, Yoshiyuki;Koike, Hidekazu;Hashita, Tadahiro;Katsuyama, Yoshihiko;Sekine, Yoshitaka;Nomura, Masashi;Shibata, Yasuhiro;Hatori, Motoaki;Ito, Kazuto;Yamamoto, Koujirou;Ohmori, Shigeru;Suzuki, Kazuhiro, 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935

Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer, Matsuyama, Hideyasu;Shimabukuro, Tomoyuki;Hara, Isao;Kohjimoto, Yasuo;Suzuki, Kazuhiro;Koike, Hidekazu;Uemura, Hirotsugu;Hayashi, Taiji;Ueno, Munehisa;Kodaira, Kiichiro;Tomita, Yoshihiko;Sakurai, Toshihiko;Shimizu, Nobuaki, 2014, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 5, 946, 954

Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan, Onozawa, Mizuki;Hinotsu, Shiro;Tsukamoto, Taiji;Oya, Mototsugu;Ogawa, Osamu;Kitamura, Tadaichi;Suzuki, Kazuhiro;Naito, Seiji;Namiki, Mikio;Nishimura, Kazuo;Hirao, Yoshihiko;Akaza, Hideyuki, 2014, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 10, 969, 981

A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Suzuki, Kazuhiro;Ozono, Seiichiro;Yamaguchi, Akito;Koike, Hidekazu;Matsui, Hiroshi;Nagata, Masao;Takubo, Takatoshi;Miyashita, Kana;Matsushima, Takafumi;Akaza, Hideyuki, 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 75, 2, 373, 380

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial, Saad, Fred;Fizazi, Karim;Jinga, Viorel;Efstathiou, Eleni;Fong, Peter C.;Hart, Lowell L.;Jones, Robert;McDermott, Raymond;Wirth, Manfred;Suzuki, Kazuhiro;MacLean, David B.;Wang, Ling;Akaza, Hideyuki;Nelson, Joel;Scher, Howard I.;Dreicer, Robert;Webb, Iain J.;de Wit, Ronald;ELM-PC 4 Investigators, 2015, LANCET ONCOLOGY, 16, 3, 338, 348

Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Kato, Haruo;Sekine, Yoshitaka;Furuya, Yosuke;Miyazawa, Yoshiyuki;Koike, Hidekazu;Suzuki, Kazuhiro, 2015, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 461, 1, 115, 121

Phase 3, randomized, placebo-controlled trial of orteronel (TAK-700) plus prednisone in patients (pts) with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC) (ELM-PC 4 trial), De Wit, Ronald;Fizazi, Karim;Jinga, Viorel;Efstathiou, Eleni;Fong, Peter C. C.;Wirth, Manfred;Suzuki, Kazuhiro;Moran, Susan;Wang, Ling;Akaza, Hideyuki;Nelson, Joel;Scher, Howard I.;Dreicer, Robert;Borgstein, Niels Geert;Saad, Fred, 2014, JOURNAL OF CLINICAL ONCOLOGY, 32, 15

Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association, Kanayama, Hiro-omi;Fukumori, Tomoharu;Fujimoto, Hiroyuki;Nakanishi, Hiroyuki;Ohyama, Chikara;Suzuki, Kazuhiro;Nishiyama, Hiroyuki;Eto, Masatoshi;Miki, Tsuneharu;Kamoi, Kazumi;Kubota, Yoshinobu;Takahashi, Satoru;Homma, Yukio;Naito, Seiji, 2015, INTERNATIONAL JOURNAL OF UROLOGY, 22, 9, S1, S7

Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Ishikawa, Hitoshi;Katoh, Hiroyuki;Kaminuma, Takuya;Kawamura, Hidemasa;Ito, Kazuto;Matsui, Hiroshi;Hirato, Junko;Shimizu, Nobuaki;Takezawa, Yutaka;Tsuji, Hiroshi;Suzuki, Kazuhiro;Ohno, Tatsuya;Nakano, Takashi;Gunma Heavy Ion Medical Ctr, 2015, ANTICANCER RESEARCH, 35, 10, 5559, 5566

Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer, Nozawa, Masahiro;Mukai, Hirofumi;Takahashi, Shunji;Uemura, Hiroji;Kosaka, Takeo;Onozawa, Yusuke;Miyazaki, Jun;Suzuki, Kazuhiro;Okihara, Koji;Arai, Yoichi;Kamba, Tomomi;Kato, Masashi;Nakai, Yasutomo;Furuse, Hiroshi;Kume, Haruki;Ide, Hisamitsu;Kitamura, Hiroshi;Yokomizo, Akira;Kimura, Takahiro;Tomita, Yoshihiko;Ohno, Keiji;Kakehi, Yoshiyuki, 2015, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 5, 1026, 1034

Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan, Suzuki, Kazuhiro;Namiki, Mikio;Fujimoto, Tsukasa;Takabayashi, Nobuyoshi;Kudou, Kentarou;Akaza, Hideyuki, 2015, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45, 12, 1168, 1174

Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naive prostate cancer, Miyoshi, Yasuhide;Uemura, Hiroji;Umemoto, Susumu;Sakamaki, Kentaro;Taguri, Masataka;Suzuki, Kazuhiro;Shibata, Yasuhiro;Masumori, Naoya;Ichikawa, Tomohiko;Mizokami, Atsushi;Sugimura, Yoshiki;Nonomura, Norio;Sakai, Hideki;Honma, Seijiro;Harada, Masaoki;Kubota, Yoshinobu, 2016, PROSTATE, 76, 4, 376, 382

Germline Variants of Prostate Cancer in Japanese Families, Hayano, Takahide;Matsui, Hiroshi;Nakaoka, Hirofumi;Ohtake, Nobuaki;Hosomichi, Kazuyoshi;Suzuki, Kazuhiro;Inoue, Ituro, 2016, PLOS ONE, 11, 10

Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Kato, Haruo;Furuya, Yosuke;Miyazawa, Yoshiyuki;Miyao, Takeshi;Syuto, Takahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2016, ANTICANCER RESEARCH, 36, 11, 6141, 6149

YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Nitta, Takashi;Koike, Hidekazu;Miyao, Takeshi;Miyazawa, Yoshiyuki;Kato, Haruo;Furuya, Yosuke;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH, 37, 1, 75, 80

Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Kato, Haruo;Furuya, Yosuke;Koike, Hidekazu;Suzuki, Kazuhiro, 2017, PROSTATE, 77, 4, 337, 349

Pros and cons of docetaxel used to treat metastatic hormone-sensitive prostate cancer: The cons, Suzuki, Kazuhiro, 2016, ANNALS OF ONCOLOGY, 27

ARAMIS trial: Efficacy and safety of ODM-201 in men with high-risk nonmetastatic castration-resistant prostate cancer, Suzuki, Kazuhiro;Kuss, Iris;Smith, Matthew R.;Fizazi, Karim, 2016, ANNALS OF ONCOLOGY, 27

Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata, Yasuhiro;Arai, Seiji;Miyazawa, Yoshiyuki;Shuto, Takahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro, 2017, PROSTATE, 77, 6, 672, 680

Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Shibata, Yasuhiro;Kurihara, Sota;Arai, Seiji;Kato, Haruo;Suzuki, Tomomi;Miyazawa, Yoshiyuki;Koike, Hidekazu;Ito, Kazuto;Nakamura, Tetsuya;Suzuki, Kazuhiro, 2017, JOURNAL OF INVESTIGATIVE SURGERY, 30, 4, 247, 251

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2017, BMC UROLOGY, 17

Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Fujizuka, Yuji;Ito, Kazuto;Oki, Ryo;Suzuki, Rie;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2017, INTERNATIONAL JOURNAL OF UROLOGY, 24, 8, 602, 609

Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH, 37, 7, 3667, 3671

Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism, Sekine, Yoshitaka;Nakayama, Hiroshi;Miyazawa, Yoshiyuki;Kato, Haruo;Furuya, Yosuke;Arai, Seiji;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018, ONCOLOGY LETTERS, 15, 3, 3167, 3172

Post marketing surveillance study of cabazitaxel (CBZ) in Japanese patients with castration resistant prostate cancer (CRPC) in real world settings., Matsuyama, Hideyasu;Matsubara, Nobuaki;Taguchi, Tomoyuki;Seto, Takeshi;Suzuki, Kazuhiro, 2018, JOURNAL OF CLINICAL ONCOLOGY, 36, 6

Assessment of antimicrobiral prophylaxis in transperineal prostate biopsy: A single-center retrospective study of 485 cases, Baba, Kyoko;Sekine, Yoshitaka;Miyazawa, Yoshiyuki;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018, JOURNAL OF INFECTION AND CHEMOTHERAPY, 24, 8, 637, 640

Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening, Oki, Ryo;Ito, Kazuto;Suzuki, Rie;Fujizuka, Yuji;Arai, Seiji;Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2018, INTERNATIONAL JOURNAL OF CANCER, 143, 7, 1611, 1619

Clinical Outcomes and Survival Surrogacy Studies of PSA Declines and PSA kinetics Following Enzalutamide in Men with mCRPC, Miyazawa, Yoshiyuki;Miyao, Takeshi;Nakayama, Hiroshi;Kurihara, Sota;Oki, Ryo;Syuto, Takahiro;Sekine, Yoshitaka;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018, INTERNATIONAL JOURNAL OF UROLOGY, 25, 357, 357

Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching, Onozawa, Mizuki;Akaza, Hideyuki;Hinotsu, Shiro;Oya, Mototsugu;Ogawa, Osamu;Kitamura, Tadaichi;Suzuki, Kazuhiro;Naito, Seiji;Namiki, Mikio;Nishimura, Kazuo;Hirao, Yoshihiko;Tsukamoto, Taiji, 2018, CANCER MEDICINE, 7, 10, 4893, 4902

Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study, Kubo, Nobuteru;Kawamura, Hidemasa;Oike, Takahiro;Sato, Hiro;Iwanaga, Mototaro;Mizukami, Tatsuji;Adachi, Akiko;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Nakano, Takashi, 2019, IN VIVO, 33, 4, 1235, 1241

An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Shimizu, Nobuaki;Takezawa, Yutaka;Nakamura, Toshiyuki;Miyao, Takeshi;Nakayama, Hiroshi;Kurihara, Sota;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2019, PROSTATE, 79, 12, 1462, 1470

Quality of life in prostate cancer patients receiving particle radiotherapy: A review of the literature, Kawamura, Hidemasa;Kubo, Nobuteru;Sato, Hiro;Miyasaka, Yuhei;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Ohno, Tatsuya, 2020, INTERNATIONAL JOURNAL OF UROLOGY, 27, 1, 24, 29

Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening, Ito, Kazuto;Oki, Ryo;Sekine, Yoshitaka;Arai, Seiji;Miyazawa, Yoshiyuki;Shibata, Yasuhiro;Suzuki, Kazuhiro;Kurosawa, Isao, 2019, INTERNATIONAL JOURNAL OF UROLOGY, 26, 10, 956, 970

Exploratory study of prognostic factors in mCRPC patients who administered enzalutamide focusing on early PSA decline and PSA kinetics at PSA progression: Results of retrospective multicenter study., Miyazawa, Yoshiyuki;Shimizu, Nobuaki;Takezawa, Yutaka;Nakamura, Toshiyuki;Miyao, Takeshi;Nakayama, Hiroshi;Kurihara, Sota;Syuto, Takahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2019, JOURNAL OF CLINICAL ONCOLOGY, 37, 7

Phase I trial of TAK-385 in hormone treatment-naive Japanese patients with nonmetastatic prostate cancer, Suzuki, Hiroyoshi;Uemura, Hiroji;Mizokami, Atsushi;Hayashi, Narihiko;Miyoshi, Yasuhide;Nagamori, Satoshi;Enomoto, Yutaka;Akaza, Hideyuki;Asato, Takayuki;Kitagawa, Tadayuki;Suzuki, Kazuhiro, 2019, CANCER MEDICINE, 8, 13, 5891, 5902

Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml, Ito, Kazuto;Yokomizo, Akira;Tokunaga, Shoji;Arai, Gaku;Sugimoto, Mikio;Akakura, Koichiro;Hasumi, Hisashi;Sakai, Hideki;Ouraji, Akiko;Oki, Ryo;Kashiwagi, Eiji;Kobori, Yoshitomo;Hirama, Hiromi;Kitoh, Hiroki;Uemura, Hiroji;Hakariya, Tomoaki;Suzuki, Kazuhiro;PROPHET, 2020, JOURNAL OF UROLOGY, 203, 1, 83, 91

Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study, Suzuki, Kazuhiro;Matsubara, Nobuaki;Kazama, Hirotaka;Seto, Takeshi;Tsukube, Shoko;Matsuyama, Hideyasu, 2019, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 49, 12, 1157, 1163

Prevalence and clinical characteristics of overactive bladder in systemic sclerosis, Motegi, Sei-Ichiro;Sekiguchi, Akiko;Sekine, Yoshitaka;Nakayama, Hiroshi;Suzuki, Kazuhiro;Ishikawa, Osamu, 2020, MODERN RHEUMATOLOGY, 30, 2, 327, 331

Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702", Kawamura, Hidemasa;Kubo, Nobuteru;Sato, Hiro;Mizukami, Tatsuji;Katoh, Hiroyuki;Ishikawa, Hitoshi;Ohno, Tatsuya;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Nakano, Takashi;Gunma Univ Heavy Ion Med Ctr, 2020, BMC CANCER, 20, 1

A prospective study of the relationship between clinical outcomes of enzalutamide and serum androgen levels measured by LC-MS/MS in patients with CRPC, Miyazawa, Yoshiyuki;Miyao, Takeshi;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Oka, Daisuke;Arai, Seiji;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2020, JOURNAL OF CLINICAL ONCOLOGY, 38, 6

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer, Darwis, Narisa Dewi Maulany;Oike, Takahiro;Kawamura, Hidemasa;Kawahara, Masahiro;Kubo, Nobuteru;Sato, Hiro;Miyasaka, Yuhei;Katoh, Hiroyuki;Ishikawa, Hitoshi;Matsui, Hiroshi;Miyazawa, Yoshiyuki;Ito, Kazuto;Suzuki, Kazuhiro;Gondhowiardjo, Soehartati;Nakano, Takashi;Ohno, Tatsuya, 2020, CANCERS, 12, 3

Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial, Ito, Kazuto;Kobayashi, Mikio;Komiyama, Motokiyo;Naito, Seiji;Nishimura, Kazuo;Yonese, Junji;Hashine, Katsuyoshi;Saito, Shiro;Arai, Gaku;Shinohara, Mitsuru;Masumori, Naoya;Shimizu, Nobuaki;Satoh, Takefumi;Yamauchi, Atsushi;Tochigi, Tatsuo;Takezawa, Yutaka;Fujimoto, Hiroyuki;Yokomizo, Akira;Kakimoto, Ken-Ichi;Fukui, Iwao;Karasawa, Katsuyuki;Tsukamoto, Taiji;Nozaki, Miwako;Hasumi, Masaru;Ishiyama, Hiromichi;Ohtani, Mikinobu;Kuwahara, Masaaki;Harada, Masaoki;Ohashi, Yasuo;Kotake, Toshihiko;Kakizoe, Tadao;Suzuki, Kazuhiro;Yamanaka, Hidetoshi;Natl Res Project Endocrine-Radiati, 2020, CANCER, 126, 17, 3961, 3971

Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug, Endo, Yukie;Oka, Aina;Uehara, Akihito;Toki, Sayaka;Motegi, Sei-ichiro;Ishikawa, Osamu;Miyazawa, Yoshiyuki;Suzuki, Kazuhiro, 2020, JOURNAL OF DERMATOLOGY, 47, 10, E359, E360

Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m²) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study, Matsuyama, Hideyasu;Matsubara, Nobuaki;Kazama, Hirotaka;Seto, Takeshi;Tsukube, Shoko;Suzuki, Kazuhiro, 2020, BMC CANCER, 20, 1

YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression, Miyao, Takeshi;Koike, Hidekazu;Sekine, Yoshitaka;Ohtsu, Akira;Oka, Daisuke;Suzuki, Kazuhiro, 2020, ANTICANCER RESEARCH, 40, 9, 5091, 5095

Cabazitaxel in patients aged ≥80 years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan, Matsubara, Nobuaki;Suzuki, Kazuhiro;Kazama, Hirotaka;Tsukube, Shoko;Seto, Takeshi;Matsuyama, Hideyasu, 2020, JOURNAL OF GERIATRIC ONCOLOGY, 11, 7, 1067, 1073

Improved Arterial Preservation Achieved by Combined Use of Indocyanine Green Angiography and Doppler Detector During Microsurgical Subinguinal Varicocelectomy, Kurihara, Sota;Shibata, Yasuhiro;Arai, Seiji;Sekine, Yoshitaka;Miyazawa, Yoshiyuki;Koike, Hidekazu;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Nakamura, Tetsuya, 2020, JOURNAL OF INVESTIGATIVE SURGERY, 33, 10, 941, 947

Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial, Uemura, Hiroji;Matsushima, Hisashi;Kobayashi, Kazuki;Mizusawa, Hiroya;Nishimatsu, Hiroaki;Fizazi, Karim;Smith, Matthew;Shore, Neal;Tammela, Teuvo;Tabata, Ken-ichi;Matsubara, Nobuaki;Iinuma, Masahiro;Uemura, Hirotsugu;Oya, Mototsugu;Momma, Tetsuo;Kawakita, Mutsushi;Fukasawa, Satoshi;Kobayashi, Tadahiro;Kuss, Iris;Le Berre, Marie-Aude;Snapir, Amir;Sarapohja, Toni;Suzuki, Kazuhiro, 2021, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 26, 3, 578, 590

Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese Institute, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Arai, Seiji;Oka, Daisuke;Nakayama, Hiroshi;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2021, IN VIVO, 35, 1, 373, 384

Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors, Saad, Fred;Boegemann, Martin;Suzuki, Kazuhiro;Shore, Neal, 2021, PROSTATE CANCER AND PROSTATIC DISEASES, 24, 2, 323, 334

Mitochondria E3 Ubiquitin Ligase MARCH5 Mediates Stress-Induced and NOXA-Dependent MCL1 Degradation, Arai, Seiji;Ohtsu, Akira;Sawada, Tatsuhiro;Suzuki, Kazuhiro, 2021, CANCER SCIENCE, 112, 329, 329

MCL1 inhibitor drives prostate cancer cell apoptosis in combination with mitochondria-targeting drugs, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Suzuki, Kazuhiro, 2021, CANCER SCIENCE, 112, 668, 668

Antitumor effect of a statin in castration resistant prostate cancer cells, with a focus on autophagy, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Arai, Seiji;Suzuki, Kazuhiro, 2021, CANCER SCIENCE, 112, 845, 845

Enzalutamide plus androgen deprivation therapy (ADT) versus flutamide plus ADT in men with castration-resistant prostate cancer (CRPC): AFTERCAB, Uemura, Hiroji;Kobayashi, Kazuki;Yokomizo, Akira;Hinotsu, Shiro;Horie, Shigeo;Kakehi, Yoshiyuki;Naito, Seiji;Nonomura, Norio;Ogawa, Osamu;Oya, Mototsugu;Suzuki, Kazuhiro;Saito, Atsushi;Uno, Satoshi;Akaza, Hideyuki, 2021, JOURNAL OF CLINICAL ONCOLOGY, 39, 6

Relationship between changes in serum androgen level measured by LC-MS/MS and therapeutic effect after enzalutamide treatment., Miyazawa, Yoshiyuki;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Arai, Seiji;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2021, JOURNAL OF CLINICAL ONCOLOGY, 39, 6

Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial, Yokomizo, Akira;Koga, Hirofumi;Ito, Kazuto;Takezawa, Yutaka;Komiyama, Motokiyo;Nishimura, Kazuo;Yonese, Junji;Hashine, Katsuyoshi;Masumori, Naoya;Arai, Gaku;Saito, Shiro;Shinohara, Mitsuru;Shimizu, Nobuaki;Yamauchi, Atsushi;Satoh, Takefumi;Tochigi, Tatsuo;Kobayashi, Mikio;Fujimoto, Hiroyuki;Kakimoto, Ken-ichi;Fukui, Iwao;Tsukamoto, Taiji;Nozaki, Miwako;Karasawa, Katsuyuki;Hasumi, Masaru;Ohtani, Mikinobu;Ishiyama, Hiromichi;Kuwahara, Masaaki;Harada, Masaoki;Ohashi, Yasuo;Kotake, Toshihiko;Kakizoe, Tadao;Suzuki, Kazuhiro;Naito, Seiji;Yamanaka, Hidetoshi;Locally Adv Prostate Canc Invest, 2021, CANCER MEDICINE, 10, 10, 3240, 3248

A Prospective Study of the Relationship Between Clinical Outcomes After Enzalutamide and Serum Androgen Levels Measured via Liquid Chromatography-tandem Mass Spectrometry in Patients with Castration-resistant Prostate Cancer, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Arai, Seiji;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Suzuki, Kazuhiro, 2021, EUROPEAN UROLOGY OPEN SCIENCE, 29, 59, 67

Erdafitinib in combination with BCLXL/BCL2 inhibitor induce apoptosis in urothelial carcinoma cells without FGFR mutation., Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Suzuki, Kazuhiro, 2021, CANCER RESEARCH, 81, 13

Antitumor effect mechanism of statin in PCa cells focusing on autophagy., Miyazawa, Yoshiyuki;Oka, Daisuke;Nakayama, Hiroshi;Sekine, Yoshitaka;Arai, Seiji;Suzuki, Kazuhiro, 2021, CANCER RESEARCH, 81, 13

Carbon ion radiotherapy for prostate cancer with bladder invasion, Miyasaka, Yuhei;Kawamura, Hidemasa;Sato, Hiro;Kubo, Nobuteru;Mizukami, Tatsuji;Matsui, Hiroshi;Miyazawa, Yoshiyuki;Ito, Kazuto;Nakano, Takashi;Suzuki, Kazuhiro;Ohno, Tatsuya, 2021, BMC UROLOGY, 21, 1

Presepsin as a predictor of septic shock in patients with urinary tract infection, Sekine, Yoshitaka;Kotani, Kazuhiko;Oka, Daisuke;Nakayama, Hiroshi;Miyazawa, Yoshiyuki;Syuto, Takahiro;Arai, Seiji;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Murakami, Masami;Suzuki, Kazuhiro, 2021, BMC UROLOGY, 21, 1

Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer, Sekine, Yoshitaka;Nakayama, Hiroshi;Miyazawa, Yoshiyuki;Arai, Seiji;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2021, ONCOLOGY LETTERS, 22, 6

Protein translation inhibitor homoharringtonine prevents androgen receptor-positive prostate cancer cell growth, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Suzuki, Kazuhiro, 2022, CANCER SCIENCE, 113, 1731, 1731

TRANSURETHRAL BALLOON LASER HYPERTHERMIA FOR CHRONIC NON-BACTERIAL PROSTATITIS: A CLINICAL TRIAL, SUZUKI Takanori;KUROKAWA Kohei;SUZUKI Kazuhiro;MATSUMOTO Kazuhisa;YAMANAKA Hidetoshi, Mar. 1995, Int. J. Urol., 2, 1, 29, 32

Transurethral Balloon Laser Thermotherapy: Effects of a Directionally Shielded Balloon in Canine Prostates, SUZUKI Takanori;KUROKAWA Kohei;SUZUKI Kazuhiro;NAKANO Katsuya;DAIKUZONO Norio;YAMANAKA Hidetoshi, Jan. 1996, Int J Urol, 3, 1, 35, 38

Clinical Experience of Transurethral Balloon Laser Thermotherapy for the Benign Prostatic Hypertrophy Patients, KUROKAWA Kohei;SUZUKI Takanori;SUZUKI Kazuhiro;MATSUMOTO Kazuhisa;HASHIMOTO Katsuyoshi;ONO Yoshihiro;KUBOTA Yutaka;SAITO Yoshitaka;YAMANAKA Hidetoshi, Jun. 1995, 16, 2, 19, 24

Application of YAG Laser to Prostaic Diseses : Basic Reserch and Clinical Experience-, KUROKAWA Kohei;SUZUKI Takanori;SUZUKI Kazuhiro;HIGASHI Hiroomi;YAMANAKA Hidetoshi, Mar. 1998, 19, 1, 19, 27

Tumor-associated tissue eosinophilia of penile cancer, ONO Yoshihiro;OZAWA Masashi;TAMURA Yoshimi;SUZUKI Takanori;SUZUKI Kazuhiro;KUROKAWA Kohei;FUKABORI Yoshitatsu;YAMANAKA Hidetoshi, Feb. 2002, 9, 2, 82, 87

Androgen dependency and independency of prostate cancer, SUZUKI Kazuhiro;YAMANAKA Hidetoshi, Jan. 2002, 50, 1, 83, 87

THERMAL DAMAGE TO NORMAL AND HYPERPLASTIC PROSTATES DUE TO TRANSURETHRAL BALLOON LASER THERAPY IN DOGS, SUZUKI Takanori;KUROKAWA Kohei;SUZUKI Kazuhiro;IMAI Kyoichi;YAMANAKA Hidetoshi, Jun. 1994, Int J Urol, 1, 2, 162, 166

METALLOTHIONEIN IN HUMAN SEMINAL PLASMA, SUZUKI Takanori;SUZUKI Kazuhiro;NAKAJIMA Katsuyuki;OTAKI Noriko;YAMANAKA Hidetoshi, Dec. 1994, Int. J. Urol., 1, 4, 345, 348

Surgical procedures for chronic dialysis patients at Gunma University Hospital, HATORI Motoaki;HAYASHI Masamichi;SHIONO Akihiko;HASUMI Masaru;TAKEI Tomoyuki;MATSUI Hiroshi;KAWAGUCHI Takuya;ITO Kazuto;SUZUKI Kazuhiro;KUROKAWA Kohei;FUKABORI Yoshitatsu;YAMANAKA Hidetoshi, Oct. 2002, 35, 11, 1447, 1451

Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population, SUZUKI Kazuhiro;MATSUI Hiroshi;OHTAKE Nobuaki;NAKATA Seiji;TAKEI Tomoyuki;KOIKE Hidekazu;NAKAZATO Haruki;OKUGI Hironobu;HASUMI Masaru;FUKABORI Yoshitatsu;KUROKAWA Kohei;YAMANAKA Hidetoshi, May 2003, 10, 5, 261, 266

Transurethral Balloon Laser Thermotherapy for Benign Prostatic Hyperplasia, SUZUKI TAKANORI;KUROKAWA KOHEI;SUZUKI KAZUHIRO;HIGASHI HIROOMI;YAMANAKA HIDETOSHI, Oct. 1996, 9, 2, 158, 160

Ultrastructural Changes in Subepithelial Capillaries and Their Surrounding Stroma in Rat Prostate and Seminal Vesicle after Castration, ONO YOSHIHIRO;SUZUKI KAZUHIRO;YUASA HISAKO;KUROKAWA KOHEI;FUKABORI YOSHITATSU;YAMANAKA HIDETOSHI, Sep. 2003, Tohokn J. Exp. Med., 201, 1, 29, 38

Genomewide linkage analysis of familial prostate cancer in the Japanese population, MATSUI Hiroshi;SUZUKI Kazuhiro;OHTAKE Nobuaki;NAKATA Seiji;TAKEUCHI Toshiyuki;YAMANAKA Hidetoshi;INOUE Ituro, Jan. 2004, Journal of Human Genetics, 49, 1, 9, 15

Hands-free hook for endourological procedures, ONO YOSHIHIRO;SUZUKI KAZUHIRO, Oct. 2003, 10, 10, 561, 562

Role of Androgen on Blood Flow and Capillary Structure in Rat Seminal Vesicles, ONO YOSHIHIRO;SUZUKI KAZUHIRO;KASHIWAGI BUNZO;SHIBATA YASUHIRO;ITO KAZUTO;FUKABORI YOSHITATSU;YAMANAKA HIDETOSHI, Mar. 2004, The Tohoku Journal of Experimental Medicine, 202, 3, 193, 201

A case of hemophilia B complicated with chronic renal failure and renal pelvic tumor., Magari Tomohiro;Hatori Motoaki;Ono Yoshihiro;Shiono Akihiko;Shimizu Nobuaki;Kurokawa Kohei;Fukabori Yoshitatsu;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2003, Nihon Toseki Igakkai Zasshi, 36, 12, 1731, 1736

A simple and reliable monitoring system to confirm the preservation of the cavernous nerves, KUROKAWA KOHEI;SUZUKI TAKANORI;SUZUKI KAZUHIRO;ITO KAZUTO;SHIMIZU NOBUAKI;FUKABORI YOSHITATSU;YAMANAKA HIDETOSHI, May 2001, Int J Urol, 8, 5, 231, 236

Malignant fibrous histiocytoma of the right spermatic cord : A case report, SEKINE YOSHITAKA;OHKI KAZUNARI;OKAMOTO KOHEI;NOMURA MASASHI;TOMITA HIKARU;OHTAKE NOBUAKI;SUZUKI KAZUHIRO;KUROKAWA KOHEI;MASHIMO MASAMICHI;SARUKI KAZUHISA;MORITA TAKAHIRO;NAKAZATO HARUKI;YOKOO HIDEAKI;YAMANAKA HIDETOSHI, Oct. 2001, 8, 10, 581, 584

Successful maintenance hemodialysis treatment for a patient with hemophilia A and chronic renal failure, KOIKE Hidekazu;HATORI Motoaki;NITTA Takashi;KASHIWAGI Bunzou;SUZUKI Kazuhiro;YAMANAKA Hidetoshi;UTSUMI Hideki;NOJIMA Yoshihisa, Jan. 2004, 37, 1, 91, 94

Incidence of Bladder Cancer Discovered by Urethrocystoscopy at Prostate Biopsy : Extraordinary High Incidence of Tiny Bladder Cancer in Elderly Males, OKAZAKI HIROSHI;SUZUKI KOICHI;SUZUKI TAKANORI;KUROKAWA KOHEI;ITO KAZUTO;SUZUKI KAZUHIRO;YAMANAKA HIDETOSHI, May 2004, Tohoku J. Exp. Med., 203, 1, 31, 36

Scrotal and penile edema developed in a CAPD patient for 5 years, UEI Takatoshi;MAGARI Tomohiro;KAWAGUCHI Takuya;HATORI Motoaki;SUZUKI Kazuhiro;YAMANAKA Hidetoshi, Mar. 2004, 37, 3, 249, 252

A case with combined multiple retina thrombosis probably due to heparin-induced thrombocytopenia (HIT), MAGARI Tomohiro;HATORI Motoaki;HASUMI Masaru;TANAKA Toshiyuki;MATSUI Hiroshi;MORITA Takahiro;ONO Yoshihiro;SUZUKI Kazuhiro;YAMANAKA Hidetoshi, Jun. 2004, 37, 6, 1437, 1442

;;, Apr. 1997, 73, 2

Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer, MIYAMOTO SHIGEHITO;ITO KAZUTO;KUROKAWA KOHEI;SUZUKI KAZUHIRO;SUZUKI KEIJI;YAMANAKA HIDETOSHI, Jun. 2006, 13, 6, 767, 772

A pediatric case of kidney transplantation in Bartter's syndrome with end-stage renal failure, Sekine Yoshitaka;Hatori Motoaki;Takei Tomoyuki;Kashiwagi Bunzo;Magari Tomohiro;Fukuma Yuji;Nishii Masahiro;Hamano Tatsuya;Yamamoto Takumi;Shibata Yasuhiro;Ito Kazuto;Kurokawa Kohei;Machida Masami;Hayashi Masamichi;Suzuki Kazuhiro, 2007, Nihon Toseki Igakkai Zasshi, 40, 7, 623, 627

The Second Joint Meeting of American Urological Association (AUA)/Japanese Urological Association (JUA) International Program on the 102nd Annual Meeting of American Urological Association at Anaheim 2007, OGAN Kenneth;KAWAI Koji;GILL Inderbir Singh;NAITO Seiji;ISAACS Williams B;SUZUKI Kazuhiro;KIBEL Adam S;KAKEHI Yoshiyuki;YOSHIMURA Naoki;YOKOYAMA Osamu;CHANCELLOR Michael B;TAKAHASHI Satoru, Dec. 2007, 14, 12, 1116, 1123

The Follow-up Investigations on Men Who Underwent PSA Test in Takasaki Health Maintenance Center, Kurosawa Hospital, Takasaki Between 2002 and 2004, KUMASAKA Fuminari;KONO Mai;UEI Takatoshi;OGURA Haruyuki;KUROSAWA Isao;SHIMADA Kazuko;MATSUMOTO Fusae;ISHII Hidekazu;KASE Yoshiaki;YAMANAKA Hidetoshi;ITO Kazuto;SUZUKI Kazuhiro, Jun. 2005, Official Journal of Japan Society of Ningen Dock, 20, 1, 11, 14

Histological and Immunohistochemical Changes after Transurethral Balloon Laser Hyperthermia in the Canine Prostate, SUZUKI TAKANORI;KUROKAWA KOHEI;SUZUKI KAZUHIRO;MATSUMOTO KAZUHISA;YAMANAKA HIDETOSHI, Sep. 1995, Tohoku J. Exp. Med., 177, 1, 39, 48

Expression and Degradation of Rat Androgen Receptor Following Castration, Testosterone Replacement and Antiandrogens Administration : Analysis by Western Blot and Immunohistochemistry, SUZUKI KAZUHIRO;ITO KAZUTO;KUROKAWA KOHEI;SUZUKI TAKANORI;SHIMIZU NOBUAKI;FUKABORI YOSHITATSU;HONMA SEIJIRO;YAMANAKA HIDETOSHI, Nov. 1997, The Tohoku Journal of Experimental Medicine, 183, 3, 159, 172

Proprostate-specific antigen : Its usefulness in the era of multiple-core prostate biopsy, MIYAKUBO Mai;ITO Kazuto;YAMAMOTO Takumi;TAKECHI Hiroyuki;OHI Masaru;SUZUKI Kazuhiro, Jun. 2009, 16, 6, 561, 565

Treatment and its indication of prostate cancer, SUZUKI Kazuhiro, Dec. 2005, 22, 4, 206, 216

Outline of "Clinical Guidelines for Prostate Cancer - 2006 Edition", SUZUKI Kazuhiro, Mar. 2009, Official Journal of Japan Society of Ningen Dock, 23, 5, 1005, 1020

;;;;;;;, Aug. 2004, 24, 241, 243

Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010, ITO Kazuto;NAITO Seiji;KAKEHI Yoshiyuki;OKUYAMA Akihiko;IMAMURA Tomoaki;YASUNAGA Hideo;AKAZA Hideyuki;HINOTSU Shiro;ARAI Yoichi;DOKIYA Takushi;EGAWA Shin;SUZUKI Kazuhiro;KOGA Hirofumi;MASUMORI Naoya;AKAKURA Koichiro;KAWASHIMA Kiyotaka;OKIHARA Koji, Oct. 2010, Int. J. Urol., 17, 10, 830, 838

High-Density Lipoprotein and Prostate Cancer: An Overview, Kotani Kazuhiko;Sekine Yoshitaka;Ishikawa Shizukiyo;Ikpot Imoh Z.;Suzuki Kazuhiro;Remaley Alan T., 2013, Journal of Epidemiology, 23, 5, 313, 319

Intermittent Deep Coma in a Hemodialysis Patient with Liver Cirrhosis: A Case Report., Matsumoto Kazuhisa;Hayashi Masamichi;Kosaku Nozomu;Ono Yoshihiro;Yamamoto Takumi;Hatori Motoaki;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2003, The Kitakanto Medical Journal, 53, 1, 55, 57

;;;;;;;, Feb. 2003, The KITAKANTO medical journal, 53, 1, 80

;;;;;;;;;;, Feb. 2003, The KITAKANTO medical journal, 53, 1, 80, 81

;;;;;;;, Nov. 2003, The KITAKANTO medical journal, 53, 4, 423

;;;;;;;;;;, Nov. 2003, The KITAKANTO medical journal, 53, 4, 425

;;;;;;;;;;;, Nov. 2003, The KITAKANTO medical journal, 53, 4, 426

Effects of Aspirin-dialminate on Suppression in the Serum Phosphorus Levels in Patients Treated with Hemodialysis, Ito Kazuto;Kosaku Nozomu;Ono Yoshihiro;Hatori Motoaki;Suzuki Kazuhiro;Fukabori Yoshitatsu;Yamanaka Hidetoshi;Hamano Tatsuya;Matsumoto Kazuhisa;Hayashi Masamichi, 2004, The Kitakanto Medical Journal, 54, 1, 5, 8

;;;;;, Feb. 2004, The KITAKANTO medical journal, 54, 1, 41

;;;;, Feb. 2004, The KITAKANTO medical journal, 54, 1, 43

(The 51th Annual Meeting of the Kitakanto Medical Society), Aug. 2004, The KITAKANTO medical journal, 54, 3

;;;;;;;;, May 2003, The KITAKANTO medical journal, 53, 2, 217

;;;, May 2003, The KITAKANTO medical journal, 53, 2, 218

;;;;;;;;;, May 2003, The KITAKANTO medical journal, 53, 2

;;;;;;;;;, May 2003, The KITAKANTO medical journal, 53, 2, 234

Intraarterial Infusion of Lipiodol CDDP Suspension into the Internal Iliac Artery-Pre Clinical Dose Escalation Study Using Canine Model-:Pre Clinical Dose Escalation Study Using Canine Model, Okazaki Hiroshi;Kurokawa Kohei;Suzuki Kazuhiro;Matsumura Yuka;Honda Shigeru;Horiuchi Ryuya;Yamanaka Hidetoshi, 2003, The Kitakanto Medical Journal, 53, 3, 275, 279

Transurethral En Bloc Resection of an Urachal Cyst, Etsunaga Toru;Ono Yoshihiro;Koya Tomoko;Shimizu Nobuaki;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2003, The Kitakanto Medical Journal, 53, 3, 323, 324

;;;;;;;;, Aug. 2003, The KITAKANTO medical journal, 53, 3, 331

;;;;, Aug. 2003, The KITAKANTO medical journal, 53, 3, 347

The 6th Joint Meeting of Gunma and Tochigi Urological Association, ;;;;;;;;, Nov. 2004, The KITAKANTO medical journal, 54, 4

;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 134

;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2

SUPPRESSIVE EFFECTS OF THE ANTIANDROGEN FLUTAMIDE ON ADRENAL ANDROGENS IN ADVANCED PROSTATE CANCER PATIENTS, Nakazato Haruki;Suzuki Kazuhiro;Ito Kazuto;Fukabori Yoshitatu;Kurokawa Kohei;Yamanaka Hidetoshi, 2001, The Japanese Journal of Urology, 92, 1, 6, 12

;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 368

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 246

;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

;;, Jul. 2002, 2002, 127, 135

;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

;;;;;;;, Feb. 2006, The Kitakanto medical journal, 56, 1, 47, 47

Nonmyeloablative Allogenic Peripheral Blood Stem Cell Transplantation for Lung Metastases of Renal Cell Carcinoma, Doki Noriko;Matsushima Takafumi;Saito Yasuyuki;Yokohama Akihiko;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Suzuki Kazuhiro;Nojima Yoshihisa, 2006, The Kitakanto Medical Journal, 56, 3, 231, 235

;, 2006, The Japanese Journal of Urology, 97, 2

;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

Examination of Cadaveric Renal Transplantation at Gunma University Hospital during 20-year Period, Hatori Motoaki;Hayashi Masamichi;Machida Masami;Sekihara Tetsuo;Matsuo Yasuharu;Hasumi Masaru;Tanaka Toshiyuki;Sekine Yositake;Arai Seiji;Nakazato Haruki;Shibata Yasuhiro;Yamamoto Takumi;Magari Tomohiro;Koike Hidekazu;Ito Kazuto;Kawaguchi Takuya;Kato Yuichi;Yamanaka Hidetoshi;Suzuki Kazuhiro, 2007, The Kitakanto Medical Journal, 57, 2, 165, 168

;;;;;;;;;;;;;;, May 2007, The Kitakanto medical journal, 57, 2, 201, 201

PROSTATE CANCER SCREENING AT TATEBAYASHI CITY IN GUNMA PREFECTURE : RESULTS OF SCREENING WITH PSA ALONE BETWEEN 2003 AND 2005, NAKAMURA Toshiyuki;ETSUNAGA Toru;SASAKI Yasushi;NITTA Takashi;OKUGI Yasunobu;OKAZAKI Hiroshi;KATOU Nobuo;YAMAMOTO Takumi;SUZUKI Kazuhiro, May 2007, The Japanese Journal of Urology, 98, 4, 619, 628

;, 2007, The Japanese Journal of Urology, 98, 2

;;;;;, 2007, The Japanese Journal of Urology, 98, 2

;;;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

Examination of Living Donor Renal Transplantation in Gunma University Hospital in a 20-year Period, Hatori Motoaki;Hayashi Masamichi;Machida Masami;Sekihara Tetsuo;Matsuo Yasuharu;Hasumi Masaru;Tanaka Toshiyuki;Sekine Yositake;Arai Seiji;Nakazato Haruki;Shibata Yasuhiro;Yamamoto Takumi;Magari Tomohiro;Koike Hidekazu;Ito Kazuto;Kawaguchi Takuya;Kato Yuichi;Yamanaka Hidetoshi;Suzuki Kazuhiro, 2007, The Kitakanto Medical Journal, 57, 3, 225, 230

;;;;;;;, Nov. 2007, The Kitakanto medical journal, 57, 4, 328, 328

WS1-3-3 The Usefulness of [-5,-7] Pro/ Free PSA Ratio in the Era Undergoing Multiple-core Biopsies for Men with PSA Levels between 4 and 10 ng/ml(Prostate Cancer), Miyakubo Mai;Ito Kazuto;Takechi Hiroyuki;Yamamoto Takumi;Ohi Masaru;Suzuki Kazuhiro, 2008, The Japanese Journal of Urology, 99, 2

Echo Free Space in Morrison's Pouch in a Patient with Traumatic Bladder Rupture: A Case Report:A Case Report, Takahashi Yuga;Iino Yuichi;Ogino Takashi;Hagiwara Shuichi;Isaka Akira;Nameki Taro;Kagoshima Kaie;Yamada Takuro;Ito Kazuto;Suzuki Kazuhiro, 2008, The Kitakanto Medical Journal, 58, 2, 217, 219

Gene Expression Profiles of Prostate Cancer Cell Lines, LNCaP, PC-3 and DU-145, Assessed by cDNA Microarray, Okamura Keigo;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, 2008, The Kitakanto Medical Journal, 58, 4, 363, 369

CLINICAL RESEARCH OF PROSTATE CANCER DETECTED IN TONE CENTRAL HOSPITAL : COMPARISON OF SURVIVAL RATES BETWEEN PATIENTS DIAGNOSED WITH PROSTATE CANCER IN AND OUTSIDE SCREENING SYSTEM, TAMURA Yoshimi;KOYA Tomoko;MORITA Takahiro;KUBOTA Yutaka;TAKAHASHI Osamu;FUJIDUKA Isao;ITO Kazuto;SUZUKI Kazuhiro, May 2009, The Japanese Journal of Urology, 100, 4, 525, 533

;;;;;, 2009, The Japanese Journal of Urology, 100, 2

;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

;;;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

;;;;;, Nov. 2010, 101, -, S59, 70

2011, The Japanese Journal of Urology, 102, 2, 235

Hypertonicity-induced transmitter release at Drosophila neuromuscular junctions is partly mediated by integrins and cAMP/protein kinase A., Suzuki Kazuhiro;Grinnell Alan D;Kidokoro Yoshiaki, The Journal of physiology, 538, Pt 1

Clinical study on 78 cases of testicular tumor, Suzuki, Kazuhiro;Ozawa, Masashi;Nakazato, Haruki;Kurokawa, Kohei;Hayashi, Masamichi;Jinbo, Susumu;Kobayashi, Mikio;Suzuki, Takanori;Imai, Kyoichi;Yamanaka, Hidetoshi, Mar. 1995, Hinyokika Kiyo, 41, 3, 197, 203

Carboplatin-based combination chemotherapy for testicular cancer: relationship among administration dose of carboplatin, renal function and myelosuppression, Suzuki, Kazuhiro;Matsumoto, Kazuhisa;Hashimoto, Katsuyoshi;Kurokawa, Kohei;Jinbo, Susumu;Suzuki, Takanori;Imai, Kyoichi;Yamanaka, Hidetoshi;Kawashima, Kiyotaka;Takahashi, Hirotomo, Oct. 1995, Hinyokika Kiyo, 41, 10, 775, 780

Serial changes in proximal urethral function after transurethral balloon laser hyperthermia of the prostate (TUBAL-H) in a canine model, KUROKAWA, Kohei;SUZUKI, Takanori;SUZUKI, Kazuhiro;FUKABORI, Yoshitatsu;IMAI, Kyoichi;YAMANAKA, Hidetoshi, Sep. 1996, Hinyokika Kiyo, 42, 9, 655, 661

Effects of Gosha-Jinki-Gan on the function of the urinary bladder in anesthetized dogs, SUZUKI, Takanori;KUROKAWA, Kohei;SUZUKI, Kazuhiro;HIGASHI, Hiroomi;OHMA, Chikako;IMAI, Kyoichi;YAMANAKA, Hidetoshi, Dec. 1996, Hinyokika Kiyo, 42, 12, 951, 955

Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography, Suzuki, Kazuhiro;Ichinose, Yoshio;Hashimoto, Katsuyoshi;Matsumoto, Kazuhisa;Suzuki, Takanori;Imai, Kyoichi;Yamanaka, Hidetoshi, May 1990, Hinyokika Kiyo, 36, 5, 557, 560

Preliminary report on the effect of etoposide or etoposide and CDDP on recurrent prostate cancer, Suzuki, Kazuhiro;Nakamura, Toshiyuki;Kato, Nobuo;Kurita, Makoto;Nakazawa, Yasuo;Suzuki, Takanori;Imai, Kyoichi;Yamanaka, Hidetoshi, Nov. 1991, Hinyokika Kiyo, 37, 11, 1499, 1503

Age-related changes in the size and shape of the prostate observed by transrectal ultrasonography, Kurokawa, Kohei;Suzuki, Takanori;Ohtake, Nobuaki;Itoh, Kazuto;Ichinose, Yoshio;Kurihara, Jun;Suzuki, Kazuhiro;Shiono, Akihiko;Mashimo, Tooru;Machida, Masami;Fukabori, Yoshitatsu;Hayashi, Masamichi;Kumasaka, Fuminari;Imai, Kyoichi;Yamanaka, Hidetoshi, Sep. 1993, Hinyokika Kiyo, 39, 9, 813, 817

Tumor-associated tissue eosinophilia of penile cancer., Ono Yoshihiro;Ozawa Masashi;Tamura Yoshimi;Suzuki Takanori;Suzuki Kazuhiro;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 9, 2

Rapidly progressive malignant epithelioid angiomyolipoma of the kidney., Yamamoto Takumi;Ito Kazuto;Suzuki Kazuhiro;Yamanaka Hidetosi;Ebihara Kazunori;Sasaki Atsushi, The Journal of urology, 168, 1

Usefulness of PSA screening in outpatients with bladder cancer: preliminary results., Kurokawa Kohei;Suzuki Kazuhiro;Okazaki Hiroshi;Ito Kazuto;Shiono Akihiko;Fukabori Yoshitastu;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 9, 5

Usefulness of prostate-specific antigen velocity in screening for prostate cancer., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Kubota Yutaka;Fukabori Yoshitatsu;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 9, 6

Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3., Suzuki Kazuhiro;Koike Hidekazu;Matsui Hiroshi;Ono Yoshihiro;Hasumi Masaru;Nakazato Haruki;Okugi Hironobu;Sekine Yoshitaka;Oki Kazuya;Ito Kazuto;Yamamoto Takumi;Fukabori Yoshitatsu;Kurokawa Kohei;Yamanaka Hidetoshi, International journal of cancer, 99, 6

MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer., Hasumi Masaru;Suzuki Kazuhiro;Oya Nariyuki;Ito Kazuto;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, Anticancer research, 22, 2B

A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine., Tanaka Toshiyuki;Takahara Shiro;Hatori Motoaki;Suzuki Kazuhiro;Wang Jing;Ichimaru Naotsugu;Suzuki Seiichi;Morozumi Kunio;Okuyama Akihiko;Yamanaka Hidetoshi, Cancer letters, 181, 2

In vivo gene transfer of hepatocyte growth factor to skeletal muscle prevents changes in rat kidneys after 5/6 nephrectomy., Tanaka Toshiyuki;Ichimaru Naotsugu;Takahara Shiro;Yazawa Koji;Hatori Motoaki;Suzuki Kazuhiro;Isaka Yoshitaka;Moriyama Toshiki;Imai Enyu;Azuma Haruhito;Nakamura Toshikazu;Okuyama Akihiko;Yamanaka Hidetoshi, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2, 9

The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL., Ito Kazuto;Ohi Masaru;Yamamoto Takumi;Miyamoto Shigeto;Kurokawa Kohei;Fukabori Yoshitatsu;Suzuki Kazuhiro;Yamanaka Hidetoshi, Cancer, 95, 10

Biphasic modulation of synaptic transmission by hypertonicity at the embryonic Drosophila neuromuscular junction., Suzuki Kazuhiro;Okamoto Tomonori;Kidokoro Yoshiaki, The Journal of physiology, 545, 1

Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: is it possible to identify patients likely to have good treatment outcomes?, Kurokawa Kohei;Ito Kazuto;Suzuki Kazuhiro;Ono Yoshihiro;Yamamoto Takumi;Akimoto Tetsuo;Yamanaka Hidetoshi, Japanese journal of clinical oncology, 32, 11

Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population., Suzuki Kazuhiro;Ohtake Nobuaki;Nakata Seiji;Takei Tomoyuki;Matsui Hiroshi;Ono Yoshihiro;Nakazato Haruki;Hasumi Masaru;Koike Hidekazu;Ito Kazuto;Fukabori Yoshitatsu;Kurokawa Kohei;Yamanaka Hidetoshi, Anticancer research, 22, 6B

[Treatment strategy for locally advanced prostate cancer]., Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, Gan to kagaku ryoho. Cancer & chemotherapy, 30, 1

Preliminary results of a monitoring system to confirm the preservation of cavernous nerves., Kurokawa Kohei;Suzuki Takanori;SuzukI Kazuhiro;Terada Naoki;Ito Kazuto;Yoshikawa Daisuke;Arai Yoichi;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 10, 3

Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, Urology, 61, 4

Gene expression profiles of human BPH (II): Optimization of laser-capture microdissection and utilization of cDNA microarray., Matsui Hiroshi;Suzuki Kazuhiro;Hasumi Masaru;Koike Hidekazu;Okugi Hironobu;Nakazato Haruki;Yamanaka Hidetoshi, Anticancer research, 23, 1A

Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population., Suzuki Kazuhiro;Matsui Hiroshi;Ohtake Nobuaki;Nakata Seiji;Takei Tomoyuki;Koike Hidekazu;Nakazato Haruki;Okugi Hironobu;Hasumi Masaru;Fukabori Yoshitatsu;Kurokawa Kohei;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 10, 5

Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study., Suzuki Kazuhiro;Matsui Hiroshi;Nakazato Haruki;Koike Hidekazu;Okugi Hironobu;Hasumi Masaru;Ohtake Nobuaki;Nakata Seiji;Takei Tomoyuki;Hatori Motoaki;Ito Kazuto;Yamanaka Hidetoshi, Cancer letters, 195, 2

A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese., Suzuki Kazuhiro;Matsui Hiroshi;Ohtake Nobuaki;Nakata Seiji;Takei Tomoyuki;Nakazato Haruki;Okugi Hironobu;Koike Hidekazu;Ono Yoshihiro;Ito Kazuto;Kurokawa Kohei;Yamanaka Hidetoshi, Journal of biomedical science, 10, 4

Natural history of PSA increase with and without prostate cancer., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Takechi Hiroyuki;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, Urology, 62, 1

Presynaptic impairment of synaptic transmission in Drosophila embryos lacking Gs(alpha)., Hou Dongmei;Suzuki Kazuhiro;Wolfgang William J;Clay Catherine;Forte Michael;Kidokoro Yoshiaki, The Journal of neuroscience : the official journal of the Society for Neuroscience, 23, 13

Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Takechi Hiroyuki;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, The Prostate, 57, 1

Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population., Nakazato Haruki;Suzuki Kazuhiro;Matsui Hiroshi;Koike Hidekazu;Okugi Hironobu;Ohtake Nobuaki;Takei Tomoyuki;Nakata Seiji;Hasumi Masaru;Ito Kazuto;Kurokawa Kohei;Yamanaka Hidetoshi, Anticancer research, 23, 3C

Examination of Laparoscopic Nephrectomy for Renal Cancer in Elderly Patients, Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Hatori Motoaki;Ito Kazuto;Kobayashi Mikio;Suzuki Kazuhiro, 2009, The Kitakanto Medical Journal, 59, 4, 333, 336

Sunitinib Induced Immune Thrombocytopenia, Matsumoto Kumiko;Handa Hiroshi;Yuzuriha Akinori;Toyama Kohtarou;Mitsui Takeki;Hashimoto Yoko;Koiso Hiromi;Saitoh Takayuki;Uchiumi Hideki;Murakami Hirokazu;Matsui Hiroshi;Suzuki Kazuhiro;Tsukamoto Norifumi;Nojima Yoshihisa, 2011, The Kitakanto Medical Journal, 61, 2, 175, 177

A Case of Bellini Duct Carcinoma., Koike Hidekazu;Takei Tomoyuki;Ohtake Nobuaki;Masimo Masamichi;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2002, The Kitakanto Medical Journal, 52, 4, 267, 270

Primary Scrotal Sclerosing Lipogranuloma: Surgical Therapy and Conservative Therapy.:Surgical Therapy and Conservative Therapy, Ono Yoshihiro;Kosaku Nozomu;Yajima Hisanori;Takahashi Osamu;Fukabori Yoshitatsu;Suzuki Kazuhiro;Yamanaka Hidetoshi;Mashimo Masamichi;Sekihara Tetsuo;Saruki Kazuhisa;Matsumoto Kazuhisa;Hayashi Masamichi, 2002, The Kitakanto Medical Journal, 52, 4, 271, 277

A Case of Vesical Leiomyosarcoma., Kono Mai;Matsui Hiroshi;Yamamoto Takumi;Ono Yoshihiro;Fukabori Yoshitatsu;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi;Suzuki Keiji, 2002, The Kitakanto Medical Journal, 52, 4, 279, 282

Immunohistochemical study of metallothionein in human testicular tumors., Suzuki Takanori;Suzuki Kazuhiro;Ohma Chikako;Jinbo Susumu;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 2, 67, 72

Ultrastructural changes in benign prostatic hyperplasia induced by transurethral balloon laser thermotherapy., Suzuki Takanori;Kurokawa Kohei;Suzuki Kazuhiro;Hayashi Masamichi;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 3, 159, 161

Testicular epidermoid cyst with calcified capsule: A case report., Suzuki Kazuhiro;Ono Yoshihiro;Tokunaga Takashi;Tsuji Hiroaki;Kurokawa Kohei;Suzuki Takanori;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 3, 171, 172

Evaluation of Lower Urinary Tract Symptoms of Outpatients with Prostatic Disease: The Relationship among UFM, TRUS, and IPSS and QOL Score.:THE RELATIONSHIP AMONG UFM, TRUS, AND IPSS AND QOL SCORE, Suzuki Kazuhiro;Totsuka Yoshihiro;Matsumoto Kazuhisa;Ono Yoshihiro;Tsuji Hiroaki;Kurokawa Kohei;Suzuki Takanori;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 5, 305, 309

Synchonous Double Primary Cancers Consisting of Bladder and Prostatic Cances: A Case Report., Suzuki Kazuhiro;Totsuka Yoshihiro;Matsumoto Kazuhisa;Tsuji Hiroaki;Ono Yoshihiro;Kurokawa Kohei;Suzuki Takanori;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 5, 335, 337

Limitation of Conventional Cisplatin-Based Combination Chemotherapy for Disseminated Germ Cell Tumor: Implication for Introduction of Aggressive Treatment as an Initial Chemotherapy.:IMPLICATION FOR INTRODUCTION OF AGGRESSIVE TREATMENT AS AN INITIAL CHEMONTHERAPY, Suzuki Kazuhiro;Kurokawa Kohei;Hayashi Masamichi;Suzuki Tananori;Yamanaka Hidetoshi;Nakazato Haruki;Masuda Hiroshi;Shinya Hiroyuki;Shibata Yasuhiro;Nakano Katsuya;Kubota Yutaka;Shimizu Nobuaki;Fukabori Yoshitatsu, 1997, The Kitakanto Medical Journal, 47, 6, 421, 424

Endoscopic Demonstration of Obstructive Mechanism in the Prostatic Urethral Polyp., Suzuki Kazuhiro;Matsumoto Kazuhisa;Ono Yoshihiro;Kurokawa Kohei;Suzuki Takanori;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 6, 433, 434

Marked Prostate Volume Decrease Attained by Transurethral Balloon Laser Thermotherapy in a Patient with Benign Prostatic Hypertrophy: a Case Report., Kurokawa Kohei;Suzuki Takanori;Suzuki Kazuhiro;Nakano Katsuya;Kubota Yutaka;Ono Yoshihiro;Fukabori Yoshitatsu;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 6, 439, 442

Benign Prostatic Hypertrophy and Estrogen., 1998, The Kitakanto Medical Journal, 48, 1, 69, 71

Histological and Immunohistochemical Changes after Transurethral Balloon Laser Hyperthermia in the Canine Prostate., SUZUKI TAKANORI;KUROKAWA KOHEI;SUZUKI KAZUHIRO;MATSUMOTO KAZUHISA;YAMANAKA HIDETOSHI, 1995, The Tohoku Journal of Experimental Medicine, 177, 1, 39, 48

ULTRASONIC LOCALIZATION OF NORMAL MALE RAT PROSTATE AND URINARY BLADDER, SUZUKI TAKANORI;TAKEZAWA YUTAKA;SUZUKI KAZUHIRO;TAMURA YOSHIMI;OKABE KAZUHIKO;YUASA HISAKO;OHMA CHIKAKO;YAMANAKA HIDETOSHI;HAMATAKI TOSHINOBU, 1991, The KITAKANTO Medical Journal, 41, 2, 321, 325

CLINICAL EXPERIENCE WITH EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY USING DORNIER MFL 5000 FOR UPPER URINARY TRACT CALCULI, KUROKAWA KOHEI;TAKEZAWA YUTAKA;SUZUKI TAKANORI;SUZUKI KAZUHIRO;;TAMURA YOSHIMI;KURITA MAKOTO;HAYASHI MASAMICHI;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1995, The KITAKANTO Medical Journal, 45, 5, 401, 406

SURGICAL APPROACH TO PATIENTS WITH PROGRESSED-STAGE TESTICULAR CANCER : CLINICAL STUDY OF ONE-STAGE OPERATION FOR RESIDUAL MASSES IN RETROPERITONEAL, THORACIC AND CERVICAL AREAS, SUZUKI KAZUHIRO;MATSUMOTO KAZUHISA;KUROKAWA KOHEI;SUZUKI TAKANORI;YOSHIDA ICHIRO;OHTAKI AKIO;ISHIKAWA SUSUMU;YOKOE TAKAO;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1995, The KITAKANTO Medical Journal, 45, 6, 529, 535

CLINICAL STUDY OF TESTICULAR AND PARA-TESTICULAR NON-GERM CELL TUMORS, SUZUKI KAZUHIRO;TAMURA YOSHIMI;KUROKAWA KOHEI;JINBO SUSUMU;SUZUKI TAKANORI;IMAI KYOICHI;SUZUKI KEIJI;YAMANAKA HIDETOSHI, 1995, The KITAKANTO Medical Journal, 45, 6, 537, 541

LITHOTRIPSY OF THE BL ADDER STONE, KUROKAWA KOHEI;SUZUKI TAKANORI;SUZUKI KAZUHIRO;KURITA MAKOTO;NAKANO KATSUYA;HATORI MOTOAKI;ITO KAZUTO;KURITA SUSUMU;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 1, 23, 27

MECHANISMS OF TISSUE DAMAGE IN BENIGN PROSTATIC HYPERPLASIA AFTER TRANSURETHRAL BALLOON LASER THERMOTHERAPY, SUZUKI TAKANORI;KUROKAWA KOHEI;HIGASHI HIROOMI;SUZUKI KAZUHIRO;FUKABORI YOSHITATSU;IMAI KYOICHI;SUZUKI KEIJI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 2, 147, 154

QUALITY OF LIFE AFTER RADICAL PROSTATECTOMY, KUROKAWA KOHEI;SUZUKI TAKANORI;SUZUKI KAZUHIRO;OKAZAKI HIROSHI;ONO YOSHIHIRO;SHIONO AKIHIKO;TAKEZAWA YUTAKA;HAYASHI MASAMICHI;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 4, 301, 307

TRANSURETHRAL BALLOON LASER-ENHANCED THERMOTHERAPY USING ULTRAFINE CARBON PARTICLES:TEMPERATURE DISTRIBUTION IN A PHANTOM, SUZUKI TAKANORI;KUROKAWA KOHEI;HIGASHI HIROOMI;SUZUKI KAZUHIRO;DAIKUZONO NORIO;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 5, 359, 364

Successful maintenance hemodialysis treatment for a patient with hemophilia A and chronic renal failure, Koike Hidekazu;Hatori Motoaki;Nitta Takashi;Kashiwagi Bunzou;Suzuki Kazuhiro;Yamanaka Hidetoshi;Utsumi Hideki;Nojima Yoshihisa, 2004, Nihon Toseki Igakkai Zasshi, 37, 1, 91, 94

Scrotal and penile edema developed in a CAPD patient for 5 years, Uei Takatoshi;Magari Tomohiro;Kawaguchi Takuya;Hatori Motoaki;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2004, Nihon Toseki Igakkai Zasshi, 37, 3, 249, 252

Surgical procedures for chronic dialysis patients at Gunma University Hospital., Hatori Motoaki;Hayashi Masamichi;Shiono Akihiko;Hasumi Masaru;Takei Tomoyuki;Matsui Hiroshi;Kawaguchi Takuya;Ito Kazuto;Suzuki Kazuhiro;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, 2002, Nihon Toseki Igakkai Zasshi, 35, 11, 1447, 1451

A case with combined multiple retina thrombosis probably due to heparin-induced thrombocytopenia (HIT), Magari Tomohiro;Hatori Motoaki;Hasumi Masaru;Tanaka Toshiyuki;Matsui Hiroshi;Morita Takahiro;Ono Yoshihiro;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2004, Nihon Toseki Igakkai Zasshi, 37, 6, 1437, 1442

Ultrastructural Changes in Subepithelial Capillaries and Their Surrounding Stroma in Rat Prostateand Seminal Vesicle after Castration, Ono Yoshihiro;Suzuki Kazuhiro;Yuasa Hisako;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, 2003, The Tohoku Journal of Experimental Medicine, 201, 1, 29, 38

Incidence of Bladder Cancer Discovered by Urethrocystoscopy at Prostate Biopsy: Extraordinary High Incidence of Tiny Bladder Cancer in Elderly Males, Okazaki Hiroshi;Suzuki Koichi;Suzuki Takanori;Kurokawa Kohei;Ito Kazuto;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2004, The Tohoku Journal of Experimental Medicine, 203, 1, 31, 36

Contrast enhancement of ATN-4T on PC-3 prostate cancer for magnetic resonance imaging, Suzuki Takanori;Kurokawa Kohei;Suzuki Kazuhiro;Tomiyoshi Katsumi;Sakata Isao;Nakajima Susumu;Endo Keigo;Yamanaka Hidetoshi, 1995, Nippon Laser Igakkaishi, 16, Supplement, 363, 364

Application of YAG Laser to Prostaic Diseses, KUROKAWA Kohei;SUZUKI Takanori;SUZUKI Kazuhiro;HIGASHI Hiroomi;YAMANAKA Hidetoshi, 1998, Nippon Laser Igakkaishi, 19, 1, 19, 27

Interstitial temperature measurement during balloon laserthermia (PROSTALASE^TM) of the canine prostate, Kurokawa Kohei;Suzuki Takanori;Suzuki Kazuhiro;Yamanaka Hidetoshi, 1993, Nippon Laser Igakkaishi, 14, Supplement, 341, 342

Basic and clinical studies of transurethral balloon laser therapy for prostate diseases, Suzuki Takanori;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, 1994, Nippon Laser Igakkaishi, 15, Supplement, 285, 286

Basic study of the difference between Nd: YAG pulsed and continuous wave lasers on thermotherapy for the prostate gland, Suzuki Takanori;Kurokawa Kohei;Suzuki Kazuhiro;Higashi Hiroomi;Yamanaka Hidetoshi, 1996, Nippon Laser Igakkaishi, 17, Supplement, 327, 330

SQUAMOUS CELL CARCINOMA WITH CLOACAL EXSTROPHY: A CASE REPORT, Ohtsu Akira;Miyao Takeshi;Koike Hidekazu;Baba Kyoko;Aoki Masanori;Kurihara Sota;Miyazawa Yoshiyuki;Kato Haruo;Shuto Takahiro;Arai Seiji;Furuya Yosuke;Nitta Takashi;Nomura Masashi;Sekine Yoshitaka;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro;Makiguchi Takaya;Morita Hiroki;Kosaku Nozomu;Matsumoto Kazuhisa;Tomita Hikaru;Yamamoto Takumi;Hayashi Masamichi, 2015, The Japanese Journal of Urology, 106, 4, 274, 279

EFFICACY OF MICROSURGICAL SUBINGUINAL VARICOCELECTOMY USING INDOCYANINE GREEN FLUORESCENCE ANGIOGRAPHY: A PILOT STUDY, Shibata Yasuhiro;Kurihara Sota;Arai Seiji;Miyazawa Yoshiyuki;Kato Haruo;Koike Hidekazu;Ito Kazuto;Nakamura Tetsuya;Suzuki Kazuhiro, 2015, The Japanese Journal of Urology, 106, 4, 293, 298

A CASE OF GROWING TERATOMA SYNDROME, Baba Kyoko;Sekine Yoshitaka;Kurihara Sota;Koike Hidekazu;Matsui Hiroshi;Nakazato Haruki;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro;Nishii Masahiro;Mashimo Toru;Okamura Keigo;Hirato Junko, 2016, The Japanese Journal of Urology, 107, 2, 115, 120

Clinicopathological Features and Outcomes of Prostate Cancer Patients Detected using Ningen Dock (annual health check-up) System and Population-based Screening in Rural Area of Japan, Tamura Yoshimi;Ohki Kazunari;Nishii Masahiro;Ohtuka Yasuhiro;Miyakubo Mai;Nomura Masashi;Ito Kazuto;Suzuki Keiji;Suzuki Kazuhiro, 2014, Ningen Dock International, 2, 1, 27, 34

Clinical Characteristics of Hereditary and Familial Prostate Cancer in Japan, Ohtake Nobuaki;Nakata Seiji;Suzuki Kazuhiro;Yamanaka Hidetoshi;Suzuki Keiji;Fukabori Yoshitatsu, 2011, JOURNAL OF FAMILIAL TUMORS, 11, 1, 5, 10

Initial Outcome of Robot-Assisted Radical Prostatectomy, Koike Hidekazu;Sekine Yoshitaka;Miyao Takeshi;Nomura Masashi;Matsui Hiroshi;Syuutou Takahiro;Kurihara Sota;Nakayama Hiroshi;Miyazawa Yoshiyuki;Shibata Yasuhiro;Suzuki Kazuhiro;Okauchi Kenzo;Hattori Kazunori;Okegawa Takatsugu, May 2020, The Kitakanto Medical Journal, 70, 2, 83, 94

Analysis of the factors affecting the results of arteriovenous fistula surgery, Oka Daisuke;Sekine Yoshitaka;Ohtsu Akira;Aoki Masanori;Hayashi Takuma;Baba Kyoko;Nakayama Hiroshi;Kurihara Sota;Miyao Takeshi;Ohki Ryo;Miyazawa Yoshiyuki;Shibata Yasuhiro;Suzuki Kazuhiro, 2021, Nihon Toseki Igakkai Zasshi, 54, 3, 155, 158

Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population., Suzuki Kazuhiro;Nakazato Haruki;Matsui Hiroshi;Koike Hidekazu;Okugi Hironobu;Kashiwagi Bunzo;Nishii Masahiro;Ohtake Nobuaki;Nakata Seiji;Ito Kazuto;Yamanaka Hidetoshi, Cancer, 98, 7

Hands-free hook for endourological procedures., Ono Yoshihiro;Suzuki Kazuhiro, International journal of urology : official journal of the Japanese Urological Association, 10, 10

The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats., Shibata Yasuhiro;Kashiwagi Bunzo;Ono Yoshihiro;Fukabori Yoshitatsu;Suzuki Kazuhiro;Honma Seijiro;Yamanaka Hidetoshi, Oct. 2003, Urological research, 32, 1

Correlation between the Banff 97 classification of renal allograft biopsies and clinical outcome., Tanaka Toshiyuki;Kyo Masahiro;Kokado Yukito;Takahara Shiro;Hatori Motoaki;Suzuki Kazuhiro;Hasumi Masaru;Toki Kiyohide;Ichimaru Naotsugu;Yazawa Koji;Hanafusa Toru;Namba Yukiomi;Oka Kazumasa;Moriyama Toshiki;Imai Enyu;Okuyama Akihiko;Yamanaka Hidetoshi, Oct. 2003, Transplant international : official journal of the European Society for Organ Transplantation, 17, 2

Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues., Hasumi Masaru;Suzuki Kazuhiro;Matsui Hiroshi;Koike Hidekazu;Ito Kazuto;Yamanaka Hidetoshi, Cancer letters, 200, 2

Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration., Ono Yoshihiro;Suzuki Kazuhiro;Yuasa Hisako;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, The Tohoku journal of experimental medicine, 201, 1

Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate., Shibata Yasuhiro;Ono Yoshihiro;Kashiwagi Bunzo;Suzuki Kazuhiro;Fukabori Yoshitatsu;Honma Seijiro;Yamanaka Hidetoshi, Urology, 62, 5

Genomewide linkage analysis of familial prostate cancer in the Japanese population., Matsui Hiroshi;Suzuki Kazuhiro;Ohtake Nobuaki;Nakata Seiji;Takeuchi Toshiyuki;Yamanaka Hidetoshi;Inoue Ituro, Dec. 2003, Journal of human genetics, 49, 1

The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer., Hasumi Masaru;Suzuki Kazuhiro;Taketomi Ayako;Matsui Hiroshi;Yamamoto Takumi;Ito Kazuto;Kurokawa Kohei;Aoki Jun;Endo Keigo;Yamanaka Hidetoshi, Anticancer research, 23, 5b

Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia., Matsumoto Kazuhisa;Suzuki Kazuhiro;Koike Hidekazu;Hasumi Masaru;Matsui Hiroshi;Okugi Hironobu;Shibata Yasuhiro;Ito Kazuto;Yamanaka Hidetoshi, Anticancer research, 23, 5A

Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4ng/ml., Ohi Masaru;Ito Kazuto;Suzuki Kazuhiro;Yamamoto Takumi;Yamanaka Hidetoshi, European urology, 45, 1

The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less., Ito Kazuto;Yamamoto Takumi;Suzuki Kazuhiro;Kurokawa Kohei;Yamanaka Hidetoshi, The Journal of urology, 171, 2 Pt 1

Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate., Ono Yoshihiro;Suzuki Kazuhiro;Kashiwagi Bunzo;Shibata Yasuhiro;Ito Kazuto;Fukabori Yoshitatsu;Yamanaka Hidetoshi, International journal of andrology, 27, 1

Cumulative probability of PSA increase above 4.0 NG/ML in population-based screening for prostate cancer., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Takechi Hiroyuki;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, International journal of cancer, 109, 3

Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer., Kurokawa Kohei;Ito Kazuto;Yamamoto Takumi;Takechi Hiroyuki;Miyamoto Shigeto;Suzuki Kazuhiro;Yamanaka Hidetoshi, Urology, 63, 2

Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population., Suzuki Kazuhiro;Nakazato Haruki;Matsui Hiroshi;Koike Hidekazu;Okugi Hironobu;Ohtake Nobuaki;Takei Tomoyuki;Nakata Seiji;Hasumi Masaru;Yamanaka Hidetoshi, Anticancer research, 23, 6D

Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage., Koike Hidekazu;Suzuki Kazuhiro;Satoh Tetsuo;Ohtake Nobuaki;Takei Tomoyuki;Nakata Seiji;Yamanaka Hidetoshi, Anticancer research, 23, 6D

Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels., Matsumoto Kazuhisa;Suzuki Kazuhiro;Koike Hidekazu;Okamura Keigo;Tsuchiya Kiyotaka;Uchida Tatsuya;Takezawa Yutaka;Kobayashi Mikio;Yamanaka Hidetoshi, Anticancer research, 23, 6D

[The evaluation of bladder outlet obstruction using the bladder weight calculation nomogram]., Magari Tomohiro;Fukabori Yoshitatsu;Suzuki Kazuhiro;Yamanaka Hidetoshi;Ogura Haruyuki, Hinyokika kiyo. Acta urologica Japonica, 50, 1

Role of androgen on blood flow and capillary structure in rat seminal vesicles., Ono Yoshihiro;Suzuki Kazuhiro;Kashiwagi Bunzo;Shibata Yasuhiro;Ito Kazuto;Fukabori Yoshitatsu;Yamanaka Hidetoshi, The Tohoku journal of experimental medicine, 202, 3

Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo., Shibata Yasuhiro;Kashiwagi Bunzo;Arai Seiji;Fukabori Yoshitatsu;Suzuki Kazuhiro;Honma Seijiro;Yamanaka Hidetoshi, Jul. 2004, Endocrinology, 145, 10

[Acute scrotum from testicular involvement in acute lymphocytic leukemia: a case report]., Nitta Takashi;Koike Hidekazu;Fukabori Yoshitatsu;Hatori Motoaki;Ono Yoshitaka;Matsui Hiroshi;Suzuki Kazuhiro;Yamanaka Hidetoshi;Shigawa Youko;Kanazawa Takashi;Ogawa Chitose, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 95, 5

Effect of androgen concentration on seminal vesicle blood flow in rats-establishment of new highly sensitive simultaneous androgen measurement method., Kashiwagi Bunzo;Shibata Yasuhiro;Ono Yoshihiro;Suzuki Kazuhiro;Honma Seijiro;Yamanaka Hidetoshi, Urology, 66, 1

External Ca2+ dependency of synaptic transmission in drosophila synaptotagmin I mutants., Okamoto Tomonori;Tamura Takuya;Suzuki Kazuhiro;Kidokoro Yoshiaki, Journal of neurophysiology, 94, 2

Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: establishment of a new highly sensitive simultaneous androgen measurement method., Kashiwagi Bunzo;Shibata Yasuhiro;Ono Yoshihiro;Suzuki Ryota;Honma Seijiro;Suzuki Kazuhiro, Journal of andrology, 26, 5

Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia., Shibata Yasuhiro;Kashiwagi Bunzo;Arai Seiji;Fukabori Yoshitatsu;Suzuki Kazuhiro, Urology, 66, 2

Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity., Akimoto Tetsuo;Ito Kazuto;Saitoh Jun-ichi;Noda Shin-ei;Harashima Koichi;Sakurai Hideyuki;Nakayama Yuko;Yamamoto Takumi;Suzuki Kazuhiro;Nakano Takashi;Niibe Hideo, International journal of radiation oncology, biology, physics, 63, 2

Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer., Miyamoto Shigehito;Ito Kazuto;Kurokawa Kohei;Suzuki Kazuhiro;Suzuki Keiji;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 13, 6

Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population., Okugi Hironobu;Nakazato Haruki;Matsui Hiroshi;Ohtake Nobuaki;Nakata Seiji;Suzuki Kazuhiro, Jul. 2006, Cancer detection and prevention, 30, 3

Positive effect of prostaglandin on regulation of prostatic blood flow., Kashiwagi Bunzo;Shibata Yasuhiro;Ohki Kazunari;Arai Seiji;Honma Seijiro;Suzuki Kazuhiro, Urology, 68, 3

Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo., Shibata Yasuhiro;Kashiwagi Bunzo;Arai Seiji;Magari Tomohiro;Suzuki Kazuhiro;Honma Seijiro, Urology, 68, 5

Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., Sekine Yoshitaka;Ito Kazuto;Yamamoto Takumi;Nakazato Haruki;Shibata Yasuhiro;Hatori Motoaki;Suzuki Kazuhiro, Apr. 2007, Cancer detection and prevention, 31, 2

Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells., Sekine Yoshitaka;Koike Hidekazu;Nakano Takamitsu;Nakajima Katsuyuki;Suzuki Kazuhiro, Apr. 2007, Clinica chimica acta; international journal of clinical chemistry, 383, 1-2

Lead time of prostate cancer detected in population based screening for prostate cancer in Japan., Ito Kazuto;Yamamoto Takumi;Miyakubo Mai;Takechi Hiroyuki;Ohi Masaru;Shibata Yasuhiro;Suzuki Kazuhiro, Aug. 2007, The Journal of urology, 178, 4 Pt 1

Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer., Koike Hidekazu;Sekine Yoshitaka;Kamiya Makoto;Nakazato Haruki;Suzuki Kazuhiro, Mar. 2008, Urology, 72, 6

Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan., Takechi Hiroyuki;Ito Kazuto;Yamamoto Takumi;Miyakubo Mai;Ohi Masaru;Suzuki Kazuhiro, Mar. 2008, Urology, 72, 5

Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds., Yamamoto Takumi;Ito Kazuto;Miyakubo Mai;Takechi Hiroyuki;Suzuki Kazuhiro;Akimoto Tetsuo;Ishikawa Hitoshi;Nakano Takashi, Apr. 2008, Urology, 72, 4

Changes in baseline PSA levels in Japanese men from 1988 to 2003., Ohi Masaru;Ito Kazuto;Yamamoto Takumi;Miyakubo Mai;Takechi Hiroyuki;Kubota Yutaka;Suzuki Kazuhiro, May 2008, Urology, 72, 1

Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Sekine Yoshitaka;Furuya Yosuke;Nishii Masahiro;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, May 2008, Biochemical and biophysical research communications, 372, 2

Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia., Nagai Yayoi;Hasegawa Michiko;Shinmi Kahori;Kishi Chikako;Tsushima Yoshito;Endo Keigo;Okabe Kazuhiko;Suzuki Kazuhiro;Ishikawa Osamu, Acta dermato-venereologica, 88, 6

Induction of type 1 interferon receptor by zinc in U937 cells., Nagamine Takeaki;Nakajima Kastuyuki;Takada Hisashi;Sekine Yoshitaka;Suzuki Kazuhiro, Apr. 2009, Cytokine, 46, 3

Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy., Miyakubo Mai;Ito Kazuto;Yamamoto Takumi;Takechi Hiroyuki;Ohi Masaru;Suzuki Kazuhiro, May 2009, International journal of urology : official journal of the Japanese Urological Association, 16, 6

The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha1-adrenergic receptor antagonist work well for ureteral stones?, Ohki Kazunari;Ohno Yosihiro;Suzuki Kazuhiro, Jun. 2009, International urology and nephrology, 42, 1

Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor., Sekine Yoshitaka;Koike Hidekazu;Nakano Takamitsu;Nakajima Katsuyuki;Takahashi Sadao;Suzuki Kazuhiro, May 2009, Cancer epidemiology, 33, 1

Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer., Okamura Keigo;Koike Hidekazu;Sekine Yoshitaka;Matsui Hiroshi;Suzuki Kazuhiro, Cancer epidemiology, 33, 2

New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry., Arai Seiji;Miyashiro Yoshimichi;Shibata Yasuhiro;Kashiwagi Bunzo;Tomaru Yukio;Kobayashi Mikio;Watanabe Yoko;Honma Seijiro;Suzuki Kazuhiro, Sep. 2009, Steroids, 75, 1

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells., Abdulah Rizky;Faried Ahmad;Kobayashi Kenji;Yamazaki Chiho;Suradji Eka W;Ito Kazuto;Suzuki Kazuhiro;Murakami Masami;Kuwano Hiroyuki;Koyama Hiroshi, Nov. 2009, BMC cancer, 9

Oct. 2015, 11, 5, 10

;;;;;;, Nov. 2015, 28, 3, 146

;;, Oct. 2015, 2, 2, 241

;;;;;;;;, Oct. 2015, 106, 4, 293

;, Jan. 2016, 74, 1, 72

;;;;, Dec. 2015, 20, 7, OS304

;;;;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 311

;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 312

;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 313

;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 313

;, May 2016, 74, 増刊3 新前立腺癌学, 12

;;;;;;;;;;;;, Apr. 2016, 107, 2, 115

;;;;;, Apr. 2016, 3, 1, 53

;, Apr. 2016, 3, 1, 61

;;;, Sep. 2016, 24, 1, 98

Oct. 2016, 67, 11, 3027

Nov. 2016, 145, 8, 1631

Aug. 2016, 別冊, 最新遺伝性腫瘍・家族性腫瘍研究と遺伝カウンセリング, 197

;;;, Oct. 2016, 3, 2, 195

Aug. 2016, 31, 2, 125

;;, Dec. 2016, 4, 6, 559

;;;;;;;;;;;;, Apr. 2016, 104回, PP1

;;;;;;;;;;;;, Apr. 2016, 104回, PP2

;;;;;;;;;;;;, Apr. 2016, 104回, PP2

;;;;;;, Apr. 2016, 104回, PP3

;;;;;;;;;;;;;, Apr. 2016, 104回, OP

;;;;;;;;;;;;, Apr. 2016, 104回, PP3

Feb. 2017, 24, 1, 29

;;;;;;;;;;;;;;, Oct. 2016, 54回, WS23

;;;;;;;;;;;;;;, Oct. 2016, 54回, WS25

;;;;;;;;;;;;;, Oct. 2016, 54回, WS63

;;;, Oct. 2016, 54回, P51

;;;;, Oct. 2016, 54回, P54

;;;, May 2017, 30, 臨増, 914

Mar. 2017, 5, 3, 268

;, Apr. 2017, 4, 1, 59

;, Apr. 2017, 4, 1, 83

;;;;, Feb. 2017, 67, 1, 73

;;;, Aug. 2017, 25, 1, 86

;;;;;, Apr. 2017, 105回, OP39

;;;, Apr. 2017, 105回, PP86

;;;;;;;;;;;;, Sep. 2017, 4, 2, 293

Aug. 2017, 32, 2, 181

;;;;;;;;, Nov. 2017, 19, 4, 518

;;;, Nov. 2017, 35, 11, 112

;;;;;;;;;, Nov. 2017, 30, 3, 211

;, Feb. 2018, 54, 増刊, 563

;;;;;;;;;;;;;;;;;;;;, Apr. 2018, 5, 1, 147

;;;;;;;;;;;, Jun. 2018, 31, 臨増, 850

;;;;;;;;, May 2018, 51, Suppl.1, 744

;;;;;;;;;;, Jun. 2018, 13, Suppl., S382

;;;;;;;;;, Apr. 2018, 106回, OP

;;;;;;;;;;;;, Apr. 2018, 106回, OP

;;;;, Apr. 2018, 106回, OP

;;;;;;;;;;;;, Apr. 2018, 106回, PP1

;;;;;;;;;;;;, Apr. 2018, 106回, PP2

;;;, Aug. 2018, 63, 3, 394

;;;;;;;;, Aug. 2018, 31, 8, 1247

;;, Oct. 2018, 72, 11, 902

;;;, Nov. 2018, 1, 2, 75

;;, Oct. 2018, 5, 2, 195

;;;;;, Sep. 2018, 53, 総会臨時, 361

;;;;;;;;;;;;;;, Oct. 2018, 56回, P43

;;;;;;;;;, Feb. 2019, 52回, 236

;;;;;;;;;, Feb. 2019, 52回, 259

;;;;;, Feb. 2019, 52回, 270

;;, Apr. 2019, 6, 1, 65

;;, Apr. 2019, 6, 1, 83

;;;;;;;;;;;;;;;;, Apr. 2019, 107回, LBE1

;;;;;;;;, Apr. 2019, 107回, OP

;;;, May 2019, 9, 5, 512

;;;;;;;;;;;, Jun. 2019, 32, 臨増, 631

;;;;;;;;;, Sep. 2019, 54, 総会臨時, 294

;;;;;;;;;, Aug. 2019, 32, 8, 1095

;;;, Dec. 2019, 32, 12, 1515

;;;, Oct. 2019, 64, 4, 383

;;;;;, Dec. 2019, 21, 4, 445

;;;;;;, Dec. 2019, 21, 4, 459

;;;;;;;;;, Sep. 2019, 30, 1, 241

;;;;;;;;;;, Sep. 2019, 30, 1, 314

;;;;;;;;;;;;;;, Oct. 2019, 57回, O36

;;;;;;;;;;;;, Oct. 2019, 57回, P98

;;;;;;;;;;;;;;, Oct. 2019, 57回, P107

;;;;;;;;;;;;;;, Oct. 2019, 57回, P108

;;;;;, Aug. 2019, 69, 3, 292

;;, Sep. 2019, 78回, P

;;;;;;;;;, Feb. 2020, 53回, 249

;;;;;, Feb. 2020, 53回, 288

;;;;;;;;;;;;;;;;;, Nov. 2019, 69, 4, 351

;;;, Apr. 2020, 74, 4, 073

Apr. 2020, 33, 4, 338

;;;;;;;;, Nov. 2018, 32回, P

;;;;;;;, Nov. 2018, 32回, P

;;;;;;;;, Nov. 2018, 32回, P

;;;;;;;;;, Nov. 2018, 32回, P

;;;;;;;;;, Nov. 2019, 33回, P

;;;;;;;;;, Nov. 2019, 33回, P

;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 232

;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 259

;, May 2023, 72回, np540

;;;;;;, Jun. 2023, 32, 2, 274

Oct. 2023, 77, 11, 888

;;;;;;;;;;;;;;;;;;;;;, Nov. 2022, 72, 4, 424

;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 859

;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 863

;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 863

;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 876

;;;;, Sep. 2023, 58, 総会臨時, 326

;;, Oct. 2023, 10, 2, 95

Oct. 2023, 10, 2, 189

;;;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 179

;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 179

;;;;;;;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 181

;;;;;;;;;;, May 2023, 73, 2, 181

Jul. 2023, 44, 2, 21

;;;;;;;;;, Jul. 2023, 32回, 35

;;;;;;;;;;, Jul. 2023, 32回, 42

;;;;;;;;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 97

;;;;;;;;;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 97

;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 98

;;;;;;, Feb. 2023, 73, 1, 99

;;;;;;;;;;;;, Apr. 2023, 110回, AOP04

;;;;;;;;;;;;, Apr. 2023, 110回, OP15

;;;;;;;;;;;;, Apr. 2023, 110回, OP49

;;;;;;;;;;;;, Apr. 2023, 110回, OP70

;;;;;;;;;;;;, Apr. 2023, 110回, PP21

;;;;;;;;;;;;, Apr. 2023, 110回, PP26

;;;;;;;;;;;;, Apr. 2023, 110回, PP36

;;;;;;;;;;;;, Apr. 2023, 110回, PP70

;;;;;;;, Sep. 2023, 82回, 1065

;;;;;;;;;;;, Feb. 2021, 17, 臨増1, 168

;;;;;;;;;;;;, Oct. 2023, 61回, O9

;;;;;;;;;;;;;;;, Oct. 2023, 61回, P4

;;;;;;;;;;;;;;, Oct. 2023, 61回, P24

;;;;;;;;;;, Oct. 2023, 61回, P26

;;;;;;;;, Oct. 2023, 61回, P26

;;;;;;;;;;;;, Oct. 2023, 61回, P27

;;;;;;;;;;, Oct. 2023, 61回, P28

;;, Apr. 2024, 37, 特別号, 137

;;, Apr. 2024, 11, 1, 1

;;;, Apr. 2024, 37, 4, 279

;;;;;;;;;;, Aug. 2023, 73, 3, 199

;;;;;;;, Aug. 2023, 73, 3, 246

;;;, Apr. 2024, 7, 1, 05

;, Sep. 2024, 32, 1, 87

;;;;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 318

;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 320

;;, Oct. 2024, 11, 2, 103

;;, Nov. 2024, 34, 4, 8

Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease., Hamano Tatsuya;Matsui Hiroshi;Sekine Yoshitaka;Ohtake Nobuaki;Nakata Seiji;Suzuki Kazuhiro, Jun. 2010, The Journal of urology, 184, 2

Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., Arai Seiji;Miyashiro Yoshimichi;Shibata Yasuhiro;Tomaru Yukio;Kobayashi Mikio;Honma Seijiro;Suzuki Kazuhiro, Dec. 2010, Steroids, 76, 3

Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., Koike Hidekazu;Morikawa Yasuyuki;Sekine Yoshitaka;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, Feb. 2011, The Journal of urology, 185, 4

High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., Sekine Yoshitaka;Osei-Hwedieh David;Matsuda Kant;Raghavachari Nalini;Liu Delong;Furuya Yosuke;Koike Hidekazu;Suzuki Kazuhiro;Remaley Alan T, Mar. 2011, The Prostate, 71, 14

Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate., Okamoto Masahiko;Ishikawa Hitoshi;Ebara Takeshi;Kato Hiroyuki;Tamaki Tomoaki;Akimoto Tetsuo;Ito Kazuto;Miyakubo Mai;Yamamoto Takumi;Suzuki Kazuhiro;Takahashi Takeo;Nakano Takashi, May 2011, International journal of radiation oncology, biology, physics, 82, 2

[Cholesterol granuloma of the kidney: a case report]., Okamoto Kohei;Hatori Motoaki;Tomita Kensuke;Yokoyama Yoshinari;Makino Takeaki;Hirono Masanori;Muramatsu Kazumichi;Arai Seiji;Morikawa Yasuyuki;Miyakubo Mai;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 102, 3

Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation., Morikawa Yasuyuki;Koike Hidekazu;Sekine Yoshitaka;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Feb. 2012, Biochemical and biophysical research communications, 419, 3

Luteinizing hormone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: implications for the effect of LH on the adrenal glands., Nishii Masahiro;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Oyama Tetsunari;Suzuki Kazuhiro, Apr. 2012, Journal of andrology, 33, 6

Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range., Ito Kazuto;Miyakubo Mai;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, Aug. 2012, World journal of urology, 31, 2

[Septic shock following flexible transurethral lithotripsy showing favourable response after multidisciplinary treatment mainly composed of recombinant thrombomodulin : a case report]., Kato Haruo;Shibata Yasuhiro;Suzuki Tomomi;Ito Kazuto;Suzuki Kazuhiro, Hinyokika kiyo. Acta urologica Japonica, 58, 9

Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., Magari Tomohiro;Shibata Yasuhiro;Arai Seiji;Kashiwagi Bunzo;Suzuki Kazuhiro, Nov. 2012, Scandinavian journal of urology, 47, 3

Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancer., Muramatsu Kazumichi;Matsui Hiroshi;Sekine Yoshitaka;Koike Hidekazu;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Feb. 2013, Prostate international, 1, 1

Simple method for preventing inguinal hernias after radical retropubic prostatectomy., Koike Hidekazu;Matsui Hiroshi;Morikawa Yasuyuki;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Jun. 2013, Prostate international, 1, 2

Chlormadinone acetate is effective for hot flush during androgen deprivation therapy., Koike Hidekazu;Morikawa Yasuyuki;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Sep. 2013, Prostate international, 1, 3

Chronic expanding hematoma in the retroperitoneal space: a case report., Syuto Takahiro;Hatori Motoaki;Masashi Nomura;Sekine Yoshitaka;Suzuki Kazuhiro, Nov. 2013, BMC urology, 13

Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels., Magari Tomohiro;Shibata Yasuhiro;Arai Seiji;Kashiwagi Bunzo;Suzuki Keiji;Suzuki Kazuhiro, Asian journal of andrology, 16, 3

Suicide attempt with an overdose of sunitinib., Arai Seiji;Matsui Hiroshi;Ohki Ryo;Miyazawa Yoshiyuki;Koike Hidekazu;Hashita Tadahiro;Katsuyama Yoshihiko;Sekine Yoshitaka;Nomura Masashi;Shibata Yasuhiro;Hatori Motoaki;Ito Kazuto;Yamamoto Koujirou;Ohmori Shigeru;Suzuki Kazuhiro, British journal of clinical pharmacology, 78, 4

YM155 reverses rapamycin resistance in renal cancer by decreasing survivin., Koike Hidekazu;Nitta Takashi;Sekine Yoshitaka;Arai Seiji;Furuya Yosuke;Nomura Masashi;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Oyama Tetsunari;Suzuki Kazuhiro, Jun. 2014, Journal of cancer research and clinical oncology, 140, 10

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma., Ishizuka Tamotsu;Hisada Takeshi;Hatori Motoaki;Koike Akio;Hanabuchi Kikuo;Matsuzaki Shinichi;Kamide Yosuke;Utsugi Mitsuyoshi;Aoki Haruka;Yoshino Reiko;Yanagitani Noriko;Koga Yasuhiko;Ono Akihiro;Kaira Kyoichi;Sunaga Noriaki;Dobashi Kunio;Tsuburai Takahiro;Akiyama Kazuo;Yamada Masanobu;Suzuki Kazuhiro;Mori Masatomo, Jul. 2014, Inflammation research : official journal of the European Histamine Research Society ... [et al.], 63, 9

Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan., Onozawa Mizuki;Hinotsu Shiro;Tsukamoto Taiji;Oya Mototsugu;Ogawa Osamu;Kitamura Tadaichi;Suzuki Kazuhiro;Naito Seiji;Namiki Mikio;Nishimura Kazuo;Hirao Yoshihiko;Akaza Hideyuki, Aug. 2014, Japanese journal of clinical oncology, 44, 10

A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer., Suzuki Kazuhiro;Ozono Seiichiro;Yamaguchi Akito;Koike Hidekazu;Matsui Hiroshi;Nagata Masao;Takubo Takatoshi;Miyashita Kana;Matsushima Takafumi;Akaza Hideyuki, Dec. 2014, Cancer chemotherapy and pharmacology, 75, 2

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial., Saad Fred;Fizazi Karim;Jinga Viorel;Efstathiou Eleni;Fong Peter C;Hart Lowell L;Jones Robert;McDermott Raymond;Wirth Manfred;Suzuki Kazuhiro;MacLean David B;Wang Ling;Akaza Hideyuki;Nelson Joel;Scher Howard I;Dreicer Robert;Webb Iain J;de Wit Ronald; , Feb. 2015, The Lancet. Oncology, 16, 3

Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer., Nozawa Masahiro;Mukai Hirofumi;Takahashi Shunji;Uemura Hiroji;Kosaka Takeo;Onozawa Yusuke;Miyazaki Jun;Suzuki Kazuhiro;Okihara Koji;Arai Yoichi;Kamba Tomomi;Kato Masashi;Nakai Yasutomo;Furuse Hiroshi;Kume Haruki;Ide Hisamitsu;Kitamura Hiroshi;Yokomizo Akira;Kimura Takahiro;Tomita Yoshihiko;Ohno Keiji;Kakehi Yoshiyuki, Mar. 2015, International journal of clinical oncology, 20, 5

Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor., Kato Haruo;Sekine Yoshitaka;Furuya Yosuke;Miyazawa Yoshiyuki;Koike Hidekazu;Suzuki Kazuhiro, Apr. 2015, Biochemical and biophysical research communications, 461, 1

Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist., Miyazawa Yoshiyuki;Kato Haruo;Arai Seiji;Furuya Yosuke;Sekine Yoshitaka;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Jul. 2015, Basic and clinical andrology, 25

Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association., Kanayama Hiro-Omi;Fukumori Tomoharu;Fujimoto Hiroyuki;Nakanishi Hiroyuki;Ohyama Chikara;Suzuki Kazuhiro;Nishiyama Hiroyuki;Eto Masatoshi;Miki Tsuneharu;Kamoi Kazumi;Kubota Yoshinobu;Takahashi Satoru;Homma Yukio;Naito Seiji, International journal of urology : official journal of the Japanese Urological Association, 22, 9

Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life., Ishikawa Hitoshi;Katoh Hiroyuki;Kaminuma Takuya;Kawamura Hidemasa;Ito Kazuto;Matsui Hiroshi;Hirato Junko;Shimizu Nobuaki;Takezawa Yutaka;Tsuji Hiroshi;Suzuki Kazuhiro;Ohno Tatsuya;Nakano Takashi; , Anticancer research, 35, 10

Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan., Suzuki Kazuhiro;Namiki Mikio;Fujimoto Tsukasa;Takabayashi Nobuyoshi;Kudou Kentarou;Akaza Hideyuki, Oct. 2015, Japanese journal of clinical oncology, 45, 12

Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer., Miyoshi Yasuhide;Uemura Hiroji;Umemoto Susumu;Sakamaki Kentaro;Taguri Masataka;Suzuki Kazuhiro;Shibata Yasuhiro;Masumori Naoya;Ichikawa Tomohiko;Mizokami Atsushi;Sugimura Yoshiki;Nonomura Norio;Sakai Hideki;Honma Seijiro;Harada Masaoki;Kubota Yoshinobu, Nov. 2015, The Prostate, 76, 4

Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy., Shibata Yasuhiro;Kurihara Sota;Arai Seiji;Kato Haruo;Suzuki Tomomi;Miyazawa Yoshiyuki;Koike Hidekazu;Ito Kazuto;Nakamura Tetsuya;Suzuki Kazuhiro, Oct. 2016, Journal of investigative surgery : the official journal of the Academy of Surgical Research, 30, 4

Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells., Miyazawa Yoshiyuki;Sekine Yoshitaka;Kato Haruo;Furuya Yosuke;Koike Hidekazu;Suzuki Kazuhiro, Nov. 2016, The Prostate, 77, 4

YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin., Nitta Takashi;Koike Hidekazu;Miyao Takeshi;Miyazawa Yoshiyuki;Kato Haruo;Furuya Yosuke;Sekine Yoshitaka;Suzuki Kazuhiro, Anticancer research, 37, 1

Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content., Shibata Yasuhiro;Arai Seiji;Miyazawa Yoshiyuki;Shuto Takahiro;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Ito Kazuto;Suzuki Kazuhiro, Feb. 2017, The Prostate, 77, 6

Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels., Okamoto Kohei;Sekine Yositaka;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Apr. 2015, Basic and clinical andrology, 25

[A CASE OF GROWING TERATOMA SYNDROME]., Baba Kyoko;Sekine Yoshitaka;Kurihara Sota;Koike Hidekazu;Matsui Hiroshi;Nakazato Haruki;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro;Nishii Masahiro;Mashimo Toru;Okamura Keigo;Hirato Junko, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 107, 2

Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab., Miyazawa Yoshiyuki;Sekine Yoshitaka;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Anticancer research, 37, 7

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients., Miyazawa Yoshiyuki;Sekine Yoshitaka;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Aug. 2017, BMC urology, 17, 1

Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism., Sekine Yoshitaka;Nakayama Hiroshi;Miyazawa Yoshiyuki;Kato Haruo;Furuya Yosuke;Arai Seiji;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Dec. 2017, Oncology letters, 15, 3

Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer., Miyazawa Yoshiyuki;Sekine Yoshitaka;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, In vivo (Athens, Greece), 32, 2

Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml., Ito Kazuto;Yokomizo Akira;Tokunaga Shoji;Arai Gaku;Sugimoto Mikio;Akakura Koichiro;Hasumi Hisashi;Sakai Hideki;Ouraji Akiko;Oki Ryo;Kashiwagi Eiji;Kobori Yoshitomo;Hirama Hiromi;Kitoh Hiroki;Uemura Hiroji;Hakariya Tomoaki;Suzuki Kazuhiro; , Aug. 2019, The Journal of urology, 203, 1

Quality of life in prostate cancer patients receiving particle radiotherapy: A review of the literature., Kawamura Hidemasa;Kubo Nobuteru;Sato Hiro;Miyasaka Yuhei;Matsui Hiroshi;Ito Kazuto;Suzuki Kazuhiro;Ohno Tatsuya, Sep. 2019, International journal of urology : official journal of the Japanese Urological Association, 27, 1

Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese Institute., Miyazawa Yoshiyuki;Sekine Yoshitaka;Arai Seiji;Oka Daisuke;Nakayama Hiroshi;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, In vivo (Athens, Greece), 35, 1

[Ⅱ.Development of Anti-Neoplastic Agents for Prostate Cancer-Recent Trend and Perspectives]., Suzuki Kazuhiro;Miyazawa Yoshiyuki, Gan to kagaku ryoho. Cancer & chemotherapy, 48, 1

Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors., Saad Fred;Bögemann Martin;Suzuki Kazuhiro;Shore Neal, Feb. 2021, Prostate cancer and prostatic diseases, 24, 2

Understanding Treatment Strategies and Preferences in Nonmetastatic Castration-Resistant Prostate Cancer From the Japanese Physician Perspective., Suzuki Kazuhiro;Grillo Vince;Chen Yirong;Singh Shikha;Ledesma Dianne Athene, JCO global oncology, 7

Baseline characteristics may impact treatment duration of cabazitaxel in patients with mCRPC: a subanalysis of data from a post-marketing surveillance., Matsubara Nobuaki;Matsuyama Hideyasu;Kazama Hirotaka;Seto Takeshi;Sunaga Yoshinori;Suzuki Kazuhiro, Japanese journal of clinical oncology, 54, 1

A case of anterior urethral polyp after transurethral resection of prostate, ;;;;;, Nov. 2002, 56, 12, 1089, 1091

Septic Shock Following Flexible Transurethral Lithotripsy Showing Favourable Response after Multidisciplinary Treatment Mainly Composed of Recombinant Thrombomodulin : A Case Report, Kato, Haruo;Shibata, Yasuhiro;Suzuki, Tomomi;Ito, Kazuto;Suzuki, Kazuhiro, Sep. 2012, Hinyokika Kiyo, 58, 9, 499, 502

;;;;;, Jun. 2014, 68, 7, 523, 526

Endocrine therapy for prostate cancer:history and perspective, ;, Apr. 2015, 69, 5, 330, 333

A CASE OF GROWING TERATOMA SYNDROME, Baba Kyoko;Sekine Yoshitaka;Kurihara Sota;Koike Hidekazu;Matsui Hiroshi;Nakazato Haruki;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro;Nishii Masahiro;Mashimo Toru;Okamura Keigo;Hirato Junko, 2016, The Japanese Journal of Urology, 107, 2, 115, 120

;;, Oct. 2018, 72, 11, 902, 905

Usefulness of PSA screening in outpatients with bladder cancer : Preliminary results, KUROKAWA Kohei;SUZUKI Kazuhiro;OKAZAKI Hiroshi;ITO Kazuto;SHIONO Akihiko;FUKABORI Yoshitastu;YAMANAKA Hidetoshi, May 2002, Int. J. Urol., 9, 5, 237, 240

Usefulness of prostate-specific antigen velocity in screening for prostate cancer, ITO Kazuto;YAMAMOTO Takumi;OHI Masaru;KUBOTA Yutaka;FUKABORI Yoshitatsu;KUROKAWA Kohei;SUZUKI Kazuhiro;YAMANAKA Hidetoshi, Jun. 2002, Int. J. Urol., 9, 6, 316, 321

Autopsy findings of patients with urological neoplasms, ONO Yoshihiro;OZAWA Masashi;SUZUKI Koichi;OKAZAKI Hiroshi;TAMURA Yoshimi;SUZUKI Takanori;SUZUKI Kazuhiro;OGAWA Akira;SUGIHARA Shiro, Oct. 2002, Int J Clin Oncol., 7, 5, 301, 305

Preliminary results of a monitoring system to confirm the preservation of cavernous nerves, KUROKAWA KOHEI;SUZUKI TAKANORI;SUZUKI KAZUHIRO;TERADA NAOKI;ITO KAZUTO;YOSHIKAWA DAISUKE;ARAI YOICHI;YAMANAKA HIDETOSHI, Mar. 2003, 10, 3, 136, 140

;;;;;;;;;;;;;, May 2020, 70, 2, 83

;;;;;;;;;;;;, May 2020, 70, 2, 163

;;;;;;;;;;;, May 2020, 70, 2, 168

;;;;;;;;;;;, Jun. 2020, 33, 臨増, 899

;;;;;;;;;;;;, Jun. 2020, 33, 臨増, 910

;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 226

;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 226

;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231

;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231

;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231

;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 232

;;;;;;;;;;;;;, Aug. 2021, 71, 3, 232

Aug. 2021, 71, 3, 233

;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 259

;;;;;;;, Feb. 2022, 55回, 186

;;;;;;;;, Feb. 2022, 55回, 300

;;;;;;;;;;;;;;;;;;;;;;, Feb. 2022, 72, 1, 119

;;;;;;;;;, Feb. 2022, 72, 1, 121

;;;;;;;;, Nov. 2018, 32回, P

;;;;;;;, Nov. 2018, 32回, P

;;;;;;;;, Nov. 2018, 32回, P

;;;;;;;;;, Nov. 2018, 32回, P

;;;;;;;;;, Nov. 2019, 33回, P

;;;;;;;;;, Nov. 2019, 33回, P

;;;;;;;;;, Nov. 2020, 34回, P

;;;;;;;;;;;;;;, Mar. 2022, 97, 5, 1149

;;;, Mar. 2022, 19, 1, 15

;;;;;;;;;;;;;;;;;;;;;, Nov. 2022, 72, 4, 424

;;;;;;;;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 97

;;;;;;;;;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 97

;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 98

;;;;;;, Feb. 2023, 73, 1, 99

;;;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 179

;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 179

;;;;;;;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 181

;;;;;;;;;;, May 2023, 73, 2, 181

May 2022, 5回, 40

;, May 2023, 72回, np540

;;;;;;;;;;;;, May 2023, 56, Suppl.1, 699

;;;;;;;;;;;;;;;;;;;, May 2023, 56, Suppl.1, 763

;;;;;;;;;;;;, Apr. 2023, 110回, AOP04

;;;;;;;;;;;;, Apr. 2023, 110回, OP15

;;;;;;;;;;;;, Apr. 2023, 110回, OP49

;;;;;;;;;;;;, Apr. 2023, 110回, OP70

;;;;;;;;;;;;, Apr. 2023, 110回, PP21

;;;;;;;;;;;;, Apr. 2023, 110回, PP26

;;;;;;;;;;;;, Apr. 2023, 110回, PP36

;;;;;;;;;;;;, Apr. 2023, 110回, PP70

;;;;;;, Jun. 2023, 32, 2, 274

Jul. 2023, 44, 2, 21

;;;;;;;;;;, Aug. 2023, 73, 3, 199

;;;;;;;, Aug. 2023, 73, 3, 246

;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 859

;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 863

;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 863

;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 876

;;;;, Sep. 2023, 58, 総会臨時, 326

Oct. 2023, 77, 11, 888

;;;;;;;;;;;;, Oct. 2023, 61回, O9

;;;;;;;;;;;;;;;, Oct. 2023, 61回, P4

;;;;;;;;;;;;;;, Oct. 2023, 61回, P24

;;;;;;;;;;, Oct. 2023, 61回, P26

;;;;;;;;, Oct. 2023, 61回, P26

;;;;;;;;;;;;, Oct. 2023, 61回, P27

;;;;;;;;;;, Oct. 2023, 61回, P28

;;;;;;;, Sep. 2023, 82回, 1065

;;;;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 318

;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 320

;;;;;;;;;, Jul. 2023, 32回, 35

;;;;;;;;;;, Jul. 2023, 32回, 42

;;;;;;;;;;;, Feb. 2021, 17, 臨増1, 168

;;, Apr. 2024, 11, 1, 1

;;;, Apr. 2024, 37, 4, 279

;;;, Apr. 2024, 7, 1, 05

;, Sep. 2024, 32, 1, 87

;;, Oct. 2024, 11, 2, 103

;;, Nov. 2024, 34, 4, 8

;;;;;;;, Mar. 2024, 44, 29

;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 226

;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231

;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231

;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231

;;;;;;;;;;;;;, Aug. 2021, 71, 3, 232

Aug. 2021, 71, 3, 233

;, Jul. 2022, 16, 1, 25

;;;;;;;;;;;;;;, Mar. 2022, 97, 5, 1149

;;;;, Apr. 2022, 98, 1, 312

;;;;;;;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 469

;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 516

;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 674

;;;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 775

;;;;;;;;, Aug. 2022, 16, 2, 149

;;;;;, Aug. 2022, 35, 8, 860

;;;;;;, Jul. 2022, 31回, 34

;;;, Oct. 2022, 9, 2, 125

;;, Oct. 2022, 9, 2, 211

;;;, Oct. 2022, 9, 2, 221

;, Oct. 2022, 76, 11, 810

;, Sep. 2022, 68, 9, 395

;;;;;;;;;;;;;;, Oct. 2022, 60回, O4

;;;;;;;;;;;;;, Oct. 2022, 60回, O38

;;;;;;;, Oct. 2022, 60回, O73

;;;;;;;;;;;;;;, Oct. 2022, 60回, P28

;;;;;;;;;;;;;;, Oct. 2022, 60回, P49

;;;;;;;;;;;;;;, Oct. 2022, 60回, P51

;;;, Oct. 2022, 60回, P53

;;;;;;;, Oct. 2022, 57, 総会臨時, 394

;;;;;;;;;;;;;;;;;;;;;;, Feb. 2022, 72, 1, 119

;;;;;;;;;, Feb. 2022, 72, 1, 121

May 2022, 5回, 40

;;;;;;;;;;;;, May 2023, 56, Suppl.1, 699

;;;;;;;;;;;;;;;;;;;, May 2023, 56, Suppl.1, 763

;;;;, Jun. 2020, 78, 6, 937

;;;, Jun. 2020, 78, 6, 1037

;;;;;;;;;;;, Jun. 2020, 33, 臨増, 899

;;;;;;;;;;;;, Jun. 2020, 33, 臨増, 910

;;;, Oct. 2020, 26, 4, 362

;;;;;, Oct. 2020, 7, 2, 259

;;, Aug. 2020, 33, 8, 1031

;;;;;;;;;, Aug. 2020, 33, 8, 1111

;;;;;;;;;;;;;;, Oct. 2020, 58回, WS15

;;;;;;;;;;;;;;, Oct. 2020, 58回, O63

;;;;;;;;;;;;;;, Oct. 2020, 58回, P

;;;;;;;;;;;;;, May 2020, 70, 2, 83

;;;;;;;;;;;;, May 2020, 70, 2, 163

;;;;;;;;;;;, May 2020, 70, 2, 168

;;;;;;;;;, Feb. 2021, 54回, 172

;;;;;;, Feb. 2021, 54回, 210

;;;, Oct. 2020, 79回, OJ8

;;;, Oct. 2020, 79回, PJ8

;;;, Oct. 2020, 79回, PJ14

;;;;;;;;;;, Dec. 2020, 108回, 306

;;;;, Dec. 2020, 108回, 1143

;;;;;;;, Dec. 2020, 108回, 1344

;;;;;;;;;;;;, Mar. 2021, 54, 3, 155

;, Apr. 2021, 8, 1, 1

;;;, Apr. 2021, 8, 1, 99

;;;;, Apr. 2021, 13, 4, 431

;;;;;;, Jun. 2021, 26, 3, 373

;;;, Oct. 2021, 28, 4, 340

;;;, Oct. 2021, 8, 2, 184

;;;, Oct. 2021, 8, 2, 211

May 2021, 71, 2, 161

;;;, Sep. 2021, 80回, [P14

;;;;;;;;;;;;;;, Oct. 2021, 59回, O17

;;;;;;;;;;;;;;, Oct. 2021, 59回, O62

;;;;;;;;;;;, Oct. 2021, 59回, O65

;;;, Dec. 2021, 109回, AOP07

;;;;;, Dec. 2021, 109回, ISA04

;;;;;;;, Feb. 2022, 55回, 186

;;;;;;;;, Feb. 2022, 55回, 300

;;;;;;;;;, Nov. 2020, 34回, P

;;;, Mar. 2022, 19, 1, 15

;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 226

;;;;;;;, Mar. 2024, 44, 29

;;;;;;;;;;, Feb. 2025, 8, 1, 94

;;;;;;;, Aug. 2024, 74, 3, 233

;;;;;;;, Aug. 2024, 74, 3, 242

;;;;, Apr. 2025, 12, 1, 33

;;;, Apr. 2025, 12, 1, 93

;;;;;;;;;;;;, May 2025, 66, 5, 374

Carbon Ion Radiation Therapy for Nonmetastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis., Miyasaka Yuhei;Kawamura Hidemasa;Sato Hiro;Kubo Nobuteru;Katoh Hiroyuki;Ishikawa Hitoshi;Matsui Hiroshi;Miyazawa Yoshiyuki;Ito Kazuto;Suzuki Kazuhiro;Ohno Tatsuya, Dec. 2023, Advances in radiation oncology, 9, 4

Efficacy of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography for detecting renal cell carcinoma in patients with end-stage renal disease., Hirasawa Hiromi;Taketomi-Takahashi Ayako;Katsumata Natsumi;Higuchi Tetsuya;Sekine Yoshitaka;Suzuki Kazuhiro;Kaneko Yoriaki;Hiromura Keiju;Fukushima Yasuhiro;Tsushima Yoshito, May 2024, Japanese journal of radiology, 42, 10

Japanese clinical practice guidelines for prostate cancer 2023., Kohjimoto Yasuo;Uemura Hiroji;Yoshida Masahiro;Hinotsu Shiro;Takahashi Satoru;Takeuchi Tsutomu;Suzuki Kazuhiro;Shinmoto Hiroshi;Tamada Tsutomu;Inoue Takahiro;Sugimoto Mikio;Takenaka Atsushi;Habuchi Tomonori;Ishikawa Hitoshi;Mizowaki Takashi;Saito Shiro;Miyake Hideaki;Matsubara Nobuaki;Nonomura Norio;Sakai Hideki;Ito Akihiro;Ukimura Osamu;Matsuyama Hideyasu;Hara Isao, Jul. 2024, International journal of urology : official journal of the Japanese Urological Association, 31, 11

Analysis of urinary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospective study., Miyazawa Yoshiyuki;Nakayama Hiroshi;Kawamura Hidemasa;Miyasaka Yuhei;Onishi Masahiro;Kaminuma Takuya;Sekine Yoshitaka;Matsui Hiroshi;Ohno Tatsuya;Suzuki Kazuhiro, Nov. 2024, Radiation oncology (London, England), 19, 1

Afebrile tuberculous prostatic abscess with rectal fistula after intravesical Bacillus Calmette-Guérin immunotherapy., Sawada Tatsuhiro;Igarashi Ayaka;Arai Seiji;Ohtsu Akira;Fujizuka Yuji;Nakazawa Shun;Sekine Yoshitaka;Koike Hidekazu;Furuya Yosuke;Suzuki Kazuhiro, Nov. 2024, IJU case reports, 8, 1

Effect of dasatinib on blood concentrations of sunitinib and adverse events in a patient with metastatic renal cell carcinoma treated with sunitinib: A case report., Sato Miki Takenaka;Yashima Hideaki;Araki Takuya;Nomura Masashi;Suzuki Kazuhiro;Yamamoto Koujirou, Feb. 2025, Experimental and therapeutic medicine, 29, 4

Current Evidence on Cabazitaxel for Prostate Cancer Therapy: A Narrative Review., Suzuki Kazuhiro;Matsuyama Hideyasu;Matsubara Nobuaki;Kazama Hirotaka;Ueno Fumiko;Uemura Hirotsugu, Feb. 2025, International journal of urology : official journal of the Japanese Urological Association, 32, 5

Computer-assisted scatter plot analysis of cell and nuclear areas distinguishes urothelial carcinoma in urine cytology specimens., Hoshino Chinami;Kobayashi Sayaka;Nishijima Yoshimi;Arai Seiji;Suzuki Kazuhiro;Saio Masanao, Feb. 2025, CytoJournal, 22

;;;;, Apr. 2025, 12, 1, 33

;;;, Apr. 2025, 12, 1, 93

;;;;;;;;;;;;, May 2025, 66, 5, 374

Jun. 2025, 40, 1, 36

;;;;;;;;;;, Aug. 2025, 38, 8, 871

FIVE-YEAR CHANGES IN URINARY FUNCTION AND PROSTATE VOLUME IN PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH CARBON ION RADIOTHERAPY: A PROSPECTIVE STUDY, Yoshiyuki Miyazawa; Hiroshi Nakayama; Hidemasa Kawamura; Yuhei Miyasaka; Masahiro Onishi; Takuya Kaminuma; Yoshitaka Sekine; Hiroshi Matsui; Tatsuya Ohno; Kazuhiro Suzuki, May 2025, JOURNAL OF UROLOGY, 213, 5S, Summary international conference

Five-year changes in urinary function and prostate volume in patients with localized prostate cancer treated with carbon ion radiotherapy: A prospective study., Yoshiyuki Miyazawa; Hiroshi Nakayama; Hidemasa Kawamura; Yuhei Miyasaka; Masahiro Onishi; Takuya Kaminuma; Yoshitaka Sekine; Hiroshi Matsui; Tatsuya Ohno; Kazuhiro Suzuki, 10 Feb. 2025, JOURNAL OF CLINICAL ONCOLOGY, 43, 5_SUPPL, Summary international conference

2025, 38th

Safety and efficacy of Carbon-ion radiotherapy for prostate cancer in Gunma University Heavy Ion Medical Center: Comparison of 12 fraction and 16 fraction treatments., 松井博; 松井博; 大西真弘; 宮澤慶行; 藤塚雄司; 新井誠二; 野村昌史; 関根芳岳; 小池秀和; 鈴木和浩; 鈴木和浩; 河村英将; 大野達也, 2025, 泌尿器外科, 38, 8

Examination of Sexual Function Affecting Overall Satisfaction after Robot-assisted Radical Prostatectomy, 小池秀和; 関根芳岳; 宮澤慶行; 澤田達宏; 青木雅典; 大津晃; 藤塚雄司; 新井誠二; 野村昌史; 松井博; 鈴木和浩, 2025, Kitakanto Medical Journal, 75, 1

The usefulness of phi as a diagnostic marker for prostate cancer, 関根芳岳; 藤塚雄司; 宮澤慶行; 新井誠二; 鈴木和浩, 2025, Prostate Journal, 12, 1

2024, 89th (CD-ROM)

2024, 89th (CD-ROM)

2024, 89th (CD-ROM)

Re-evaluation of T Stage in Referred Prostate Cancer Patients through In-Hospital Joint Conferences, 大西真弘; 河村英将; 渋谷圭; 松井博; 関根芳岳; 宮澤慶行; 鈴木和浩; 大野達也, 2024, 泌尿器外科, 37, 8

Clinical results of salvage intensity-modulated radiation therapy after radical prostatectomy, 大西真弘; 大西真弘; 河村英将; 小池秀和; 松井博; 関原哲夫; 羽鳥基明; 大竹伸明; 福間裕二; 長谷川正俊; 鈴木和浩; 大野達也, 2023, 日本泌尿器科学会総会(Web), 110th

Protein translation inhibitor homoharringtonine prevents androgen receptor-positive prostate cancer cell growth, Akira Ohtsu; Seiji Arai; Tatsuhiro Sawada; Kazuhiro Suzuki, Feb. 2022, CANCER SCIENCE, 113, 1731, 1731, Summary international conference

Aug. 2021, 4, 1, 40, 42

Erdafitinib in combination with BCLXL/BCL2 inhibitor induce apoptosis in urothelial carcinoma cells without FGFR mutation., Akira Ohtsu; Seiji Arai; Tatsuhiro Sawada; Kazuhiro Suzuki, Jul. 2021, CANCER RESEARCH, 81, 13, Summary international conference

Mitochondria E3 Ubiquitin Ligase MARCH5 Mediates Stress-Induced and NOXA-Dependent MCL1 Degradation, Seiji Arai; Akira Ohtsu; Tatsuhiro Sawada; Kazuhiro Suzuki, Feb. 2021, CANCER SCIENCE, 112, 329, 329, Summary international conference

MCL1 inhibitor drives prostate cancer cell apoptosis in combination with mitochondria-targeting drugs, Akira Ohtsu; Seiji Arai; Tatsuhiro Sawada; Kazuhiro Suzuki, Feb. 2021, CANCER SCIENCE, 112, 668, 668, Summary international conference

Cardiovascular disease and androgen deprivation therapy for prostate cancer., 鈴木和浩; 周東孝浩; 宮澤慶行; 新井誠二; 関根芳岳, 2021, 月刊泌尿器科, 13, 4

Palliative surgical treatment for Castration Resistant Prostate Cancer patients, 宮澤慶行; 関根芳岳; 新井誠二; 鈴木和浩, 2021, Prostate Journal, 8, 1

2021, 26, 3

Optimal combination/sequence of androgen receptor targeted, chemotherapeutic and molecular targeted agents in patients with castration-resistant prostate cancer., 鈴木和浩; 宮澤慶行; 新井誠二; 関根芳岳, 2021, 月刊腫瘍内科, 28, 4

Predictor of the effect of Enzalutamide on mCRPC patients, 宮澤慶行; 新井誠二; 関根芳岳; 鈴木和浩, 2021, Prostate Journal, 8, 2

Possibility of precision medicine in prostate cancer by using cancer tissue-originated spheroid models: Development of patient-derived xenograft models of prostate cancer, 新井誠二; 新井誠二; BALK Steven; 鈴木和浩, 2020, 泌尿器外科, 33, 8

2020, 74, 4

Predicting the efficacy of a novel androgen receptor axis targeted agents in metastatic castration-resistant prostate cancer, 宮澤慶行; 関根芳岳; 新井誠二; 鈴木和浩, 2020, 日本臨床, 78, 6

Therapeutic strategy for castration-sensitive prostate cancer: Selection of taxanes and AR inhibitors., 宮澤慶行; 関根芳岳; 新井誠二; 鈴木和浩, 2020, 月刊腫瘍内科, 26, 4

Targeting apoptosis pathway as novel therapeutic strategy for prostate cancer, 新井誠二; 大津晃; 澤田達宏; 鈴木和浩; BALK Steven P.; BALK Steven P., 2020, 日本臨床, 78, 6

Update of treatment strategy with new androgen receptor inhibitors for nonmetastatic castration-resistant prostate cancer (M0CRPC): On the basis of the final overall survival results from the phase III clinical trials including ARAMIS study, 鈴木和浩; 上村博司; 鈴木啓悦; 樋之津史郎; 大家基嗣, 2020, 泌尿器外科, 33, 11

CONSIDERATION OF CORRELATION BETWEEN CHANGES IN SERUM ADRENAL ANDROGEN LEVELS AND LOWER URINARY TRACT SYMPTOMS IN PROSTATE CANCER PATIENTS WITH ADMINISTRATION OF GNRH ANTAGONIST, Yoshiyuki Miyazawa; Akira Ohtsu; Daisuke Oka; Tomomi Saito; Hiroshi Nakayama; Sota Kurihara; Takeshi Miyao; Takahiro Syuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2019, JOURNAL OF UROLOGY, 201, 4, E1105, E1105, Summary international conference

2019, 69, 4

HIGH SERUM DEHYDROEPIANDROSTERONE EXAMINED BY ULTRASENSITIVE LIQUID-CHROMATOGRAPHY TANDEM MASS SPECTROMETRY AS A PREDICTOR OF BENIGN PROSTATE OR GLEASON SCORE <= 7 CANCER IN MEN WITH PROSTATE- SPECIFIC ANTIGEN LEVELS BELOW 10 NG/ML, Yasuhide Miyoshi; Hiroji Uemura; Kazuhiro Suzuki; Yasuhiro Shibata; Seijiro Homma; Masaoki Harada; Yoshinobu Kubota; Yutaro Hayashi, Apr. 2017, JOURNAL OF UROLOGY, 197, 4, E341, E341, Summary international conference

EFFICACY OF INDOCYANINE GREEN FLUORESCENCE ANGIOGRAPHY FOR ARTERIAL SPARING DURING MICROSURGICAL SUBINGUINAL VARICOCELECTOMY, Yasuhiro Shibata; Sota Kurihara; Seiji Arai; Takeshi Miyao; Yoshiyuki Miyazawa; Yoshitaka Sekine; Hidekazu Koike; Kazuto Ito; Tetsuya Nakamura; Kazuhiro Suzuki, Apr. 2017, JOURNAL OF UROLOGY, 197, 4, E1202, E1203, Summary international conference

Apr. 2017, 4, 1, 83, 87

Prostate cancer and lipid metabolism, Dec. 2016, 4, 6, 559, 563

EFFECTS OF ANTIANDROGEN AND 5-ALPHA-REDUCTASE INHIBITOR ON PROSTATE TISSUE ANDROGEN CONTENT, Yasuhiro Shibata; Seiji Arai; Takashi Nitta; Yoshiyuki Miyazawa; Haruo Kato; Hidekazu Koike; Kazuto Ito; Kazuhiro Suzuki, Apr. 2016, JOURNAL OF UROLOGY, 195, 4, E598, E598, Summary international conference

Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer., Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Masataka Taguri; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota, Mar. 2016, The Prostate, 76, 4, 376, 82

2016, 3, 1, 53, 60

A CASE OF GROWING TERATOMA SYNDROME., Kyoko Baba; Yoshitaka Sekine; Sota Kurihara; Hidekazu Koike; Hiroshi Matsui; Haruki Nakazato; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki; Masahiro Nishii; Toru Mashimo; Keigo Okamura; Junko Hirato, 2016, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 107, 2, 115, 120

Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan., Kazuhiro Suzuki; Mikio Namiki; Tsukasa Fujimoto; Nobuyoshi Takabayashi; Kentarou Kudou; Hideyuki Akaza, Dec. 2015, Japanese journal of clinical oncology, 45, 12, 1168, 74

01 Nov. 2015, 65, 4, 311, 311

01 Nov. 2015, 65, 4, 313, 314

01 Nov. 2015, 65, 4, 312, 312

01 Nov. 2015, 65, 4, 313, 313

泌尿器疾患におけるBone Management Bone Scan Index(BSI)による骨転移の評価, 鈴木 和浩; 堀越 浩幸; 溝上 敦, Oct. 2015, Prostate Journal, 2, 2, 241, 244

Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Hitoshi Ishikawa; Hiroyuki Katoh; Takuya Kaminuma; Hidemasa Kawamura; Kazuto Ito; Hiroshi Matsui; Junko Hirato; Nobuaki Shimizu; Yutaka Takezawa; Hiroshi Tsuji; Kazuhiro Suzuki; Tatsuya Ohno; Takashi Nakano, Oct. 2015, ANTICANCER RESEARCH, 35, 10, 5559, 5566

Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer, Masahiro Nozawa; Hirofumi Mukai; Shunji Takahashi; Hiroji Uemura; Takeo Kosaka; Yusuke Onozawa; Jun Miyazaki; Kazuhiro Suzuki; Koji Okihara; Yoichi Arai; Tomomi Kamba; Masashi Kato; Yasutomo Nakai; Hiroshi Furuse; Haruki Kume; Hisamitsu Ide; Hiroshi Kitamura; Akira Yokomizo; Takahiro Kimura; Yoshihiko Tomita; Keiji Ohno; Yoshiyuki Kakehi, Oct. 2015, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 5, 1026, 1034

Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association, Hiro-omi Kanayama; Tomoharu Fukumori; Hiroyuki Fujimoto; Hiroyuki Nakanishi; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Tsuneharu Miki; Kazumi Kamoi; Yoshinobu Kubota; Satoru Takahashi; Yukio Homma; Seiji Naito, Sep. 2015, INTERNATIONAL JOURNAL OF UROLOGY, 22, 9, S1, S7

Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Yoshiyuki Miyazawa; Haruo Kato; Seiji Arai; Yosuke Furuya; Yoshitaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 03 Jul. 2015, Basic and Clinical Andrology, 25, 1, 7

Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor., Haruo Kato; Yoshitaka Sekine; Yosuke Furuya; Yoshiyuki Miyazawa; Hidekazu Koike; Kazuhiro Suzuki, 22 May 2015, Biochemical and biophysical research communications, 461, 1, 115, 21

May 2015, 92, 5, 533, 537

01 May 2015, 65, 2, 162, 162

01 May 2015, 65, 2, 159, 159

01 May 2015, 65, 2, 160, 160

EFFICACY OF MICROSURGICAL SUBINGUINAL VARICOCELECTOMY USING INDOCYANINE GREEN FLUORESCENCE ANGIOGRAPHY, Yasuhiro Shibata; Sota Kurihara; Yoshiyuki Miyazawa; Haruo Kato; Hidekazu Koike; Kazuto Ito; Tetsuya Nakamura; Kazuhiro Suzuki, Apr. 2015, JOURNAL OF UROLOGY, 193, 4, E944, E944, Summary international conference

Endocrine therapy for prostate cancer : history and perspective, Apr. 2015, 69, 5, 330, 333

Apr. 2015, 2, 1, 63, 68

DECREASING SURVIVIN BY YM155 REVERSES RAPAMYCIN RESISTANCE IN RENAL CANCER, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Apr. 2015, JOURNAL OF UROLOGY, 193, 4, E458, E458, Summary international conference

血中dihydrotestosteroneレベルはPSA3-10 ng/mLの男性においてGleason score 7-10の前立腺癌を予測する独立した因子である, 三好 康秀; 梅本 晋; 上村 博司; 柴田 康博; 鈴木 和浩; 窪田 吉信; 矢尾 正祐, Apr. 2015, 日本泌尿器科学会総会, 103回, 493, 493

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial., Fred Saad; Karim Fizazi; Viorel Jinga; Eleni Efstathiou; Peter C Fong; Lowell L Hart; Robert Jones; Raymond McDermott; Manfred Wirth; Kazuhiro Suzuki; David B MacLean; Ling Wang; Hideyuki Akaza; Joel Nelson; Howard I Scher; Robert Dreicer; Iain J Webb; Ronald de Wit, Mar. 2015, The Lancet. Oncology, 16, 3, 338, 48

維持血液透析患者に認めた子宮頸管妊娠の1例, 林 拓磨; 宮澤 慶行; 野村 昌史; 関根 芳岳; 岡 大祐; 馬場 恭子; 栗原 聰太; 宮尾 武士; 加藤 春雄; 周東 孝浩; 新田 貴士; 古谷 洋介; 小池 秀和; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩; 北原 慈和; 井上 直樹; 小林 未央; 小松 央憲; 飯塚 円香; 今井 文晴; 中里 智子; 岸 裕司; 峯岸 敬, Feb. 2015, The Kitakanto Medical Journal, 65, 1, 101, 101

01 Feb. 2015, 65, 1, 104, 104

01 Feb. 2015, 65, 1, 102, 102

01 Feb. 2015, 65, 1, 103, 103

A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer., Kazuhiro Suzuki; Seiichiro Ozono; Akito Yamaguchi; Hidekazu Koike; Hiroshi Matsui; Masao Nagata; Takatoshi Takubo; Kana Miyashita; Takafumi Matsushima; Hideyuki Akaza, Feb. 2015, Cancer chemotherapy and pharmacology, 75, 2, 373, 80

2015, 106, 4, 274, 279

Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels., Kohei Okamoto; Yositaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2015, Basic and clinical andrology, 25, 3, 3

2015, 106, 4, 293, 298

2015, 42, 1, 32, 35

2015, 42, 2, 159, 163

Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist., Yoshiyuki Miyazawa; Haruo Kato; Seiji Arai; Yosuke Furuya; Yoshitaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2015, Basic and clinical andrology, 25, 1, 7, 7

Oct. 2014, 1, 2, 231, 236

Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan, Mizuki Onozawa; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Hideyuki Akaza, Oct. 2014, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 10, 969, 981

Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer., Hideyasu Matsuyama; Tomoyuki Shimabukuro; Isao Hara; Yasuo Kohjimoto; Kazuhiro Suzuki; Hidekazu Koike; Hirotsugu Uemura; Taiji Hayashi; Munehisa Ueno; Kiichiro Kodaira; Yoshihiko Tomita; Toshihiko Sakurai; Nobuaki Shimizu, Oct. 2014, International journal of clinical oncology, 19, 5, 946, 54

Suicide attempt with an overdose of sunitinib, Seiji Arai; Hiroshi Matsui; Ryo Ohki; Yoshiyuki Miyazawa; Hidekazu Koike; Tadahiro Hashita; Yoshihiko Katsuyama; Yoshitaka Sekine; Masashi Nomura; Yasuhiro Shibata; Motoaki Hatori; Kazuto Ito; Koujirou Yamamoto; Shigeru Ohmori; Kazuhiro Suzuki, Oct. 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935, Report scientific journal

YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Seiji Arai; Yosuke Furuya; Masashi Nomura; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713

Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan., Mizuki Onozawa; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Hideyuki Akaza, Oct. 2014, Japanese journal of clinical oncology, 44, 10, 969, 81

High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients., Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Satoshi Morita; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota, 26 Sep. 2014, BMC cancer, 14, 717, 717

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Tamotsu Ishizuka; Takeshi Hisada; Motoaki Hatori; Akio Koike; Kikuo Hanabuchi; Shinichi Matsuzaki; Yosuke Kamide; Mitsuyoshi Utsugi; Haruka Aoki; Reiko Yoshino; Noriko Yanagitani; Yasuhiko Koga; Akihiro Ono; Kyoichi Kaira; Noriaki Sunaga; Kunio Dobashi; Takahiro Tsuburai; Kazuo Akiyama; Masanobu Yamada; Kazuhiro Suzuki; Masatomo Mori, Sep. 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796

Aug. 2014, 64, 3, 260, 260

01 Aug. 2014, 64, 3, 261, 262

01 Aug. 2014, 64, 3, 260, 261

01 Aug. 2014, 64, 3, 259, 259

01 Aug. 2014, 64, 3, 259, 259

01 Aug. 2014, 64, 3, 260, 260

Development of prostate cancer in a patient with primary hypogonadism :intratumoural steroidogenesis in prostate cancer tissue, 新井 誠二; 柴田 康博; 関根 芳岳; 伊藤 一人; 鈴木 和浩; 中村 保宏; 笹野 公伸; 柏木 文蔵; 上井 崇智; 都丸 行雄; 宮代 好通; 本間 誠次郎; 橋本 貢士, 01 Aug. 2014, The Kitakanto medical journal = 北関東医学, 64, 3, 262, 262

Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Tsuneharu Miki; Kazumi Kamoi; Hiroyuki Fujimoto; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Kazuya Mikami; Yukio Homma, Aug. 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 8, S1, S6

Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort., Teruo Inamoto; Haruhito Azuma; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Suzuki Kazuhiro; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Michiyuki Usami; Masaru Murai; Hideyuki Akaza, Jul. 2014, Journal of cancer research and clinical oncology, 140, 7, 1197, 204

Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort, Teruo Inamoto; Haruhito Azuma; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Suzuki Kazuhiro; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Michiyuki Usami; Masaru Murai; Hideyuki Akaza, Jul. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 7, 1197, 1204

Jun. 2014, 49, 3, 1434, 1434

原発性性腺機能低下症患者に発生した前立腺癌 前立腺癌組織内アンドロゲン合成に関する検討, 新井 誠二; 柴田 康博; 中村 保宏; 柏木 文蔵; 上井 崇智; 登丸 行雄; 宮代 好通; 本間 誠次郎; 橋本 貢士; 関根 芳岳; 伊藤 一人; 笹野 公伸; 鈴木 和浩, May 2014, 泌尿器外科, 27, 臨増, 765, 765

Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Tomohiro Magari; Yasuhiro Shibata; Seiji Arai; Bunzo Kashiwagi; Keiji Suzuki; Kazuhiro Suzuki, May 2014, ASIAN JOURNAL OF ANDROLOGY, 16, 3, 457, 460

Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Hiroyuki Fujimoto; Hiroyuki Nakanishi; Tsuneharu Miki; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Yukio Homma; Kazumi Kamoi, May 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 5, 527, 534

Apr. 2014, 1, 1, 63, 68

Apr. 2014, 102回, 478, 478

Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer, Hirofumi Mukai; Shunji Takahashi; Masahiro Nozawa; Yusuke Onozawa; Jun Miyazaki; Keiji Ohno; Kazuhiro Suzuki, Apr. 2014, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 4, 703, 710

Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer., Hirofumi Mukai; Shunji Takahashi; Masahiro Nozawa; Yusuke Onozawa; Jun Miyazaki; Keiji Ohno; Kazuhiro Suzuki, Apr. 2014, Cancer chemotherapy and pharmacology, 73, 4, 703, 10

01 Feb. 2014, 64, 1, 72, 72

01 Feb. 2014, 64, 1, 71, 72

01 Feb. 2014, 64, 1, 71, 71

Phase I clinical study of cabazitaxel plus prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in a Japanese population., Shunji Takahashi; Hirofumi Mukai; Hirotsugu Uemura; Hiroji Uemura; Takeo Kosaka; Hiroyuki Nishiyama; Kazuhiro Suzuki; Yoshiyuki Kakehi; Koji Okihara; Shunichi Namiki; Osamu Ogawa; Masashi Kato; Yasutomo Nakai; Keiji Ohno, Feb. 2014, JOURNAL OF CLINICAL ONCOLOGY, 32, 4, Summary international conference

スニチニブ大量内服による自殺企図を来した腎癌症例における薬物動態の検討, 新井誠二; 松井博; 大木亮; 小池秀和; 柴田康博; 伊藤一人; 鈴木和浩; 坡下真大; 山本康次郎; 勝山善彦; 大森栄, 01 Feb. 2014, Kitakanto Medical Journal, 64, 1, 71

2014, 102nd

Chronic expanding hematoma in the retroperitoneal space: A case report, Takahiro Syuto; Motoaki Hatori; Nomura Masashi; Yoshitaka Sekine; Kazuhiro Suzuki, 18 Nov. 2013, BMC Urology, 13, 60

01 Nov. 2013, 63, 4, 390, 390

01 Nov. 2013, 63, 4, 390, 390

01 Nov. 2013, 63, 4, 391, 391

01 Nov. 2013, 63, 4, 390, 390

01 Nov. 2013, 63, 4, 389, 389

Oct. 2013, 75, 増刊, 119, 119

High-density lipoprotein and prostate cancer: an overview., Kazuhiko Kotani; Yoshitaka Sekine; Shizukiyo Ishikawa; Imoh Z Ikpot; Kazuhiro Suzuki; Alan T Remaley, 05 Sep. 2013, Journal of epidemiology, 23, 5, 313, 9

Sep. 2013, 48, 3, 1477, 1477

Sep. 2013, 48, 3, 1498, 1498

01 Aug. 2013, 63, 3, 291, 291

01 Aug. 2013, 63, 3, 289, 289

01 Aug. 2013, 63, 3, 290, 291

01 Aug. 2013, 63, 3, 289, 289

01 Aug. 2013, 63, 3, 290, 290

01 Aug. 2013, 63, 3, 292, 292

前立腺癌患者の初回内分泌療法と診断時年齢の関係, 稲元輝生; 東治人; 樋之津史郎; 塚本泰司; 大家基嗣; 小川修; 北村唯一; 鈴木和浩; 内藤誠二; 並木幹夫; 西村和郎; 平尾佳彦; 宇佐美道之; 村井勝; 赤座英之, 15 Jun. 2013, 泌尿器外科, 26, 6, 960, 963

Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., Tomohiro Magari; Yasuhiro Shibata; Seiji Arai; Bunzo Kashiwagi; Kazuhiro Suzuki, Jun. 2013, Scandinavian journal of urology, 47, 3, 236, 41

01 May 2013, 26, 5, 809, 823

Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy, Y. Shibata; K. Suzuki; S. Arai; Y. Miyoshi; S. Umemoto; N. Masumori; N. Kamiya; T. Ichikawa; Y. Kitagawa; A. Mizokami; Y. Sugimura; N. Nonomura; H. Sakai; S. Honma; Y. Kubota, May 2013, ANDROLOGY, 1, 3, 505, 511

Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range., Kazuto Ito; Mai Miyakubo; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2013, World journal of urology, 31, 2, 305, 11

Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Kazuto Ito; Mai Miyakubo; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2013, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311

Lower urinary tract symptoms of neurological origin in urological practice, Tomohiro Magari; Yoshitatsu Fukabori; Haruyuki Ogura; Kazuhiro Suzuki, Apr. 2013, Clinical Autonomic Research, 23, 2, 67, 72

01 Feb. 2013, 63, 1, 66, 66

2013, 12, 5, 515, 521

Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancer., Kazumichi Muramatsu; Hiroshi Matsui; Yoshitaka Sekine; Hidekazu Koike; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2013, Prostate international, 1, 1, 10, 5

High-density lipoprotein and prostate cancer: An overview, Kazuhiko Kotani; Yoshitaka Sekine; Shizukiyo Ishikawa; Imoh Z. Ikpot; Kazuhiro Suzuki; Alan T. Remaley, 2013, Journal of Epidemiology, 23, 5, 313, 319

2013, 1, 2, 76, 80

2013, 1, 3, 113, 116

Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation, Tomohiro Magari; Yasuhiro Shibata; Sew Arai; Bunzo Kashiwagi; Kazuhiro Suzuki, 2013, SCANDINAVIAN JOURNAL OF UROLOGY, 47, 3, 236, 241

Androgen receptor coactivator p120 subtype beta is highly expressed in prostate cancer, Muramatasu, Kazumichi; Matsui, Hiroshi; Sekine, Yoshitaka; Koike, Hidekazu; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013, Prostate International, 1, 1, 10-15.

Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues, S. Arai; Y. Shibata; Y. Nakamura; B. Kashiwagi; T. Uei; Y. Tomaru; Y. Miyashiro; S. Honma; K. Hashimoto; Y. Sekine; K. Ito; H. Sasano; K. Suzuki, Jan. 2013, ANDROLOGY, 1, 1, 169, 174

Simple method for preventing inguinal hernias after radical retropubic prostatectomy., Hidekazu Koike; Hiroshi Matsui; Yasuyuki Morikawa; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2013, Prostate international, 1, 2, 76, 80

Chlormadinone acetate is effective for hot flush during androgen deprivation therapy., Hidekazu Koike; Yasuyuki Morikawa; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2013, Prostate international, 1, 3, 113, 6

Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Y. Fukuma; H. Matsui; H. Koike; Y. Sekine; I. Shechter; N. Ohtake; S. Nakata; K. Ito; K. Suzuki, Dec. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 4, 339, 345

01 Nov. 2012, 62, 4, 434, 434

Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Masahiro Nishii; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, Nov. 2012, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238

Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme, M. Nomura; K. Ito; M. Miyakubo; Y. Sekine; Y. Tamura; N. Shimizu; S. Aoki; K. Suzuki, Jun. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 2, 202, 209

01 May 2012, 62, 2, 234, 235

SOME TECHNIQUES TO ACHIEVE HIGH ENUCLEATION EFFICIENCY WHEN PERFORMING HOLMIUM LASER ENUCLEATION OF THE PROSTATE, Yasuhiro Shibata; Yosuke Furuya; Seiji Arai; Hidekazu Koike; Kazuto Ito; Kazuhiro Suzuki, Apr. 2012, JOURNAL OF UROLOGY, 187, 4, E633, E634, Summary international conference

HIGH-FAT DIET INCREASES RENAL CANCER GROWTH ACCOMPANIED BY LEPTIN INCREASE, AND SURVIVIN INHIBITION IS EFFECTIVE FOR SIMVASTATIN RESISTANT RENAL CANCER, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Yosuke Furuya; Yasuyuki Morikawa; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2012, JOURNAL OF UROLOGY, 187, 4, E59, E60, Summary international conference

ANDROGEN PRODUCTION IN PERIPROSTATIC ADIPOSE TISSUE IN PROSTATE CANCER PATIENTS, Seiji Arai; Yasuhiro Shibata; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Seijiro Honma; Kazuhiro Suzuki, Apr. 2012, JOURNAL OF UROLOGY, 187, 4, E389, E390, Summary international conference

Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Yasuyuki Morikawa; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 16 Mar. 2012, Biochemical and Biophysical Research Communications, 419, 3, 584, 589

Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation., Yasuyuki Morikawa; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 16 Mar. 2012, Biochemical and biophysical research communications, 419, 3, 584, 9

Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy, S. Miyamoto; K. Ito; M. Miyakubo; R. Suzuki; T. Yamamoto; K. Suzuki; K. Suzuki; H. Yamanaka, Mar. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 1, 75, 86

01 Feb. 2012, 62, 1, 79, 79

01 Feb. 2012, 62, 1, 81, 81

01 Feb. 2012, 62, 1, 80, 80

Hormonal therapy for localized prostate cancer in Japan: The outcome of J-CaP database, Shiro Hinotsu; Hideyuki Akaza; Osamu Ogawa; Mototsugu Oya; Tadaichi Kitamura; Kazuhiro Suzuki; Taiji Tsukamoto; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao, Feb. 2012, JOURNAL OF CLINICAL ONCOLOGY, 30, 5, Summary international conference

Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate, Masahiko Okamoto; Hitoshi Ishikawa; Takeshi Ebara; Hiroyuki Kato; Tomoaki Tamaki; Tetsuo Akimoto; Kazuto Ito; Mai Miyakubo; Takumi Yamamoto; Kazuhiro Suzuki; Takeo Takahashi; Takashi Nakano, 01 Feb. 2012, International Journal of Radiation Oncology Biology Physics, 82, 2, e211, e217

Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate., Masahiko Okamoto; Hitoshi Ishikawa; Takeshi Ebara; Hiroyuki Kato; Tomoaki Tamaki; Tetsuo Akimoto; Kazuto Ito; Mai Miyakubo; Takumi Yamamoto; Kazuhiro Suzuki; Takeo Takahashi; Takashi Nakano, 01 Feb. 2012, International journal of radiation oncology, biology, physics, 82, 2, e211-7, e217

2012

2012

2012

2012

2012

2012

Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., 2012

Serous borderline tumor of the paratestis in a child., 2012, BJUI.org

Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related induces in men with total PSA in the 2.0-10.0ng/ml range., 2012, World J Urol

01 Nov. 2011, 61, 4, 554, 555

01 Nov. 2011, 61, 4, 553, 553

01 Nov. 2011, 61, 4, 553, 554

HDL and Sphingosine-I-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and SIP Receptors, and Promote Cell Migration and Invasion (vol 71, pg 690, 2011), Yoshitaka Sekine; Kazuhiro Suzuki; Alan T. Remaley, Sep. 2011, PROSTATE, 71, 13, 1480, 1480, Others

May 2011, 24, 5, 851, 869

01 May 2011, 61, 2, 239, 239

01 May 2011, 61, 2, 239, 240

PREDICTION OF FUTURE CASTRATION RESISTANT PROSTATE CANCER BY PRE-TREATMENT PROSTATE TISSUE ANDROGEN CONTENT, Yasuhiro Shibata; Seiji Arai; Kazuhiro Suzuki; Seijiro Honma; Yasuhide Miyoshi; Yoshinobu Kubota; Taiji Tsukamoto; Tomohiko Ichikawa; Mikio Namiki; Yoshiki Sugimura; Akihiko Okuyama; Hiroshi Kanetake, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, E918, E919, Summary international conference

HIGH-FAT DIET INCREASED RENAL CANCER GROWTH, AND THE ANTITUMOR SENSITIZATION EFFECT DUE TO SURVIVIN INHIBITION IN SIMVASTATIN TREATMENT FOR RENAL CANCER CELLS, Hidekazu Koike; Yoshitaka Sekine; Takashi Nitta; Yosuke Furuya; Yasuyuki Morikawa; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, E96, E96, Summary international conference

EXPRESSION OF GENES ENCODING ENZYMES INVOLVED IN ANDROGEN SYNTHESIS IN HUMAN ADIPOSE TISSUE POSSIBILITY OF ADIPOSE TISSUE AS THE THIRD ORGAN PRODUCING ACTIVE ANDROGEN IN PROSTATE CANCER PATIENTS-, Seiji Arai; Yasuhiro Shibata; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Seijiro Honma; Kazuhiro Suzuki, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, E58, E58, Summary international conference

Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D-3 Induced Cell Growth Inhibition in Prostate Cancer, Hidekazu Koike; Yasuyuki Morikawa; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, 1497, 1503

HIGH FAT DIET REDUCES THE EXPRESSION OF GLUTATHIONE PEROXIDASE 3 IN MOUSE PROSTATE, Yoshitaka Sekine; Yosuke Furuya; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki; Alan Remaley, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, E293, E294, Summary international conference

Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., Hidekazu Koike; Yasuyuki Morikawa; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2011, The Journal of urology, 185, 4, 1497, 503

Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Yukio Tomaru; Mikio Kobayashi; Seijiro Honma; Kazuhiro Suzuki, Feb. 2011, Steroids, 76, 3, 301, 8

Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues, Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Yukio Tomaru; Mikio Kobayashi; Seijiro Honma; Kazuhiro Suzuki, Feb. 2011, STEROIDS, 76, 3, 301, 308

15 Jan. 2011, 4525, 69, 72

2011

2011

2011

2011

2011

2011

2011

2011

01 Nov. 2010, 60, 4, 388, 388

01 Nov. 2010, 60, 4, 388, 389

01 Nov. 2010, 60, 4, 389, 389

Nov. 2010, 101, S59, 70

Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010, Seiji Naito; Yoshiyuki Kakehi; Akihiko Okuyama; Tomoaki Imamura; Hideo Yasunaga; Hideyuki Akaza; Shiro Hinotsu; Yoichi Arai; Takushi Dokiya; Shin Egawa; Kazuhiro Suzuki; Hirofumi Koga; Naoya Masumori; Koichiro Akakura; Kiyotaka Kawashima; Koji Okihara; Kazuto Ito, Oct. 2010, INTERNATIONAL JOURNAL OF UROLOGY, 17, 10, 830, 838

Association of SNP rs1447295 and Microsatellite Marker DG8S737 With Familial Prostate Cancer and High Grade Disease, Tatsuya Hamano; Hiroshi Matsui; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Aug. 2010, JOURNAL OF UROLOGY, 184, 2, 738, 742

Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease., Tatsuya Hamano; Hiroshi Matsui; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Aug. 2010, The Journal of urology, 184, 2, 738, 42

DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION, Yasuhiro Shibata; Seiji Arai; Bunzo Kashiwagi; Kazuto Ito; Seijiro Honma; Kazuhiro Suzuki, Apr. 2010, JOURNAL OF UROLOGY, 183, 4, E542, E543, Summary international conference

NOVEL CANDIDATE GENE FOR PROSTATE CANCER (PC) SUSCEPTIBILITY, FARNECYL-DIPHOSPHATE FARNECYLTRANSFERASE 1 (FDFT1): ASSOCIATIONS OF FDFT1 GENE VARIANTS WITH PC RISK, AND FDFT1 PROTEIN FUNCTION EVALUATION IN PC CELLS, Hiroshi Matsui; Yuji Fukuma; Tatsuya Hamano; Hidekazu Koike; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Apr. 2010, JOURNAL OF UROLOGY, 183, 4, E267, E267, Summary international conference

HIGH DENSITY LIPOPROTEIN INDUCES PROLIFERATION AND MIGRATION OF HUMAN PROSTATE ANDROGEN INDEPENDENT CANCER CELLS VIA ATP-BINDING CASSETTE TRANSPORTER A1 BY A CHOLESTEROL-INDEPENDENT MECHANISM, Yoshitaka Sekine; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan Remaley, Apr. 2010, JOURNAL OF UROLOGY, 183, 4, E42, E43, Summary international conference

STATIN INHIBITS THE PROLIFERATION OF HUMAN RENAL CANCER CELLS VIA DOWN-REGULATION OF THE SURVIVIN THROUGH IGF-1 SIGNALING, Hidekazu Koike; Yasuyuki Morikawa; Takashi Nitta; Yosuke Furuya; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, Apr. 2010, JOURNAL OF UROLOGY, 183, 4, E32, E32, Summary international conference

The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha 1-adrenergic receptor antagonist work well for ureteral stones?, Kazunari Ohki; Yosihiro Ohno; Kazuhiro Suzuki, Mar. 2010, INTERNATIONAL UROLOGY AND NEPHROLOGY, 42, 1, 113, 117

20 Feb. 2010, 101, 2, 275, 275

01 Feb. 2010, 60, 1, 78, 78

01 Feb. 2010, 60, 1, 77, 77

01 Feb. 2010, 60, 1, 75, 75

01 Feb. 2010, 60, 1, 76, 76

Feb. 2010, 101, 2, 305, 305

2010, 23, 8, 1057, 1059

2010

2010

2010

2010

2010

THE INFLUENCE OF CASTRATION ON BLADDER BLOOD FLOW AND FUNCTION DURING RAPID PHASE OF ANDROGEN DEPRIVATION, T. Magari; Y. Shibata; S. Arai; B. Kashiwagi; K. Suzuki, 2010, NEUROUROLOGY AND URODYNAMICS, 29, 6, 912, 914, Summary international conference

2010, 23, 5, 719

New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry, Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Bunzo Kashiwagi; Yukio Tomaru; Mikio Kobayashi; Yoko Watanabe; Seijiro Honma; Kazuhiro Suzuki, Jan. 2010, STEROIDS, 75, 1, 13, 19

The investigation of ureteral sympathetic innevation, using semi-serial sections: why dose the alpha1-adrenergic receptor antagonist work well for ureteral stones?, 2010, Int Urol Nephrol

New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry., Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Bunzo Kashiwagi; Yukio Tomaru; Mikio Kobayashi; Yoko Watanabe; Seijiro Honma; Kazuhiro Suzuki, Jan. 2010, Steroids, 75, 1, 13, 9

Development of an enzyme-linked immunosorbent assay for metallothionein-I and -II in plasma of humans and experimental animals, Katsuyuki Nakajima; Tsukasa Kodaira; Mihoko Kato; Kyoumi Nakazato; Yoshiharu Tokita; Hiroki Kikuchi; Hiromi Sekine; Keiji Suzuki; Takeaki Nagamine, 2010, Clinica Chimica Acta, 411, 9-10, 758, 761

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells., Rizky Abdulah; Ahmad Faried; Kenji Kobayashi; Chiho Yamazaki; Eka W Suradji; Kazuto Ito; Kazuhiro Suzuki; Masami Murakami; Hiroyuki Kuwano; Hiroshi Koyama, 30 Nov. 2009, BMC cancer, 9, Nov30, 414, 414

01 Nov. 2009, 59, 4, 369, 369

01 Nov. 2009, 59, 4, 367, 367

01 Nov. 2009, 59, 4, 369, 369

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells, Rizky Abdulah; Ahmad Faried; Kenji Kobayashi; Chiho Yamazaki; Eka W. Suradji; Kazuto Ito; Kazuhiro Suzuki; Masami Murakami; Hiroyuki Kuwano; Hiroshi Koyama, Nov. 2009, BMC CANCER, 9, Nov30, 414

下大静脈腫瘍血栓を伴う腎細胞癌症例の臨床的検討, 廣野 正法; 鈴木 和浩; 伊藤 一人; 小林 幹男; 篠原 信雄; 公文 裕巳; 早川 正道; 内藤 誠二; 大園 誠一郎; 福井 巌; 金武 洋; 近藤 幸尋, Sep. 2009, 日本癌治療学会誌, 44, 2, 540, 540

01 Aug. 2009, 59, 3, 307, 307

Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Keigo Okamura; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, Aug. 2009, Cancer Epidemiology, 33, 2, 137, 141

Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor., Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Sadao Takahashi; Kazuhiro Suzuki, Jul. 2009, Cancer epidemiology, 33, 1, 16, 23

Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor, Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Sadao Takahashi; Kazuhiro Suzuki, Jul. 2009, CANCER EPIDEMIOLOGY, 33, 1, 16, 23

Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy., Mai Miyakubo; Kazuto Ito; Takumi Yamamoto; Hiroyuki Takechi; Masaru Ohi; Kazuhiro Suzuki, Jun. 2009, International journal of urology : official journal of the Japanese Urological Association, 16, 6, 561, 5

Induction of type 1 interferon receptor by zinc in U937 cells, Takeaki Nagamine; Kastuyuki Nakajima; Hisashi Takada; Yoshitaka Sekine; Kazuhiro Suzuki, Jun. 2009, CYTOKINE, 46, 3, 346, 350

Proprostate-specific antigen: Its usefulness in the era of multiple-core prostate biopsy, Mai Miyakubo; Kazuto Ito; Takumi Yamamoto; Hiroyuki Takechi; Masaru Ohi; Kazuhiro Suzuki, Jun. 2009, INTERNATIONAL JOURNAL OF UROLOGY, 16, 6, 561, 565

01 May 2009, 59, 2, 213, 213

01 May 2009, 59, 2, 214, 214

01 May 2009, 59, 2, 214, 215

DETERMINATION OF ANDROGENS CONCENTRATIONS IN PROSTATE TISSUE TAKEN BY NEEDLE BIOPSY BY LC/MS/MS PRELIMINARY STUDY FOR DIAGNOSIS OF MALIGNANCY FROM ANDROGEN LEVEL IN PROSTATE TISSUE, Yasuhide Miyoshi; Susumu Umemoto; Hiroji Uemura; Yasuhiro Shibata; Seiji Arai; Kazuhiro Suzuki; Seiji Honma; Yoshinobu Kubota, Apr. 2009, JOURNAL OF UROLOGY, 181, 4, 658, 658, Summary international conference

AGE-RELATED CHANGES OF ADRENAL ANDROGEN AND ESTROGEN LEVELS IN THE PROSTATIC TISSUE WITH BENIGN PROSTATIC HYPERPLASIA, Seiji Arai; Yasuhiro Shibata; Yoshimichi Miyashiro; Bunzo Kashiwagi; Yukio Tornaru; Mikio Kobayashi; Seijiro Honma; Kazuhiro Suzuki, Apr. 2009, JOURNAL OF UROLOGY, 181, 4, 504, 504, Summary international conference

SURVIVIN IS ASSOCIATED WITH CELL PROLIFERATION AND PLAYS A ROLE IN 1A,25-DIHYDROXYVITAMIN D-3 INDUCED CELL GROWTH INHIBITION IN PROSTATE CANCER, Hidekazu Koike; Yoshitaka Sekine; Yasuyuki Morikawa; Seiji Arai; Yosuke Huruya; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2009, JOURNAL OF UROLOGY, 181, 4, 52, 53, Summary international conference

FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE 1 IS ASSOCIATED WITH THE GROWTH OF RENAL CANCER: ASSOCIATION WITH ANTICANCER EFFECT OF STATIN, Hidekazu Koike; Yoshitaka Sekine; Yasuyuki Morikawa; Yosuke Furuya; Hiroshi Matsui; Kazuhiro Suzuki, Apr. 2009, JOURNAL OF UROLOGY, 181, 4, 154, 154, Summary international conference

USEFULNESS OF REAL-TIME TRANSRECTAL ULTRASOUND NAVIGATION DURING HOLMIUM LASER ENUCLEATION OF THE PROSTATE, Yasuhiro Shibata; Seiji Arai; Hidekazu Koike; Motoaki Hatori; Kazuto Ito; Kazuhiro Suzuki, Apr. 2009, JOURNAL OF UROLOGY, 181, 4, 764, 764, Summary international conference

01 Feb. 2009, 59, 1, 90, 90

01 Feb. 2009, 59, 1, 75, 75

01 Feb. 2009, 59, 1, 89, 89

01 Feb. 2009, 59, 1, 88, 88

01 Feb. 2009, 59, 1, 88, 88

Examination of Laparoscopic Nephrectomy for Renal Cancer in Elderly Patients, Nomura Masashi; Koike Hidekazu; Matsui Hiroshi; Shibata Yasuhiro; Hatori Motoaki; Ito Kazuto; Kobayashi Mikio; Suzuki Kazuhiro, 2009, The KITAKANTO Medical Journal, 59, 4, 333, 336

2009, 81, 2, 200

Epidemiology of prostate cancer and benign prostatic hyperplasia, SUZUKI K, 2009, JMAJ, 52, 6, 478, 483

2009, 138, 2, 251

2009, 7, 2, 10, 16

2009, 58, 11, 2351, 352

2009, 16, 11, 1064

Epidemiology of prostate cancer and benign prostatic hyperplasia, Kazuhiro Suzuki, 2009, JMAJ, 52, 6, 478

Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer., Okamura K; Koike H; Sekine Y; Matsui H; Suzuki K, 2009, Cancer Epidemiolo, 33, 2, 137, 141

Gene Expression of Survivin and Its Spliced Isoforms Associated With Proliferation and Aggressive Phenotypes of Prostate Cancer, Hidekazu Koike; Yoshitaka Sekine; Makoto Kamiya; Haruki Nakazato; Kazuhiro Suzuki, Dec. 2008, UROLOGY, 72, 6, 1229, 1233

Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer., Hidekazu Koike; Yoshitaka Sekine; Makoto Kamiya; Haruki Nakazato; Kazuhiro Suzuki, Dec. 2008, Urology, 72, 6, 1229, 33

Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population, Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki, Dec. 2008, INTERNATIONAL UROLOGY AND NEPHROLOGY, 40, 4, 947, 951

01 Nov. 2008, 58, 4, 422, 422

01 Nov. 2008, 58, 4, 420, 421

01 Nov. 2008, 58, 4, 421, 421

Prostate-Specific Antigen Kinetics in Screen-Detected Prostate Cancer in Japan, Hiroyuki Takechi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Masaru Ohi; Kazuhiro Suzuki, Nov. 2008, UROLOGY, 72, 5, 1111, 1115

Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan., Hiroyuki Takechi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Masaru Ohi; Kazuhiro Suzuki, Nov. 2008, Urology, 72, 5, 1111, 5

Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds, Takumi Yamamoto; Kazuto Ito; Mal Miyakubo; Hiroyuki Takechi; Kazuhiro Suzuki; Tetsuo Akimoto; Hitoshi Ishikawa; Takashi Nakano, Oct. 2008, UROLOGY, 72, 4, 892, 897

Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds., Takumi Yamamoto; Kazuto Ito; Mai Miyakubo; Hiroyuki Takechi; Kazuhiro Suzuki; Tetsuo Akimoto; Hitoshi Ishikawa; Takashi Nakano, Oct. 2008, Urology, 72, 4, 892, 7

Japanese urological association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan, Kazuto Ito; Yoshiyuki Kakehi; Seiji Naito; Akihiko Okuyama; Tomoaki Imamura; Hideo Yasunaga; Hideyuki Akaza; Shiro Hinotsu; Yoichi Arai; Takushi Dokiya; Shin Egawa; Kazuhiro Suzuki; Hirofumi Koga; Naoya Masumori; Koichiro Akakura; Kiyotaka Kawashima; Koji Okihara, Sep. 2008, International Journal of Urology, 15, 9, 763, 768, Book review

Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Yoshitaka Sekine; Yosuke Furuya; Masahiro Nishii; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, 25 Jul. 2008, Biochemical and biophysical research communications, 372, 2, 356, 61

Changes in baseline PSA levels in Japanese men from 1988 to 2003, Masaru Ohi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Hiroyuki Takechi; Yutaka Kubota; Kazuhiro Suzuki, Jul. 2008, UROLOGY, 72, 1, 95, 98

Changes in baseline PSA levels in Japanese men from 1988 to 2003., Masaru Ohi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Hiroyuki Takechi; Yutaka Kubota; Kazuhiro Suzuki, Jul. 2008, Urology, 72, 1, 95, 8

01 May 2008, 58, 2, 264, 264

01 May 2008, 58, 2, 264, 264

01 May 2008, 58, 2, 265, 265

01 May 2008, 58, 2, 266, 266

01 May 2008, 58, 2, 265, 265

Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues, Seiji Arai; Yasuhiro Shibata; Bunzo Kashiwagi; Yukio Tomaru; Mikio Kobayashi; Yoshimichi Miyashiro; Seijiro Honma; Kazuhiro Suzuki, Apr. 2008, JOURNAL OF UROLOGY, 179, 4, 191, 191, Summary international conference

Survivin and its spliced isoforms gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Hidekazu Koike; Keigo Okamura; Yoshitaka Sekine; Kazuhiro Suzuki, Apr. 2008, JOURNAL OF UROLOGY, 179, 4, 211, 211, Summary international conference

Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Tatsuya Hamano; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Mar. 2008, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26

01 Feb. 2008, 58, 1, 98, 98

01 Feb. 2008, 58, 1, 99, 99

01 Feb. 2008, 58, 1, 100, 100

Editorial comment, Kazuhiro Suzuki, Feb. 2008, International Journal of Urology, 15, 2, 161, Report scientific journal

2008, 21, 8, 1123, 1126

2008, 21, 12, 1585

Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population., Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki, 2008, International urology and nephrology, 40, 4, 947, 51